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INTRODUCTION 
Myocardial infarction is defined as myocardial necrosis due ischemia caused by coronary artery 
disease because of  atherosclerotic plaque or due to spasm to the  coronary arteries (1). 
Prognosis of myocardial infarction depends on patient’s age, co-morbidities (diabetes and 
hypertension), and extent of ischemic myocardium and severity of left ventricular dysfunction. 
(2). Left ventricular dysfunction after infarction can be improved by intervention, depending on 
the amount of residual viable tissue (3). 
Myocardial viability  
Hibernating and stunned myocardium represent viable myocardium, with contractile 
dysfunction. 
Hibernating myocardium: Chronic impaired coronary blood flow at rest causes decreased 
myocardial contraction, which can potentially recover with revascularization (4). 
Stunned myocardium: Myocardium that shows depressed cardiac contraction due to repeated 
episodes of ischemia with stress but, has normal blood flow at rest. Myocardial contractile 
dysfunction is reversible with time in stunned myocardium (4).  
Revascularization results in significant improvement in contraction in the viable myocardial 
segments of the heart. However, careful patient selection is needed  due to the high mortality 
and  morbidity  associated with revascularization procedures (4). If there is significant residual 
viable myocardium in an arterial territory, then it is amenable for revascularization. However, if 
most of the arterial territory is infracted, then there is less chance of functional recovery and 
revascularization procedures are not advised. 
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ECG, ECHO, stress SPECT, cardiac MRI, CT Coronary angiography and conventional coronary 
angiography are some of the investigations used in assessment of viability of myocardium. 
ECG  
Electrocardiogram (ECG) is a primary diagnostic test for myocardial infarction. ST – segment, 
T wave and QRS complex show changes in myocardial infarction. ST segment elevation or 
depression, pathological Q waves will generally indicate myocardial infarction and the leads in 
which these changes are seen would indicate the segments that are involved. Exercise induced 
ST elevation and reciprocal ST depression indicates residual tissue viability. 
Echocardiography 
 In myocardial infarction, ECHO is used to look at regional wall motion abnormalities, 
assessment of the left ventricular function and complications. Dysfunctional but viable 
myocardium has preserved contractile reserve which can be evoked by appropriate stimulus like 
low dose Dobutamine infusion where viable myocardium shows improvement in LV ejection 
fraction depending on the number of segments of involvement.  
Cardiac MRI 
Cardiac MR imaging has now surpassed most other modalities in cardiac morphological, 
functional assessment and tissue characterization. Viable myocardium usually shows normal 
contractility and does not show any late gadolinium enhancement. Viability is assessed by 
systolic wall thickening and end diastolic wall thickness by cine MRI. End diastolic left 
ventricular wall thickness > 5.5 mm generally indicates viable myocardium. On late gadolinium 
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enhancement (LGE) images, infarcted tissues show enhancement whereas normal tissues show 
washout of the Gadolinium. Good recovery of LV function after revascularization is seen if the 
LGE in a myocardial segment is <25% of its thickness. Segments with 26 -50 % transmural 
LGE show intermediate recovery and segments with > 50% transmural enhancement generally 
do not show significant functional improvement with revascularization. 
Late gadolinium enhancement helps in better tissue characterization and the pattern of 
enhancement can also be used to differentiate ischemic and non-ischemic cardiomyopathies. In 
infarction, the enhancement starts in the sub-endocardial region and proceeds towards the 
epicardium with increasing degree of infarction. In contrast, in non-ischemic cardiomyopathies, 
the enhancement is usually mid-myocardial or epicardial in location. These cardiac MR imaging 
sequences are qualitative (visual) and comparisons of relative signals (semi quantitative in 
evaluation). So, there could be errors in disease assessment, especially if there is diffuse 
involvement. 
Adenosine stress cardiac MRI can be done to look for inducible ischemia. Dobutamine infusion 
Cine MRI assesses the contractile reserve, which can predict response to coronary 
revascularization. This is superior to Dobutamine echocardiography. 
Cardiac single photon emission computed tomography (SPET) 
Technetium 99m sestamibi and Technitium 99m tetrofosmin are the common radiotracers used. 
Myocardial perfusion imaging is done at rest and after stress and by noting regional differences 
in the radiotracer uptake at rest and stress, viable or infarcted myocardium can be identified. 
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Fixed perfusion defects in rest and stress indicate infarcted myocardium, while normalization on 
the rest imaged suggest inducible ischemia with viable myocardium. 
PET:  
To assess myocardial viability 18F-FDG is the tracer is used. Cardiac glucose uptake and 
distribution is used to assess the myocardial perfusion. Normal perfusion and 18F FDG uptake 
indicates normal healthy myocardium. Mismatch pattern with reduced perfusion and preserved 
18F FDG uptake is seen in hibernation. Matched reduction in the perfusion and 18F –FDG 
uptake denotes scarred or infarcted myocardium. Sub endocardial / transmural scar can be 
assessed depending on percentage of tracer uptake(4).  
Parametric Myocardial T1 and T2 Mapping: 
Parametric myocardial mapping are noninvasive techniques, enabling direct quantitative 
analysis of tissue alterations of myocardium in cardiac diseases using cardiac MRI. Changes in 
the myocardial tissue can be quantified with spatial visualization depending on the changes in 
the extracellular volume (ECV), T2*(star), T1and T2 relaxation times. These changes may be 
intracellular in the cardiomyocytes as seen in iron overload and glycosphingolipids deposition in 
Fabrys disease. Extracellular changes in the cardiac interstitium are seen in myocardial fibrosis 
and amyloidosis. Myocardial edema shows both intracellular and extracellular changes(5).  T1 
mapping consists of quantifying the T1 relaxation time of a tissue by using analytical 
expressions of image-based signal intensities.   
T1 is longitudinal (spin lattice) relaxation time of tissue. Basic T1 mapping principle is 
acquiring many images with different T1 weighting and signal intensity of images is fitted into 
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the equation for T1 relaxation. Equilibrium magnetization is nulled or inverted by RF pulses. 
Summary of temporal and spatial changes of inversion recovery are T1 maps. T1 maps are 
displayed using color / threshold scales and Grey scale to enable visual interpretation. 
Myocardial mapping produces images that have standardized, reproducible scales. Myocardial 
tissue at particular field strength exhibits a range of normal relaxation times, deviation from 
which indicates cardiac disease.  
T2 mapping is more sensitive to detection of myocardial tissue edema than T2-weighted 
Cardiovascular Magnetic Resonance (CMR). 
Normal values: Due to variability of T1 and T2 values in regard to age and inhomogeneities in 
tissue properties and also variation from machine to machine, there is a need to standardize 
normal values in regard to local population and each machine. 
Applications of T1, T2 mapping in patients with Myocardial infarction: 
T1 values of infarcted tissue prolongs as compared to normal myocardium. Therefore T1 
mapping may be helpful to detect infarcted myocardium without the use of Gadolinium. This 
could be useful in patient in whom Gadolinium is contraindicated (like in renal failure).  As 
LGE tends to assess only relative enhancement, hibernating or ischemic myocardium does not 
show any abnormality on the LGE images. Similarly diffuse myocardial involvement could also 
be potentially missed on LGE imaging as it relies on differential enhancement.  
We sought to establish normal values for our population and investigate the potential use of T1 
and T2 mapping in assessing myocardial viability and also to assess the values in in ischemic 
and hibernating myocardium. 
P a g e  | 8 
 
AIMS AND OBJECTIVES 
Aim of the study:  To carry out T1and T2 mapping of the myocardium in normal subjects and in 
patients with myocardial infarction and study the differences between them. 
Objectives: 
1. To study the native (pre contrast) T1 and T2 and post contrast T1 relaxation times of 
myocardium in normal subjects and establish a baseline reference value for our institution. 
2. To study the native T1, T2 relaxation and post contrast T1 times of myocardium in myocardial 
infarction. 
3. To see if native T1, T2, post contrast T1relaxation times in infracted myocardium differ 
significantly from the normal values. 
4. To assess if T1 and T2 relaxation times help to differentiate normal from abnormal and viable 
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REVIEW OF LITERATURE 
Rising incidence of cardiovascular disease in India   
Heart diseases are becoming an epidemic in India. Cardiovascular disease (CVD) is a leading 
cause of mortality in India including poorer states and rural India. CVD affects Indians a decade 
earlier in the most productive midlife in comparison to the western population. India has ~ 30 
million heart patients and on average 2 lakh heart surgeries are performed every year based on 
the latest statistics. Death rate due to heart disease in India is ~ 275per lakh greater than global 
average of ~ 235per lakh. High case fatality and younger age of onset of heart disease are 
features of concern in our sub-continent (6). So there is a need to improve the imaging 
techniques in the detection, follow up and treatment of myocardial infarction.  
Rationale for viability imaging 
Revascularization procedures, medical therapy and cardiac transplant are treatment options for 
cardio vascular diseases. The left ventricular dysfunction after infarction can be improved by 
interventional procedures  depending  on the amount of residual viable myocardial tissue(3). 
Coronary artery bypass graft (CABG graft) and endovascular stenting are the revascularization 
procedures in treatment of heart disease(7). Newer imaging techniques are being developed to 
identify the viable myocardial tissue and thus help in planning for revascularization procedures. 
Pathology of viable myocardium 
 Imbalance between oxygen supply and demand leads to myocardial ischemia. Regional 
myocardial perfusion and rate of force of myocardial contraction determine the extent of 
ischemia (7). The different possible outcomes of coronary artery occlusion are myocardial 
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infarction, myocardial ischemia, stunned myocardium, hibernating myocardium and normal 
structure and function. If there is good collateral blood flow, infarction is prevented and 
myocardium remains normal. Myocardial infarction is due to gross reduction of blood flow 
resulting in low ATP levels causing cellular necrosis and cell death. Pre ischemic state of the 
myocardium, collateral vessels and diameter of the occluded vessel determine the extent of 
myocardial infarction. Myocardial infarction spreads from endocardium to the epicardium.  










In the early 1980’s it was assumed that LV dysfunction at rest was an irreversible process. 
Regional and global improvement in LV functions following coronary artery revascularization 
led to the concept of assessing myocardial viability. Viable, but dysfunctional myocardium is 
hibernating and stunned myocardium. Mechanical dysfunction that develops even after the 
establishment of normal / near normal coronary blood flow in the absence of irreversible 
damage to the myocardium is stunned myocardium.  Dysfunction may last for days to hours but 
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there is improvement in LV function with time(7). In hibernating myocardium, chronically 
reduced resting coronary blood flow leads to hypokinesia, even in the absence of infarction, 
which is the adaptive response of the myocardium. 
 
 









Image courtesy: Nuclear Medicine Imaging of Myocardial Viability [Internet]. Radiology 








Image courtesy: Nuclear Medicine Imaging of Myocardial Viability [Internet]. Radiology 
Fig.3: Outcome of Coronary artery occlusion 
Fig.2: Hibernating Myocardium 
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Metabolism of the myocardium  
Metabolism of the myocardium is aerobic under physiological conditions(8). Normal 
myocardium is considered metabolically omnivorous. By oxidative metabolism of fatty acids 
and glucose, heart meets its energy demands. Non-esterified fatty acids are energy source even 
in fasting conditions. There is switch to glucose in post – prandial state.  
Metabolic changes in stunned and hibernating myocardium 
The process of oxidation of fatty acids is very sensitive to hypoxia. Ischemic myocytes prefer 
glucose as energy substrate. Under ischemic conditions there is impairment of oxidation of fatty 
acids which is taken over by aerobic and anaerobic oxidation of glucose to keep the myocardium 
viable(3,9). Metabolic stunning, with delay in the utilization of free fatty acids with restoration 
of blood flow is seen in animal models of repetitive stunning(10). Due to reactivation of fetal 
gene programme there is metabolic switch from fat to glucose metabolism in hibernating 
myocardium (11). 
The goal of myocardial viability assessment is to identify patients with reversible LV 
dysfunction. Stunned myocardium (due to transient myocardial ischemia), hibernating 
myocardium (chronic hypoperfusion) are conditions with reversible LV dysfunction. After 
revascularization, different imaging studies can be used to assess the improvement in global and 
regional LV function, LV ejection fraction and  LV volumes. Revascularization prevents sudden 
cardiac death due to ventricular arrhythmias with  improvement in exercise capacity and long 
term survival. However revasculazation (CABG and percutaneous plasty and stenting) 
procedures are associated with significant procedure related mortality and morbidity. Due to the 
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high risk of therapautic intervention procedures, there is need for careful patient selection, by 
assessing the viability of myocardium. 
 Myocardial viability assesement – multi modality imaging  
There is increase in the incidence of coronary  artery disease (CAD) leading to chroinc heart 
failure  despite significant improvement in the prevention and treatment of heart disease(12).  
Five year survival for ischemic cardiomyopathy is ~ 59%,which is worse than non ischemic 
cardiomyopathy(13). Various imaging modalities can differentiate viable myocardium from 
necrosis or scar depending on properties of viable myocardium.  Non – invasive viability testing 
for assesment of viable myocardium by using various indirect parameters are: 
1) Stress echocardiography (ECHO) 
ECHO can assess myocardial viability by measuring left ventricular wall thickness or 
myocardial contractile reserve. A marker of viability in resting ECHO is left ventricular end 
diastolic wall thickness (EDWT) more than 6 mm and is used as marker of functional recovery 
following revascularization(14). LV EDWT < 6mm   has less likelyhood to recover LV 
function(14). 
Assesment of contractile reserve is another criteria to assess viable myocardium. Stress ECHO 
with dobutamine stress, adenosine or dipyridamole is used to assess the contractile reserve(11). 
ECHO imaging is obtained  at baseline, low dose dobutamine and high dose dobutamine.  
With low dose dobutamineinfusion of 5-10mg/kg/min, viable myocardium shows increased 
contractile function, while non viable myocardium shows no response.  
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Biphasic response: Viable myocardium can also be detected by biphasic response. Low dose 
dobutamine  shows increased acitivity in the hibernating segment. With high dose dobutamine, 
there is reduced function (due to ischemia; worsening at peak stress). In patients with biphasic 
response the initial inotrophic response to low dose dobutamine is due to hibernating 
myocardium and worsening LV funtion at high dose is due to ischemia(15). 
Sustained contractile response: Here, there is improvement in contractile response with low dose 
Dobutamine with no further deterioration of contractile respone at peak stress. In sustained 
contractile response, there is  sufficient  coronary flow even at peak stress and patients are less 
likely to benefit from revascularization procedures(15). 
Worsening contractile response: There is no improvement at any stage with worsening 
contractile function even with low dose Dobutamine. Patients with worsening function are likely 
to have significant scar, do not have contractile reverse and will not benefit from 
revasculazition. 
75% of segments with biphasic response have been shown to recove LV function at 14 months 
follow up, while only only 22 % of segments with sustained response showed recovery. Patients 
with worsening of function rarely recovered(16). High dose dobutamine in comparison to low 
dose dobutamine protocol has higher sensitivity and specificity in predicting functional recovery 
following revascularization(17). 
Limitations of stress echo are operator dependency in both data acquisition and interpretation. 
Adequate acoustic window is also a limitation. Main advantages of stress echocardiography are 
wide availablity, relatively low cost, no radiation burden and ease of use in patients with 
implanted devices(18). 
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2) Nuclear imaging techniques to identify myocardial viability 
Scintigraphic techniques for evaluating viable myocardium are Positron emission tomography 
(PET) and Single photon emission tomography (SPET). Radiotracers that can be used in cardiac 
imaging are Tc 99m/ Thallium 201for perfusion, thallium 201 for cell membrane integrity, Tc 
99m MIBI for intact mitochondria, 18FDG for preserved glucose metabolism, iodine 123-
labelled fatty acids for free fatty acid metabolism (betamethyliodophenylpentadecanoic 
acid(BMIPP))(7). 
Single photon emission tomography (SPET): Single photon  emmitting radio isotopes are used to 
detect viable myocardium in SPET. Cell membrane integrity and myocardial perfusion 
determine the  uptake of  radiotracer. Viable myocardial segments have preserved radiotracer 
uptake. Imaging myocardial contractile reserve/ substrate metabolism myocardial viability can 
be assessed (15). 
Technetium99m: Tc99m emit high energy photons with a narrow peak energy width. Half life is 
shorter as compared to thallium and so a higher dose of radiotracer can be given and a better 
image quality can be obtained. Tc 99m may under evaluate viability compared to thallium as it 
undergoes less redistribution(19). 
123I- labelled 15 –(p-iodophenyl)3-R,S- methylpentadecanoic acid(BMIPP)  is a radio labelled 
fatty acid tracer to demonstrate fatty acid metabolism . Following revascularization for acute 
MI, decreased BMIPP uptake compared to myocardial perfusion in myocardial segments, 
suggest metabolically dysfunctional myocardium indicating low likelyhood of functional 
recovery(20).  
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The sensitivity and specificity of Technetium 99m SPET to predict functional recovery 
following revascularization is estimated to be 83% and 65%(17). Although SPET is easy to 
perform and highly reproducible, its limitations include higher cost, radiation risk, limited 
spatial resolution and difficultly to visualise small transmural infarcts. Interpreting images in 
patients with 3 vessel ischemia is also difficult (balanced ischemia). Attenuation artifacts from 
diaphram /breast is also a limitation(15). It has lower cost and good sensitivity compared to 
PET(17). 
Positron emission tomography(PET) 
Positron emiting radotracers that can be used in cardiac PET are, Rubidium-82, Ammonia -13, 
Oxygen -15 and Fluorine -18 fluorodeoxyglucose (18 FDG). Most validated radiotracer in 
cardiac PET metabolism is 18 FDG, a glucose analogue. For the assesement of ischemia and 
hypoxic myocardium, glucose is a prefered metabolite(18,21). Viability assessement includes 
myocardial perfusion and metabolism. Myocardial perfusion can be assessed at rest and 
pharmocological stress (for stress induced ischemia) by using Rubidium -82 /N-13 ammonia. 18 
FDG glucose (glucose metabolism), C-11 acetate (oxidative metabolism), C-11 palmitate (fatty 
acid metabolism) assess the myocardial metabolism(15). Most commonly, FDG is used to assess 
myocardial metabolism in clinical practice. Since FDG is metabolised to F-18 FDG 6 phosphate, 
which cannot be further metabolised , itis trapped in the myocytes(11). Glucose load and 
intravenously admistered insulin improves FDG image quality(22). Uptake and metabolism of 
18 FDG, depends on viable glucose transporters and viable myocytes. Normal FDG uptake and 
normal perfusion is seen in viable myocytes. Preserved FDG uptake and reduced perfusion is 
seen in hibernating myocardium. Scarred myocardium has absent FDG  uptake and  no 
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perfusion (21,23). In viable, but, jeopardised myocardium, FDG uptake increases due to  
preference for glucose than fatty acid metabolism (shift to anaerobic metabolism). By analysis 
of segmental myocardial perfusion and metabolism, amount of normal, hibernating and necrotic 
myocardium can be assessed. 
Viable, but jeopardised myocardial segments show reduced perfusion and normal / increased 
glucose metabolism – i.e there is a mis-match between perfusion and glucose uptake. In 
transmural myocardial infarction,  there is < 50% uptake with matched perfusion and metabolic 
defect. Non transmural infarct without viability has >50% uptake with less severe matched 
perfusion and metabolic defect. In stunned myocardium, myocardial perfusion is  normal / 
nearly normal and FDG uptake is normal / reduced. Stress perfusion is typically reduced and  
myocardial contractility is  reduced. 
 PET and CT imaging combined together  are excellent for imaging of microvascular no reflow 
phenomena, myocardial scar and detailed assessment of myocardial metabolism(24). Stress 
testing is not required in cardiac PET for myocardial viability. Extensive studies done on 
diagnostic performance of FDG PET and value in clinical management, have shown sensitivity 
of 92 % and specificty of 63% (17). High cost, limited availability and use of radiotracer are 
main limitations of PET. Wide spread use is limited because most of the radiotracers are 
cyclotron produced. Radiation exposure from PET is high as compared to SPET.  
3) Multidectector computer tomography(MDCT) 
CT coronary angiography is a widely used technique. Delayed contrast enhanced CT can assess 
myocardial viability, but, is currently a research application. Principle is same as late gadolinium 
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enhancement (LGE) of cardiac MRI in evaluation of myocardial scar. Like gadolinium, 
iodinated CT contrast agents have extracellular distribution and similar kinetics. Arterial phase 
hypo enhancing myocardium suggests macro/ micro vascular obstruction. Hyper enhancement at 
5 minutes suggests infarct due to extra cellular accumulation of contrast. 
5 minutes post contrast CT scan has been shown to differentiate infarcted from normal 
myocardium in animal models(21). To the standard coronary CT protocol, myocardial viability 
protocol can be added. Extra contrast is not needed and there is only 5 minutes extra scan time 
with mild increase in radiation dose, in comparison to coronary CT angiography. Studies on 
cardiac CT were mostly done on animal models. There is no data available to predict functional 
recovery following revascularization using cardiac CT. 
4) Cardiac MRI 
         Cardiac MRI is currently the gold standard in the evaluation of cardiac anatomy and function. 
Cardiac MRI is a noninvasive diagnostic tool and has unique ability to characterize the 
myocardium. CMR has the ability to overcome limitations of nuclear medicine(18). Late 
gadolinium enhancement (LGE) is the fundamental CMR technique which helps in the detection 
of replacement fibrosis like scar and regional abnormalities by qualitative methods. However, it 
fails to detect diffuse disease that involves whole of the myocardium(25). MRI gives high 
contrast and high resolution images, making it an excellent technique for measuring ventricular 
volumes, ejection fraction, myocardial mass and regional wall motion. Up to 1-2 mm of spatial 
resolution and temporal acquisition of 20-50 ms can be achieved. By accurately defining the 
extent of necrosis, CMR is able to distinguish transmural variations in viability. Thus, excellent 
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spatial resolution is one of the strongest points of cardiac MRI which is relatively poor in PET 
and scintigraphy. 
Cardiac MRI follows the same principles as other MRI techniques with additional ECG gating. 
The main techniques used in cardiac MRI are: 
Spin echo imaging: In this technique heart tissue is visualized as bright and blood appears black, 
so, it is called “black blood technique”. This technique is used to study the anatomy of the heart. 
Gradient echo imaging: In this technique myocardium appears dark and blood appears bright, 
so, it is called “bright blood technique. Ventricular mass, left and right ventricular sizes and 
function, intracardiac shunts, and intracardiac masses are evaluated by this technique. SSFP 
(steady state free precession) is the main sequence used here, which can generate high spatial 
(~2 mm in-plane) and temporal (<30 ms) resolution cine images within an 8 to 12 seconds 
breath hold. 
Flow velocity encoding: It is also called phase contrast technique and it directly quantifies the 
blood flow. It helps in quantifying the severity of valve regurgitation and stenosis, size of intra 
cardiac shunts and severity of arterial stenosis. 
Gating: Two types of gating are used in cardiac MRI, ECG gating to monitor the cardiac cycle 
and respiratory gating by monitor respiration. Real time CMR methods acquire the entire image 
in < 100 ms, but, are limited by low temporal and spatial resolution. So ECG gating is used and 
data is acquired over multiple cardiac cycles. Good ECG gating methods give excellent image 
quality in sinus rhythm, even in atrial fibrillation, atrial or ventricular premature beats. By breath 
holding most of the images can be acquired. However images which require long acquisition 
time can be done by using respiratory gating in addition to cardiac ECG gating. This technique 
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is useful to get high resolution imaging of coronary arteries. Respiratory gating is done using 
navigator to track the movement of the diaphragm or using elastic band around the chest which 
can monitor respiratory motion. 
Basic Cardiac axis imaging planes in CMR 
SSFP scout view is used for planning to acquire imaging planes in the direction of cardiac axis. 
On true transverse slices, by a plane transecting mitral valve and apex, left ventricular vertical 
long-axis (VLA) is obtained. Acquiring a plane transecting the VLA through apex and mitral 
valve, horizontal long axis (HLA) is obtained. Stack of short axis images are obtained 
perpendicular to HLA from base to apex. By a plane transecting both LV and RV, four chamber 
of left ventricle is obtained. Perpendicular to 4 chamber, two chamber is obtained. By a plane 





     
          
 
   
 
Fig.4: True axial SSFP image of the chest showing four 
cardiac chambers 
Fig.5: Four chamber view SSFP image in end-diastole 
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In CMR, the three principal techniques used to assess viability are, late gadoliniumlinum 
delayed enhancement (LGE), end diastolic wall thickness(EDWT) and dobutamine/ adenosine 
stress(25). Viability is predicted by assesement of EDWT. To predict functional recovery 
following revascularization, EDWT > 5.5 cm is taken as cut off(26). On dobutamine stress 
Fig.6: Two chamber view SSFP image in end-diastole Fig.7: Three chamber left ventricular outflow tract 
Fig.8: Short axis mid cavity view of heart Fig.9: Short axis apical view of heart 
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CMR, viable myocardium shows increased contractility of dysfunctional myocardium, while 
non viable myocardium remains dysfunctional. Wall motion changing from akinetic to 
hypokinetic or hypokinetic to normal with Dobutamine infusion, predicts improvement with 
vascularization.  
In CMR, wall motion abnormality can be scored qualitatively by visual assessment as:  
0 – normal, 1 - Mild or moderate hypokinesia, 2 - Severe hypokinesia, 3 - Akinesia, and  
4 – Dyskinesia. 
Late gadolinium enhancement MRI imaging: In this technique 0.1-0.2 m mol/kg bolus of 
Gadolinium based contrast is injected. After 10-20 minutes, T1 scout images are obtained and 
from the T1 scout images, the adequate inversion time (TI) to null the normal myocardium is 
chosen. Correct inversion time should be chosen to get good quality images. Optimal inversion 
time varies from person to person and by factors like cardiac output and dosage of contrast. 
“Optimal TI time” is which results in complete suppression of signal from normal myocardium 
with bright signal from myocardial cavity and even brighter signal from the infarcted tissue.  
Gadolinium is restricted to the interstitial and extravascular spaces. So when there is a loss of 
membrane integrity in the form of sarcolemmal breakdown in the infarcted tissue, Gadolinium 
accumulates in the extravascular and interstitial spaces with delayed wash out due to poor 
vascularity and fibrosis. Thus on delayed imaging, infarcted tissue shows enhancement or 
increased signal due to the T1 times as a result of the gadolinium. Inversion recovery sequence 
where the normal myocardium is nulled is the ideal method to demonstrate this enhancement.  
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By selecting the correct inversion time, sub endocardial, mid myocardial and transmural late 
gadolinium enhancement can be accurately quantified and intramural thrombus can also be 
visualized. In myocardial infarction, LGE is seen in a coronary arterial territory and the 
enhancement starts from subendocardial region and progresses toward the epicardium with 
varying degrees of thickness of myocardium being involved, based on the degree of ischemia 
Based on the thickness of myocardium that is involved, the delayed enhancement in myocardial 
infarction can be  scored as follows: 
0 – No hyper enhancement with regional wall motion abnormality (RWMA)   
1 - Sub endocardial hyper enhancement of 1 to 25% thickness of wall thickness with RWMA  
2 – Sub endocardial hyper enhancement of 25 to 50% thickness of wall thickness with RWMA  
3 – Sub endocardial hyper enhancement of 51 to 75% thickness of wall thickness with RWMA  
4 – Hyper enhancement of 76 to 100% thickness of the myocardial wall with RWMA 
LGE is very sensitive in picking up even small sub endocardial infarction. In detecting sub 
endocardial infarction in patients with coronary artery disease and LV dysfunction, CMR has 
been shown to have greater sensitivity than PET (27). 
Fig10: PSIRimage–short axis view at the basal level Fig11: PSIR image – short axis view at mid cavity level 
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Microvascular obstruction:  Myocardial segments that are hypo enhanced in the first pass 
perfusion are due to microvascular obstruction even though the epicardial vessels are patent(26). 
Regions with severe microvascular obstruction show no LGE with poor LV function, suggesting 
non-viable myocardium and generally a poorer prognosis.  
T2 weighted STIR imaging: Myocardial segments can be hyper intense on T2 STIR images due 
to edema which can be seen in acute infarcts. Myocardial edema usually extends beyond the 
area of infarction.  
Delayed enhancement and T2 differentiates acute and chronic infarcts: Both acute and chronic 
infarcts show delayed enhancement (DE).Myocardial edema is a marker of acute MI and is 
depicted on T2W STIR imaging. So combination of DE and T2W STIR imaging is a clinically 
reliable tool to differentiate acute from chronic MI.  
A study by Kim et al(29) showed that CMR is an excellent tool to predict chances of myocardial 
recovery following revascularization. In this study, myocardial segments with no LGE showed 
100% recovery in function, segments with 26 -50 % transmural scar had 45 % recovery in 
function, 51 – 75% transmural scar had 7% recovery in function and segments with 76 – 100% 
transmural scar had no recovery(15).  
CMR is the best current diagnostic modality in detection of myocardial infarct and assessing the 
transmural extent of the infarction. Some internal cardiac defibrillators (ICD) and pace makers 
are presently a contraindication to CMR. However, more recently manufactured pacemakers are 
MRI compatible with modified MRI pulse sequence protocols. Due to risk of nephrogenic 
systemic fibrosis in renal failure patients with (GFR<30 ml/min) gadolinium is contraindicated 
in patients with poor renal function. In 5-10% of patients, claustrophobia limits the use of CMR. 
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This could be overcome by using large bore magnets and sedation. In unstable patients it is 
difficult to treat dobutamine related arrhythmias and ischemia inside the magnet. 
  In LGE images, myocardial infarctions are displayed as high signal intensity, on arbitrary scale. 
Signals cannot be quantified or compared between different subjects. Visualization of disease 
depends on contrast between normal and abnormal myocardium(30).   
Myocardial parametric mapping 
Myocardial parametric mapping quantifies the T1 relaxation time,  T2 relaxation time and 
extracellular volume (ECV) of myocardial tissues by using analytical expression of images 
based on signal intensities(31). Relaxation of hydrogen nuclei (or protons) determines the signal 
intensity of the pixel.  Different tissues such as fibrosis, fatty tissue and edema have different 
relaxation times. Quantitative T1 and T2 gives more diagnostic information than conventional 
MRI(32). These quantitative T1 and T2 techniques provide voxel by voxel map of the entire 
myocardium and are simple in imaging and analysis, with less subjectivity and high 
reproducibility(30). These are now integrated into routine CMR protocol(33) as an additional 
quantitative study(34). Changes from visualization to quantification is true “revolution”  in 
CMR(35). Parametric maps are not only useful as a biomarker for diagnosis of non-ischemic 
and ischemic cardiomyopathies, but also helpful in the planning of treatment and monitoring 
progression of disease process. Quantification and visualization of the myocardial diseases is 
possible by myocardial mapping, irrespective of the disease being diffuse or focal(5). Late 
gadolinium enhancement assesses focal fibrosis as against T1 mapping which assesses focal as 
well as diffuse fibrosis.  
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Mapping techniques: T1 mapping is acquired in a single breath hold. There are three standard 
sequences which can be used - Shortened MOLLI (ShMOLLI) sequence, Standard Look-Locker 
(LL) sequence and Modified LL inversion-recovery (MOLLI) sequence.  
Look locker (LL sequences): These sequences are obtained prospectively and continuously 
throughout cardiac cycle without cardiac gating, without any reference to specific phase. Images 
are obtained at multiple TIs after application of single 180 degree pulse. This sequence is called 
LL sequence or “TI scout”. 
MOLLI (Modified Look –Locker inversion recovery): MR sequence is applied for acquiring 
native T1 values(33). Equilibrium magnetization is inverted or nulled by RF pulse for measuring 
T1. After inversion or saturation, pulse images are acquired at different times. The curve fitting 
of all images in a sequence generates a pixel map of the T1 values which is represented in a 
single image which is the T1 map(34). 
Selective data acquisitions are performed at end diastole of successive heart beats and hence the 
limitations of LL sequence are overcome by this way. With each heartbeat, single image is 
obtained and multiple images are obtained at each IR. With set of 3 consecutive IRs with 
increasing TIs with one breath hold, 11 images are obtained over 17 heart beats. By using 
narrow acquisition window and parallel imaging techniques, cardiac motion is minimized. 
Many studies have shown MOLLI sequences to be accurate for myocardial mapping  (30),(36).  
MOLLI has lower T1 value than LL sequences(37). Merging of image sets from different IR 
acquisitions with different TIs into single dataset are possible by MOLLI. T1 values in each 
voxel are represented by signal intensity and are displayed as parametric color maps. T1 values 
are obtained directly using region of interest (ROI) with specialized T1 mapping software(38). 
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SHMOLLI: Piechnik et al investigated the SHMOLLI sequence in order to decrease the long 
breath hold of  ~ 18 sec of MOLLI sequence(39).  Normal subjects at end expiration can hold 
their breath ~ for 20.9 sec (range 13 to 74 sec)(40). Patients with pulmonary compromise have 
average breath hold of ~ 9 sec ( range 2-  16 sec)(40). Patients with low heart rate cannot hold 
their breath for long time. Average breath hold in SHMOLLI sequence is 9 sec (± 1.1 sec) and 











Image courtesy: T1 Mapping: Basic Techniques and Clinical Applications 
 
Fig.12:  MOLLI SEQUENCE 
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Techniques Method Advantage Disadvantage 
LL T1- measured by a periodic and 
continuous train of  RF pulses 
followed by the inversion pulse 
T1 relaxation measured 
at multiple time points 
of cardiac cycle 
Partial volume effect due 
to physiological motion 
and misregistration, 
variability with heart rate 
MOLLI IR-weighted images at different 
inversion times are acquired 
following which the images are 
sorted into a single data set 
according to consecutive 
inversion times 
Single breath hold, 
within a cardiac cycle, 
single slice and single 
readout 
Single breath hold with 17 
heartbeat, heart rate 
dependent 
shMOLLI modification of MOLLI Faster acquisition time, 
short breath-hold 
duration of only nine 
heartbeats 
Reduced precision 
SASHA The SR pulse non-selectively 
saturates the longitudinal 
magnetization to zero, 
independent of previous 
acquisitions. Recovery periods 
are not required between 
successive saturation pulses 
because recovery always begins 
from a saturated state. The best-
known T1 method is SASHA 
The best-known T1 
method is SASHA 
T2-dependence, 
magnetization transfer 
effect and dependence on 
inversion efficiency 
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T1 mapping: Spin-lattice or longitudinal relaxation time commonly called “native T1” or T1 
relaxation time is used to characterize different tissues and is a tissue specific constant time. 
Depending upon rate of energy transfer from an excited proton to its surroundings, T1 relaxation 
time varies. It varies depending upon magnetic field strength, temperature, molecular shape, size 
and viscosity. Native T1 value varies according to the field strength and is directly proportional 
to the field strength. T1 values vary with sex and age of the patient. Higher T1 values are seen in 
older patients and men(33). Fat, water, iron etc have unique constitutional T1 relaxation time 
depending upon the interstitial and cellular composition. Change in the constituents in 
myocardial diseases alter the T1 and T2 values(34).  940 to 1000 m sec is the normal T1 
relaxation time of the myocardium using 1.5 T MRI. Diseases causing fibrosis, edema or 
amyloid deposition cause prolongation of T1 values. Siderosis, fat deposition and Anderson –
Fabry disease cause shortening of T1 values. Increase in interstitial space due to fibrosis 
(infarction, scar and cardiomyopathy) and  edema (recent infarction/inflammation) are also 
increase the native T1 (41). 
Depending upon the severity and nature of cardiac disease, there are two possible types of 
collagen deposition within cardiac tissue, focal scarring and diffuse or interstitial fibrosis.  
Focal scarring: Focal scarring is seen on LGE with visual difference in the signal intensity 
between the area of focal scarring and normal myocardium. 
 Interstitial fibrosis or diffuse fibrosis: This is not seen on LGE as it lacks the difference in 
signal intensity to be visually appreciated. An inversion pulse with LGE uniformly suppresses 
the entire myocardium despite retention of contrast. By measuring the intrinsic T1 time ms, T1 
mapping overcomes this limitation.  
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Post gadolinium T1: Gadolinium chelates are admistered at dose of 0.15 mmol/kg. Since 
gadolinium is continuously excreted by the kidneys, T1 values vary with wash out phase. T1 
values are typically obtained at 12 and 25 minutes after administration of contrast(31). Native T1 
versus post gadolinium T1: Native T1 values are longer than post gadolinium T1 values in 
normal myocardium due to relaxing effect of residual gadolinium. In diffuse fibrosis due to 
increased volume of retained contrast relaxing effect is greatly amplified than regional scarring. 
Fibrotic myocardium has shortened T1 on post gadolinium T1 sequences with good correlation 
with endomyocardial biopsy(31). Even without use of gadolinium, native T1 is a promising 
sequence to detect myocardial abnormalities (33). 
Myocardial T2 mapping: Spin- spin or transverse relaxation time or “T2 relaxation time” is also 
tissue specific. Bright blood T2-preparation pulse based sequences or dark blood turbo spin echo 
are used in myocardial T2 mapping.  Applying a T2 preparation pulse based sequence followed 
by read out using SSFP (steady state free precession) sequence and T2 decay curve is calculated 
by which T2 parametric maps are obtained(33). T2 CMR can differentiate acute and chronic 
infarct by noting presence / absence of edema. T2 relaxation time is sensitive to myocardial 
edema after cardiac ischemia and reperfusion(42). It detects edema even beyond the limits of T2 
weighted CMR(43). Normal myocardial T2 relaxation time is 52.18msec at 1.5 Tesla and 45.1 at 
3T( tesla)(33).   
A study by Florian Bonner on myocardial T2 mapping showed that T2 decreased towards the 
heart bases. Significant higher T2 values were obtained in female volunteers in all myocardial 
regions. T2 time correlated significantly to age. Results showed that T2 maps are highly 
reproducible. Presence of diabetes, hypertension, female sex and aging showed increased 
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myocardial T2 values. Mid ventricular long and short axis are used to measure native T1, T2 and 
post Gadolinium T1 values used for small samples. Short axis at base, mid cavity and apex are 
preferred for larger sample volume. 
Native T1 values from normal population are used as base line reference. Reference values are 
obtained in healthy control population acquired under same scanning condition like scanner 
type, scan time and contrast agent. Determination of T1 times is done by manual ROIs or by 
applying automatic threshold. 
A study by Tiago in 2014 (44) compared the three T1 mapping sequences (Sh MOLLI, MOLLI, 
SASHA). They used mid ventricular slice for mapping. Results showed no association of T1 
with cardiovascular risk group. Depending on the sequence used T1 differed significantly. In 
their study, T1 values using MOLLI was 1199 ± 28 (m sec), ShMOLLI was 1174 ± 37 (m sec) 
and SASHA was1487 ± 36(m sec)(44). 
Application of parametric maps in non-ischemic cardiomyopathies: 
Dilated cardiomyopathy: Important cause of cardiac dysfunction is “diffuse myocardial fibrosis” 
and has prognostic significance. Late gadolinium enhancement (LGE) can detect fibrosis only in 
the presence of normal myocardium elsewhere, showing a contrast between normal and scarred 
myocardium. LGE fails to detect fibrosis in diffuse myocardial fibrosis due to absence of normal 
myocardium. Parametric maps are useful in diffuse myocardial fibrosis and show high T1 and 
T2 values and lower post Gadolinium T1 values compared to the control healthy population. 
High native T1 value in dilated cardiomyopathy predicts adverse out come with high diagnostic 
accuracy. 








Image source: Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol 2017;18 (1):113-131 
Hypertrophic cardiomyopathy: One of the most common hereditary myocardial diseases is 
hypertrophic cardiomyopathy. Morphological type of HCM and the extent of fibrosis can be 
evaluated by cardiac MRI. Extent of fibrosis in the myocardial muscle can be evaluated by T1 
maps. Diffuse interstitial fibrosis in HCM shows significant increase in native T1 and low post 
contrast T1values. Diffuse myocardial fibrosis in HCM, not detected by LGE can be detected by 
T1 mapping. Elevated T1 values correlated with increase in the myocardial muscle hypertrophy 
and disease severity. ECV is considered a potential biomarker to distinguish between hereditary 







Image source:- Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol 2017;18 (1):113-131 
Fig13: Dilated cardiomyopathy 
Fig.14: Hypertrophic cardiomyopathy 
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Amyloidosis: Cardiac involvement in amyloidosis is seen with immunoglobulin light chain or 
transthyretin types of amyloidosis. Being a depositional disease, infiltration and expansion of 
the interstitial space by amyloid is seen histologically. Endomyocardial biopsy is the mainstay 
of diagnosis. Global and circumferential sub endocardial enhancement being hall mark of the 
disease is seen late in the disease course or may not be seen. However in amyloidosis there is 









Image source: Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol 2017;18 (1):113-131 
Myocarditis: Inflammation of the myocardium by various agents causes myocarditis. Sub 
epicardial and mid myocardial LGE localized to the inferior and lateral walls is typically seen in 
myocarditis. This type of LGE is either subtle or often not seen. Underlying edema and 
inflammation cause significant elevation of native T1values. Distinguishing between acute and 
recovering phase of myocarditis is possible by T1 mapping. Myocardial edema is better detected 
by T2 mapping.  
Fig.15: Amyloidosis 
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Fabry disease: It is a X linked storage disorder. Mutation in the gene of alpha galactosidase 
causes the disease. Left ventricular hypertrophy of Fabry disease has to be differentiated from 
other causes of LVH. LGE is seen in the inferior lateral wall in Fabry disease. Deposition of 
glycophosphingolipids in the myocytes in the left ventricular septum is distinctive feature of 




                                          
 
                                       
                                                
Image source- Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol 2017;18(1):113-131 
Application of parametric maps in ischemic cardiomyopathies: 
Acute myocardial infarction (AMI): Evaluation of acute myocardial infarction is based on the 
location, size, transmural extension of the infarction, micro vascular obstruction (MVO), area at 
risk (AAR) and hemorrhage.  Both diagnosis and risk stratification can be achieved by cardiac 
MRI. Parametric mapping is an evolving tool in the evaluation of AMI. Acute myocardial 
edema due to the content of free water, increases both T1 and T2 values. So native T1 detects 
myocardial edema in acute myocardial infarction.  
Native T1-mapping in comparison to T2-weighted CMR for detection of acute myocardial 
edema: For detecting acute myocardial edema T2 weighted CMR is a standard technique (45).  
Fig.16: Fabry disease 
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It is used to differentiate chronic MI and acute MI (46) and estimating  of areas at risk(47). A 
study by Ferreira showed nativeT1-mapping with ShMOLLI is the best method for detecting 
myocardial edema(48). T1 mapping shows great sensitivity in the detection of free water 
content. For assessing myocardial edema, compared to T2-weighted imaging, T1-mapping is a 
complementary technique. Significantly larger area was seen in T1-mapping compared to T2-
weighted methods(48). Acute myocardial infarction can be diagnosed by native T1 with correct 
cut off value(33).For evaluation of area at risk (AAR) after acute myocardial infarction (AMI) 
both T1 and T2 values showed same qualitative results(49).  Areas with microvascular 
obstruction (MVO) have shown higher native T1 values than remote myocardium and lower 
native T1 values than infarcted myocardium(50). 
Messroghli et al, studied the utility of T1 mapping of myocardium in acute MI(51) at 1.5 tesla 
MRI. Look lockers sequence (LL sequence) was used in this study. Native T1 obtained in their 
study, in acute myocardial infarction was 849 ± 60 ms compared to 721 ± 37 ms in controls. 
Post Gadolinium T1 in acute myocardial infarction was 262 ± 19 (m sec) compared to 362 ± 27 
ms in controls. This study established T1 prolongation in area of infarct seen in all patients. T1 
prolongation was larger in spatial extent of area of than hyper enhanced areas on LGE images. 
Compared to non-infarcted areas, T1 values were increased by 18± 7 % (SE p< 0.05) in 
infarcted areas. Significant reduction was seen in post contrast myocardial T1 values as 
compared to remote myocardium in acute myocardial infarction and the areas showing T1 
reduction were same as hyper-enhanced regions on conventional T1-weighted images. 
Compared to non-infarcted tissue, reduction in post gadolinium T1 values by 27 ± 4% (p, 0.05) 
was seen in infarcted tissue. Without the use of contrast media T1 mapping can detect 
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myocardial necrosis. Using a combination of pre and post contrast T1 maps, much more 
information can be obtained that exceeds conventional contrast studies(51).  
In another study by Messroghli et al evaluated acute or chronic myocardial infarction(36) by T1 
mapping with modified look locker inversion recovery sequence (MOLLI). In this study, native 
T1 of 1011 ± 66 (acute infarction), Post Gadolinium T1 of was 494 ± 23(acute infarction), 
Native of 987 ± 34(chronic infarction) was reported. This study concluded that in acute and 
chronic infarction, pre contrast T1 values were higher than T1 values in remote 
myocardium(36). T1 values were different  in acute and chronic MI. Precontrast threshold T1 
maps showed 96% sensitivity with 91% specificity in segmental abnormalities caused by acute 
MI. Study done by Dall ‘Armellina et al. correlated native T1 values to the degree of myocardial 
damage. They compared T1, LGE and T2 values. They concluded that functional recovery after 
AMI could be predicted based on the T1 values(50). Intramyocardial hemorrhage can show T1 
shortening effect and native T1 can detect it(52). 
Chronic myocardial infarction: Cardiac MRI plays an important role in chronic MI by assessing 
the infarct size, edema, LV remodeling and complications. Native T1 values can help to 
differentiate acute and chronic MI, based on myocardial edema(36), which usually resolved 6 
months after acute MI. 
In a study done by Klein et al on ischemic cardiomyopathy(53) using (MOLLI) Modified look 
locker inversion recovery sequence, native T1 values of 720 ± 18 ms and Post gadolinium T1 
values of 250 ± 30 ms were obtained in patients in contrast to native T1 values of 720 ± 11 and 
Post gadolinium T1 values of 340 ± 40ms in controls. This study concluded that in ischemic 
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cardiomyopathy, post contrast T1 values were significantly decreased compared with normal 
myocardium(53).  
Kali et al used 3T CMRI to detect chronic MI in canine models.  Transmurality and infarct size 
were overestimated in acute MI, on T1 mapping as compared to LGE images which was not 
seen in chronic MI. Chronic MI territories showed extensive replacement fibrosis on histology. 
Results showed high diagnostic accuracy of  native T1 maps to determine the size, location and 
transmurality of chronic MI at 3 T. Clinical translation  requires studies in  patients (54). 
Bauner et al studied chronic myocardial infarction(31) using MOLLI sequence. In their study 
native T1 was 1160 ± 80 ms and Post gadolinium T1 was 239 ± 74 ms in chronic infarction in 
contrast to a native T1 of 1001 ± 47 ms and Post contrast T1 of 380 ± 59 ms in controls. This 
study showed post gadolinium T1 values in chronically infarcted myocardium are significantly 
different from those in healthy normal myocardium. 
Reza Nezafat et al(55) concluded that 3T native T1 mapping has great potential for replacing 
LGE (56).  
Dastidar et al (57) tried to show that native T1 and T2 mapping can assess myocardial viability 
without use of gadolinium. Patients and controls underwent 1.5T to assess LV function and 
presence and extent of myocardial infarction (scar transmurality). MOLLI sequence with motion 
corrected was used. Grading of the scar was done using scale of 0-4 for 16 AHA segments. 
Grade 0 was no scar, Grade 1 was 1-24%, Grade2 was 25-49%, Grade3 was 50-74% and Grade 
4 was >75% scar thickness. Segments < 50% LGE were considered viable. LGE viability was 
compared with corresponding native segmental T1and T2 values obtained from T1 maps and T2 
maps. Total of 800 segments were analyzed (320 healthy controls and 480 MI patients). 
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(57)Mean segmental T1 and T2 values for scar transmurality grade 0-4 were, 1031 ± 31 ms, 
1070±33 ms, 1103± 32 ms, 1164± 58ms and 1206± 118 ms (p< 0.001) respectively; For T2: 
Grade 0: 52± 4 ms, Grade1: 55± 4 ms, Grade2: 58± 5 ms, Grade3: 59± 8 ms, Grade 4: 66± 9 ms 
(p<0.001) in chronic MI. ROC analysis of 480 segments of chronic MI, demonstrated that native 
T1 mapping had an excellent diagnostic performance for myocardial viability assessment, as 
compared to LGE as gold standard. 
Native T1 had high diagnostic accuracy for viability compared to T2 mapping, LV wall 
thickness and regional wall motion abnormality. In their study, T1 threshold of 1090 ms best 
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MATERIALS AND METHODOLOGY 
Study period 
Study was conducted in the department of Radiology between December 2016 and September 
2017 after obtaining approval from the Institutional Review Board (IRB Min No: 10171 
(OBSERVE) DATED 06.07.2016)  
Study design: Prospective cross sectional descriptive study 
Recruitment of subjects  
Inclusion criteria: 
Normal subjects: Patients who were referred for MRI of other body parts who were 
normotensive, non-diabetic and who did not have any cardiac risk factors and who gave consent 
for performing the study were included as normal subjects.  
The status “normal subject” was based on: 
 i) No cardiac related medical history 
ii) Absence of any symptoms indicating cardiovascular dysfunction 
iii) Normal cardiac dimensions and function proven by cine CMR  
A detailed questionnaire and assessment of available lab parameters was used to ensure that the 
normal subjects were free of cardiac risk factors (enclosed). The study for normal subjects was 
done using the fluid research grant fund, an institutional grant for the research project. 
Cases: All patients referred for cardiac MRI between December 2016 and September 2017 for 
myocardial viability assessment and who had given their consent for the study were included in 
the study. 
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In addition to routine cardiac MRI sequences, native T1, post contrast T1 and T2 mapping were 
done. Contrast injection (gadolinium) was part of all routine cardiac MR studies. 
Informed consent: Informed consent (enclosed) was taken by the principal investigator. 
Exclusion criteria: Patients who were not able to co-operate were excluded from the study. 
Patients with contraindications for gadolinium injection (like reduced GFR less than 30ml/min) 
were also excluded. No vulnerable groups (e.g., pregnant women, children) were enrolled in the 
study. 
Sampling strategy: Consecutive patients referred for cardiac MRI and who gave consent for the 
research project voluntarily, were recruited for the study. 
Sample size calculation: Required sample size to show the difference in T1 of 17.5 units (17 
cardiac segments per patient) with 80% power and 5% level of significance with variability of 
126 units (RadioGraphics 2014; 34:1594–1611) was found to be 814*2 = 1628 segments (50 
healthy controls and 50 patients) 
Data collection 
Demographic details: Relevant data like history of risk factors (age, sex, family history, 
smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity), number of years of 
hypertension and diabetes were collected using a questionnaire which was part of the clinical 
research form (enclosed). Indication for referral was noted. Weight and height, systolic and 
diastolic blood pressure along with lipid profile values were also documented.  Patients were 
asked questions about his/her medical history and the medication(s) he/she was taking.  
Demographic data were also collected from the patient records and direct patient interview 
before the cardiac MRI. 
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MRI Machine: All examinations were performed in 1.5T clinical MRI system (Siemens Magne-
tom Avanto fit, Erlangen, Germany). 
Technical details of the MRI machine: System length: 160 cm, Bore size: 60cm, system weight 
5.3 tons, RF Tim:204x48, Gradient strength: SQ Gradients (45mT/m@200T/m/s), Helium 
composition: zero helium boil-off technology. Total imaging matrix (TIM) – integrated coil 
technology, provides up to 204 coil elements and 48 channels. Dot Go- an MRI exam software 
helps in streamlining the protocols. It is powered by new syngo MR E11 software – platform.  
Details of the MRI procedure 
The procedure was explained to the patients and normal subjects in detail and the ‘patient 
information sheet’ was given, following which an informed consent was obtained. 
Normal subjects: After completing their regular MRI, ECG leads were placed and T1 and T2 
mapping was performed followed by post contrast T1 mapping. In addition, short axis cine 
images of heart and LV function calculation were done to ensure that ejection fraction was 
normal. It took an additional of 3-5 minutes for T1andT2 mapping of the myocardium in 
controls. 
Cases 
Sequences performed in cases were:  
* Routine SSFP axial sections of the thorax covering the heart, from apex to base 
* SSFP cine sequences in 4 chamber, 2 chamber and short axis views from base to apex 
* Native T1 and T2 mapping was done in short axis view at three levels, including basal 
segment, mid cavity and apical segment, 2 chamber and 4 chamber view  
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* Gadolinium was admistered IV, at a dose of 0.1 m mol/kg. Late Gadolinium scans were 
acquired 10 minutes after IV injection of contrast agent Gadolinium, after nulling the 
myocardium in the short axis, 2 chamber and 4 chamber view with magnitude and PSIR (phase 
sensitive inversion recovery) images.  
Inversion Recovery (IR) pulses were used to null the signal from normal 
myocardium during delayed enhanced imaging, so that enhancement of the abnormal 
myocardium is well appreciated. TI scout images or look locker images were performed where 
each image in the series has a progressively larger TI and the appropriate TI time at which the 
normal myocardium is dark or nulled was chosen for the late gadolinium enhancement images.  
Inversion time is usually 330 msec after the RF pulse, but varies from person to person.  
* Post contrast T1 mapping images done. 
17 cardiac segment model as described by the American Heart Association was used to describe 
the T1 and T2 mapping. 
Personnel: Cardiac MRI was done by trained radiographers from department of Radiology, who 
were well versed with cardiac imaging. No additional training was required to perform T1 and 
T2 mapping. 
Details of T1 and T2 mapping sequences: The native T1, post contrast T1 mapping cardiac MRI 
scans were performed using the MOLLI sequence on 1.5-T MRI scanner (1.5T Siemens Magne-
tom Avanto fit). Modified Look-Locker inversion recovery sequence (MOLLI) T1 mapping 
were done with FOV 320 × 320; TR/TE/flip-angle: 3.3 ms/1.57 ms/50°, interpolated voxel size 
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0.9 × 0.9 × 8 mm, phase encoding steps n = 166, HR adapted trigger delay, with 11 (3-3-5) 
phase sampling arrangements.  
T1 mapping: T1 mapping with Myomaps was performed using an inversion recovery based 
pulse sequence. The software provides a flexibe interface to enable evaluation of myocardial 
tissue T1 relaxation time.Native T1 values of the myocardial tissue were evaluated using long 
T1 protocols. 
FOV of 360 x 360; slice thickness 8 mm; TR 279.84 ms; TE 1.13 ms was used. 8 images with 
varying inversion times (TI values), with wide range from 120 to 3800 were used from which 
computer generated color coded maps of the T1 relaxation times were obtained, after motion 
correction.  
In addition, another Seimens sequence of short T1 was also acquired, where images with 9 
different inversion times with shorter range from 120 to 1800. T1 short sequence had FOV 360 
x 360; slice thickness 8 mm; TR 359.84 ms; TE 1.13 ms. 
T2 mapping used FOV 360 x360; slice thickness 8 mm; TR 193.27 ms; TE 1.07 ms. 
T2 had different prep times of 0, 25, 55 msec. 
 T1 (T1 short and T1 long) T2 and T1 post gadolinium mapping were displayed using standard 
color maps. 
Measuring T1 and T2 Values:  T1 and T2 values in all the segments in normal subjects as well 
as patients (including normal myocardium, hibernating segments and infarcted segments) were 
recorded by the primary investigator from the above sequences and was checked by   guide / co-
guide. 
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Manually drawn ROIs were used to measure the T1 and T2 values. Small ROI <20 pixel were 
avoided. Large drawing ROIs covering complete area of each segment was used. ROIs were 
placed accurately in the central myocardium on the color maps, avoiding partial volume artifacts 
of adjacent blood pool and extra cardiac tissue. 
                                                                        
T1 and T2 relaxation times of the LV myocardium were recorded for the 17 cardiac segments on 
short axis views as well as the 4 chamber and 2 chamber views, in patients and normal subjects. 
At the time of recording the T1 and T2 values, the investigator was blinded to the findings on 
the rest of the images including the findings on LGE images. Following this, MRI scans were 
reported in a standardized format and checked by Guide / co-guides. Other findings including 
segments of wall motiona abnormality. late Gadolinium enhancement and final diagnosis based 
on clinical and routine cardiac MRI sequences were also documented.  
Recording MRI Findings 
We followed the 17 segment model of the heart, described by the 
American Heart association for T1 and T2 mapping of the myocardium. 
Fig.18: Manually drawn  large segmental ROIs Fig.17: Manually drawn large segmental ROIs 
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T1 Mapping – Native T1 relaxation times in all segments were documented by manually drawn 
region of interest on the computer generated color maps for complete area of each segment. 
T2 Mapping – T2 relaxation times in all segments was documented by manually drawn region of 
interest on the computer generated color maps for complete area of each segment. 
T1 Post Gadolinium Mapping – Post contrast T1 relaxation times in all segments was 
documented by manually drawn region of interest on the computer generated color maps for 
complete area of each segment. 
Wall motion abnormality was scored qualitatively by visual assessment as follows:  
 0 – normal; 1 - Mild or moderate hypokinesia; 2 - Severe hypokinesia; 3 - Akinesia, and 
  Fig.19:  Seventeen segment model of the heart 
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4 – Dyskinesia 
Late gadolinium enhancement (LGE) was scored as follows: 0 – No late gadoliniumlium 
enhancement; 1 - LGE of 1 to 25% thickness of the myocardium; 2 - LGE of 26 to 50% 
thickness of the myocardium; 3 - LGE of 51 to 75% thickness of the myocardium. 
4 - LGE of 76 to 100% thickness of the myocardium; <50% LGE was taken as viable 
myocardium.  
Based on the final diagnosis on the routine cardiac MRI images including the late 
gadoliniumlium enhancement images, all subjects included in the study were categorized as 
follows, for further statistical analysis -  
Category 0: healthy normal control.  
Category 1:  normal segments in MI patients (no LGE or wall motion abnormality).  
Category 2: hibernating myocardium (wall motion abnormality with no LGE). 
Category 3: Infarct with residual viable myocardium (wall motion abnormality with LGE in 1 - 
24%thickness of myocardium). 
Category 4: Infarct with residual viable myocardium (wall motion abnormality with LGE in 26-
49% thickness of myocardium). 
Category 5: Infarct with no significant residual viable myocardium (wall motion abnormality 
with LGE in 50-74% thickness of myocardium). 
Category 6: Infarct with no residual viable myocardium (wall motion abnormality with LGE in 
>75% thickness of myocardium or transmural infarct). 
These categories were assigned at a later stage and at the time of recording the T1 and T2 
values, the principal investigator was blinded to the categories. 
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RESULTS AND ANALYSIS 
Data was entered using EPIDATA software and screened for outliers and extreme values using 
Box-Cox plot and histogram (for shape of the distribution). All the statistical analysis was 
performed using SPSS 18.0 and Dx test software. 
 
A total number of 71 people underwent cardiac MRI for T1 and T2 mapping of the myocardium. 
Out of these, 31 were healthy normal controls and 40 were patients with myocardial infarction 
who were referred for viability CMRI. 
Demography: 
A. Age distribution: The mean age of the subjects included in the study was 42 years in controls 









 Fig 20: Age distribution  
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B. Gender: 68% (No.: 20) were males and 32 % (No.:10) were females in controls. 85% were 
males (No.:34) and 15% were females (No.:6) in the patient group 
  
 
C. Risk profile: Most prevalent risk factor in the study patients was diabetes (35%) and 
















Gender Distribution in Patients
Males Females











Family history of Heart Disease
Fig.21: Gender distribution in Control group and Patients 
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Number of myocardial segments analyzed 
Total number of myocardial segments in 71 subjects, including normal controls and myocardial 
infarction patients, including all the segments that could be assessed on short axis, 4 and 2 
chamber images were 1775. Out of these 98% (No: 1731) segments were analyzed and 2 % (No: 
44) of the segments could not be assessed due to artifacts and other reasons. 
Of the segments that could be analyzed, 58% (1000 segments) were from patients and 42% (731 
segments) were from controls.  
Based on the final diagnosis on the routine cardiac MRI images including the late 
gadoliniumlium enhancement images, all subjects included in the study were categorized as 
follows, for further statistical analysis -  
Category 0: healthy normal control.  
Category 1:  normal segments in MI patients (no LGE or wall motion abnormality).  
Category 2: hibernating myocardium (wall motion abnormality with no LGE). 
Category 3: Infarct with residual viable myocardium (wall motion abnormality with LGE in 1 - 
24%thickness of myocardium). 
Category 4: Infarct with residual viable myocardium (wall motion abnormality with LGE in 26-
49% thickness of myocardium). 
Category 5: Infarct with no significant residual viable myocardium (wall motion abnormality 
with LGE in 50-74% thickness of myocardium). 
Category 6: Infarct with no residual viable myocardium (wall motion abnormality with LGE in 
>75% thickness of myocardium or transmural infarct). 
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Of the total number of segments analyzed in patients, 37% of segments were considered to be 
normal (category 1) on conventional CMRI as they did not show any wall motion abnormality 
or abnormal enhancement. 33 % of analyzed segments were in category 6 (i.e. these segments 
showed hypo or akinesia and >75% to transmural late gadolinium enhancement). 
Segments with infarcts, but, significant residual viable myocardium were 23%.  
 No of hibernating segments (Group 2): 15%.  
  No of segments with < 25 % infarction (Group 3): 2%.  
 No of segments with <50% infraction (Group 4):6%.   
Thus 23 % of segments could potentially show improvement after revascularization procedures. 
Total non-viable segments was 40% 
No of segments with 50-75% infarction were7% 

















Distribution of segments analysed in Patients
1- Normal
2- Hybernating Myocardium
3- < 25 % Subendocardial Infarct
4- <50 % Infarct
5- < 75 % Transmural Infarct
6- > 75 % Transmural Infarct




Groups in Patients Frequency Percent 
 1-Normal 366 36.6 
2-Hibernating 150 15.0 
3-< 25% Subendocardial 23 2.3 
4 < 50% of myocardial 65 6.5 
5 < 75% of transmural 65 6.5 
6 - > 75% transmural 331 33.1 
Total 1000 100.0 
 
Table.1: No. of segments in each group 
 
 
T1 and T2 Mapping 
ANOVA was used to compare T1 Short, T1 Long, T2 and Post-gadolinium T1 values in the 
different categories, with the normal values obtained from healthy normal subjects. A receiver-
operating characteristic analysis was performed to calculate areas under the curves and the 
Youeden Index was used to depict optimal cutoff values from the receiver-operating 
characteristic curves 
 A. Mean segmental T1 and T2 values in the controls:  
T1 short:   956.57 ± 65.6 ms, 
 T1 long:   1040.47±74 ms,   
T2:        51.3±16 ms  
 post gadolinium T1: 561.65 ±70 ms  
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Table.2: T1, T2 values of group 1-Normal segments in patients 










Mean segmental T1 and T2 values group 1(Normal appearing segments in patiensts): 
Native T1 (long T1): 1077.90 ±75.5 ms  
T1 short: 993.70± 62.9 ms 
T2       : 53.21±5.6 ms 
T1 post Gadolinium: 516.05± 89 ms 
 
T1, T2 values in the normal appearing segments (with no LGE or RWMA) in myocardial 
infarction patients were higher in comparison with healthy controls. Post gadolinium T1 values 
of normal segments (no LGE and RWMA) in myocardial infarction patients were lower in 
comparison with healthy controls. This suggests that even the seemingly normal segments in 
patients with myocardial infarction in other areas, are actually abnormal. LV remodeling and 
adverse cardiac event possibly causes increase in the native T1 in remote areas of the heart. 
1-Normal in patients T1short T1long T2 post_gadolinium 
 Mean 993.70 1077.09 53.21 516.05 
Median 987.00 1069.00 52.00 505.00 
Std. Deviation 62.975 75.580 5.631 89.054 
Range 534 475 41 870 
Minimum 777 912 39 289 
Maximum 1311 1387 80 1159 
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Table.3: Comparison between Controls and group 1-Normal in patients and t-test    
Group-1-Normal Mean Std. Deviation 
T1 short 
Normal 956.57 65.641 
Abnorm 993.70 62.975 
T1 long         
Normal 1040.47 74.391 
Abnorm 1077.09 75.580 
T2 
Normal 51.32 16.791 
Abnorm 53.21 5.631 
T1 – post 
gadolinium     





t-test for Equality of Means 




T1 short .000 -37.128 4.338 
.000 -37.128 4.277 
T1 long        .000 -36.614 4.861 
.000 -36.614 4.885 
T2 .041 -1.893 .924 
.008 -1.893 .717 
T1 – post 
gadolinium      
.000 45.600 5.676 
.000 45.600 6.130 
 












Fig. 24: Comparison of T1, T2 and post gadoliniumlinium T1 values between Controls and group 1- 





















1-Normal  segments in patients Vs controls
Normal Abnormal
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Table.4: T1, T2 values of group 2-Hibernating Myocardium 
C. Group 2: hibernating myocardium: 
2-Hibernating T1short T1long T2 post_gad
 Mean 1066.56 1101.56 53.20 513.86 
Median 1009.00 1100.00 52.00 513.00 
Std. Deviation 600.035 74.569 5.100 86.112 
Range 340 577 33 360 
Minimum 861 917 43 318 




Mean Segmental T1 and T2 values in group 2: hibernating myocardium: 
T1 short: 1066.56± 600ms 
T1 long: 1101.56±74.5ms 
T2: 53.2± 5.1ms 
T1 post gadolinium: 513.86±86 ms 
Segments with regional wall motion abnormality, but, no LGE, suggesting hibernating 
myocardium (Group: 2) also showed difference in the T1 and T2 values as compared to normal 
subjects which was statistically significant with p<0.05 and with 95% confidence intervals. 
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Table. 5: Comparison between Controls and group 2-Hibernating Myocardium and t-test 
Fig. 25: T1,T2 values of group 2-Hibernating Myocardium 
Group-2-Hibernating Mean Std. Deviation 
T1 short 
Normal 956.57 65.641 
Abnormal 1066.56 600.035 
T1 long        
Normal 1040.47 74.391 
Abnormal 1101.56 74.569 
T2 
Normal 51.32 16.791 
Abnormal 53.20 5.100 
T1 - 
Gadolinium     
Normal 561.65 70.639 
Abnormal 513.86 86.112 
 
t-test for Equality of Means 




T1 Short .000 -109.991 23.688 
.030 -109.991 50.241 
T1 Long .000 -61.092 6.759 
.000 -61.092 6.769 
T2 .182 -1.881 1.409 
.016 -1.881 .777 
T1 - 
Gadolinium     
.000 47.789 6.855 






















2-Hibernating Myocardium Vs controls
Normal Abnormal
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D: Group 3 < 25% sub endocardial infarction: 
 
3-< 25% Sub-endocardial 
Infarct 
T1short T1long T2 
post_gadolini
um 
 Mean 1042.94 1149.09 56.05 570.83 
Median 1030.50 1149.50 54.00 606.00 
Std. Deviation 66.719 97.564 6.344 72.352 
Range 275 439 23 215 
Minimum 943 964 49 437 
Maximum 1218 1403 72 652 
 
Table.6: T1, T2 values of group 3- < 25 % sub endocardial Infarction 
 
Mean segmental T1 and T2 values in group 3 < 25% sub endocardial infarction: 
In Group 3, mean  
T1 short was 1042.94±66.7 ms,  
T1 long: 1149.09±97.5 ms,  
T2:56±6.3 ms and  
T1post Gadolinium was 570.83±72 ms  











Normal 956.57 65.641 
Abnormal 1042.94 66.719 
T1 long         
Normal 1040.47 74.391 
Abnormal 1149.09 97.564 
T2 
Normal 51.32 16.791 
Abnormal 56.05 6.344 
T1 - 
Gadolinium 
Normal 561.65 70.639 
Abnormal 570.83 72.352 
 







T1 Short .000 -86.376 15.683 
.000 -86.376 15.928 
T1 Long .000 -108.618 16.281 
.000 -108.618 20.992 
T2 .199 -4.729 3.675 
.004 -4.729 1.530 
T1 - 
Gadolinium     
.588 -9.186 16.928 
.602 -9.186 17.314 
 
Table.7: Comparison between Controls and group 3- < 25 % Sub endocardial Infarct and t-test 
 
 






















3- < 25 % Subendocardial Infarct Vs controls
Normal Abnormal
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E: Group 4 < 50% of myocardial infarction: 
 
4 - < 50% of myocardial 
infarction 
T1short T1long T2 
post_gadoli
nium 
 Mean 983.78 1082.05 52.68 488.73 
Median 988.00 1078.00 52.00 484.00 
Std. Deviation 137.751 73.069 5.038 65.401 
Range 406 346 26 289 
Minimum 820 958 43 347 
Maximum 1226 1304 69 636 
 
Table8: T1, T2 values of group 4- <50 % Infarct 
 
Mean segmental T1 and T2 values in group 4 < 50% of myocardial infarction: 
Group 4: T1 short: 983.7 ±137 ms,  
T1 long: 1082±73 ms,  
T2:52.6±5 ms,  
T1 post gadolinium: 488.7±65 ms, p<0.05%.  
Native T1 shows significant relation to the degree of myocardial damage assessed by late 
gadolinium enhancement.  Myocardial segments with <50% infarction are considered viable.T1 
values predict the functional recovery after MI. Mean T1 long 1082±73 ms of group 4 can 
potentially be taken as cut- off to differentiate viable and non-viable myocardium. 
 









Normal 956.57 65.641 
Abnormal 983.78 137.751 
T1 long        
Normal 1040.47 74.391 
Abnormal 1082.05 73.069 
T2 
Normal 51.32 16.791 
Abnormal 52.68 5.038 
T1 - 
Gadolinium    
Normal 561.65 70.639 
Abnormal 488.73 65.401 
 







T1 Short .005 -27.212 9.755 
.123 -27.212 17.403 
T1 Long .000 -41.574 9.636 
.000 -41.574 9.494 
T2 .521 -1.364 2.126 
.135 -1.364 .909 
T1 - 
Gadolinium     
.000 72.915 9.838 
.000 72.915 9.237 
 
Table.9: Comparison between Controls and group 4- <50 % Infarct and t-test 
 




















4 - <50 % Infarct Vs controls
Normal Abnormal
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Table10: T1, T2 values of group 5- < 75 % Transmural Infarct 
Mean segmental T1 and T2 values in group 5 (50- 75% of transmural infarction): 
Group 5: T1 short: 1018.32±106 ms,  
T1 long: 1115.78±104 ms,  
T2:55.4± 7ms,  
T1 post gadolinium: 427.6±114 ms, p<0.05% 
Myocardial segments with 50-75% thickness of LGE are non-viable segments and there is low 
chance of improvement after revascularization procedures. In this group, native T1 was less 




5 - < 75% of transmural 
infarction 
T1short T1long T2 post_gadoli
nium 
 Mean 1018.32 1115.78 55.40 427.62 
Median 1022.00 1107.00 55.00 427.00 
Std. Deviation 106.340 104.333 7.161 114.284 
Range 620 777 45 390 
Minimum 671 816 45 231 
Maximum 1291 1593 90 621 
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Normal 956.57 65.641 
Abnormal 1018.32 106.340 
T1 long         
Normal 1040.47 74.391 
Abnormal 1115.78 104.333 
T2 
Normal 51.32 16.791 
Abnormal 55.40 7.161 
T1 - 
Gadolinium    
Normal 561.65 70.639 
Abnormal 427.62 114.284 
 







T1 Short .000 -61.747 9.602 
.000 -61.747 14.310 
T1 Long .000 -75.309 10.104 
.000 -75.309 13.345 
T2 .053 -4.081 2.102 
.000 -4.081 1.101 
T1 - 
Gadolinium     
.000 134.025 11.577 
.000 134.025 17.297 
 
Table11: Comparison between Controls and group 5- < 75 % Transmural Infarct 
 
 




















5- < 75 % Transmural Infarct
Normal Abnormal
P a g e  | 62 
 








Table12: T1, T2 values of group 6- > 75 % Transmural Infarct 
 
Mean segmental T1 and T2 values in group 6 > 75% transmural infarction: 
Group 6: T1 short: 1037.46±112 ms,  
T1 long: 1125±17 ms,  
T2:58.11±8ms,  
T1 post gadolinium: 420.9±113 ms, p<0.05%. 
6 - > 75% transmural 
infarction T1short T1long T2 
post_gadol
inium 
 Mean 1037.46 1125.17 58.11 420.93 
Median 1030.00 1116.00 56.00 410.00 
Std. Deviation 112.689 111.933 8.992 113.989 
Range 916 895 53 944 
Minimum 574 646 39 230 
Maximum 1490 1541 92 1174 
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Normal 956.57 65.641 
Abnormal 1037.46 112.689 
T1 long        
Normal 1040.47 74.391 
Abnormal 1125.17 111.933 
T2 
Normal 51.32 16.791 
Abnormal 58.11 8.992 
T1 - 
Gadolinium   
Normal 561.65 70.639 
Abnormal 420.93 113.989 
 







T1 Short .000 -80.891 5.699 
.000 -80.891 6.834 
T1 Long .000 -84.695 5.940 
.000 -84.695 6.849 
T2 .000 -6.793 1.013 
.000 -6.793 .827 
T1 - 
Gadolinium     
.000 140.716 6.357 
.000 140.716 7.321 
 
 
Table13: Comparison between Controls and group 6- > 75 % Transmural Infarct 
 
 





















6 - > 75 % Transmural Infarct Vs controls
Normal Abnormal
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Diagnostic accuracy of native T1 values was better than T2 values in the assessment of different 
groups of myocardial infarctions. 
Ranges of T1 values (short and long), T2 values and post gadolinium T1 values in the different 
categories are shown below. 
 
Fig.: 30 
For T1 values assessed by short T1 method, controls and normal segments in patients showed very 
narrow range of values, which significantly differed from each other. Similarly, the range of values in 
segments with different degrees of infarcts was different from controls except in group 4, which showed 
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overlap with normal values. Overlap in the ranges of viable (groups 3 and 4) and non-viable infarcts 
(groups 5 ad 6) is also evident. 
 
Fig. 31 
For T1 values assessed by long T1 method, Controls and normal segments in patients showed a 
narrow range of values, which significantly differed from each other. Similarly, all types of 
segments in patients differed from controls. Again, overlap in the ranges of viable (groups 3 and 
4) and non-viable infarcts (groups 5 ad 6) was present, but, to a lesser degree than short T1 
method. 
 




There was considerable overlap in the ranges of T2 values across different categories. T2 maps 
mainly depict edema in acute MI and, can differentiate acute and chronic infarction based on the 
presence and absence of edema. Myocardial edema usually resolves six months after acute 
insult. As almost all of our patients had chronic MI, T2 mapping was not very helpful to 
differentiate the groups. 
 




Post gadolinium T1 values show significant reduction in non-viable infarction (> 50%  
infarction) as compared to normals and also as compared to < 50% infarct with no significant 
overlap in the ranges. Post contract T1 values are more accurate in the detection non-viable 
infarction.  
There was some overlap between 1-25% infarct and normal subjects. As the number of 
segments in the 1-25% infarct category is small, these results could be spurious. 
 
 




Combined graph of all the maps shows a trend of increasing native T1 (long and short) with 
increasing degree of infarct, and decreasing post gadolinium T1 values, with higher grades of 
infarcts. T2 values were not significantly different as most of our patients had chronic MI and 
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                                                           ROC Curve: 
Viable Vs Non-viable infarction 
(<25% and <50% Vs <75% and>75% infarction) 
Using ROC curves, a threshold of 1086 ms on T1 short imaging, best differentiated viable and 
non-viable myocardium with sensitivity of 91.3% and specificity of 29.2%. A T1 long threshold 
of 1091ms best differentiated viable and non-viable myocardium with sensitivity of 51.8% and 






                          
Graph.1:  combined T1 short and long for viable Vs non-viable infarction 




Area under the ROC curve (AUC) 
Variable AUC 95% CI 
T1_Short 0.595 0.493, 0.692 
T1_Long 0.576 0.473, 0.674 
 
Summary 
Variable Cutoff Sensitivity (%) Specificity (%) 
T1_Short 1086 91.358 29.201 
T1_Long 1091 51.852 61.433 
 
Comparison 
Comparison AUC Diff. P – Value 
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ROC Curve:  (T1 Short) 
 
Graph. 2:  T1 short for viable Vs non-viable infarction 
Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.597   ( 0.495, 0.694) 
Standard Error : 0.032 
Prob > Z (P - Value) : 0.001 
 
Summary 
Cutoff : 1086 
Sensitivity (%) : 91.358 
Specificity (%) : 29.301 
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                                               ROC Curve:  (T1 Long) 
 
Graph. 3:  T1 long for viable Vs non-viable infarction 
Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.578   ( 0.475, 0.676) 
Standard Error : 0.033 
Prob > Z (P - Value) : 0.009 
 
Summary 
Cutoff : 1091 
Sensitivity (%) : 51.724 
Specificity (%) : 62.176 
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ROC Curve: 
Normal (controls) Vs. Infarcted myocardial segments 
(<25%, <50 %,< 75%, >75% infarction) 
A T1 short threshold of 979 ms best differentiated normal and infarcted myocardium with 
sensitivity of 67% and specificity of 67%. A T1 long threshold of 1099ms best differentiated 
normal and infarcted myocardium with sensitivity of 47% and specificity of 84%. 
 
Graph. 4:  Normal (controls) Vs. Infarcted myocardial segments (Combined) 
 





Area under the ROC curve (AUC) 
Variable AUC 95% CI 
T1short 0.721 0.622, 0.806 
T1long 0.708 0.609, 0.795 
 
Summary 
Variable Cutoff Sensitivity (%) Specificity (%) 
T1short 979 67.14 67.025 




Comparison AUC Diff. P – Value 
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ROC Curve:  (T1 Short) 
 
Graph. 6:  T1 short of normal (controls) Vs. infarcted myocardial segments 
Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.724   ( 0.626, 0.809) 
Standard Error : 0.013 
Prob > Z (P - Value) : <0.001 
 
Summary 
Cutoff : 979 
Sensitivity (%) : 67.277 
Specificity (%) : 67.259 
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ROC Curve (T1 Long) 
 
Graph. 7:   T1 long of normal (controls) Vs. infarcted myocardial segments 
Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.718   ( 0.619, 0.803) 
Standard Error : 0.012 
Prob > Z (P - Value) : <0.001 
 
Summary 
Cutoff : 1066 
Sensitivity (%) : 64.694 
Specificity (%) : 68.353 
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T1, T2 mapping of the myocardium with non- viable infarct with >75% of transmural 
enhancement  










                
                                                                                     
 
 






Fig.35: >75% transmural infarction - LGE 
Fig.36:  >75% transmural infarction -LGE 
Fig.37: T1 Long - >75% transmural infarction Fig.38: T1 Long->75% transmural infarction 
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Fig.40T2 - >75% transmural infarction 
 
 


















   
 
Fig.39: T2 - >75% transmural infarction 
Fig.41:  T1 short- >75% transmural infarction Fig.42:   T1 short- >75% transmural infarction 
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Fig.43: T1 post gadoliniumlinium- >75% transmural 
infarction 
Fig.44:  T1 post gadoliniumlinium- >75% transmural  
      infarction 
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T1, T2 mapping of the myocardium with non- viable infarct with >75% of transmural 
enhancement  
 
                                                                                                   
 










                                                                                                                                             
 
 




Fig.46:    >75% transmural infarction - LGE 
Fig.47:  T1 long: >75% transmural infarction 
Fig.45:  >75% transmural infarction - LGE 
Fig.48:   T1 long: >75% transmural infarction 
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Fig.50:  T2: >75% transmural infarction 
Fig.51:  T1 Short: >75% transmural                                               
infarction 
Fig.52:  T1 Short: >75% transmural infarction 
















Fig.53: T1 post gadolinium: >75% transmural 
infarction 
Fig.54: T1 post gadolinium: >75% transmural infarction 




Parametric T1 and T2 mapping of the myocardium is a novel technique for quantitative 
measurements of T1 and T2 relaxation times of myocardium, which can reflect disease process. 
These values can be depicted on colour coded maps and the values can be calculated by drawing 
ROIs on the colour maps. Routine acquisition of T1 and T2 maps are now possible in all 
patients referred for cardiac MRI, due to improvement in technology and T1 mapping is a 
clinical tool now. 
Terminology: 
Technical terms used in T1 and T2 mapping of the myocardium 
Terminology                        Meaning of the term 
Native T1                 T1 that is acquired without  contrast media   
T1ms   Time constant for T1 recovery (spin-lattice relaxation or longitudinal 
magnetization) 
T2ms             Time constant for T2 recovery or spin-spin relaxation(transverse 
magnetization) 
Parametric   mapping Additional images obtained from each pixel (T1 and T2 magnetic 
tissue properties) 
T1 post Gadolinium T1 values acquired after contrast is given 
 
Table. 14 Technical terms used in T1 and T2 mapping of the myocardium 
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Normal values: The composition of the myocardial tissue is uniform and has a regular magnetic 
property. When acquired under the same conditions, T1 and T2 relaxation values have a narrow 
range. T1 and T2 values are different at 1.5T and 3T CMRI. In this study, the native T1, post 
contrast T1 and T2 mapping of myocardium was performed using the MOLLI sequence, on 1.5-
T MRI scanner (1.5T Siemens Magnetom Avanto fit).  
Number of healthy individuals required for reference ranges for low precision, which is 
sufficient for large magnitude biological changes (like acute myocardial injury, amyloid, iron 
deposition) are 20 normal subjects. High precision is necessary for small magnitude biological 
changes (like diffuse myocardial fibrosis), and for a high precision, sample size of 50 healthy 
individuals was calculated. 
In our study, control group had 31 healthy individuals, which was sufficient to take it as a 
reference range for myocardial infarction (with low precision). Mean and lower and upper range 
of normal was obtained by mean ± 2 SD of the normal data in our study. 
Color coded maps were generated and the T1 and T2 relaxation values in different segments 
were calculated by manually drawing ROIs in the 17 segment model as described by the 
American Heart Association was used to describe the T1 and T2 mapping. Large drawing ROIs 
covering complete area of each segment was used. ROIs were placed accurately in the central 
myocardium on the color maps, avoiding partial volume artifacts of adjacent blood pool and 
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Mean segmental T1 and T2 values in the controls: 
 
Values In our study ms 
Standard Reference values quoted in literature 
(which may vary in different machines) ms 
Native T1 (long 
T1 method) 
1040.47±74 982±46 (58)  
T1 short  956.57 ± 65.6 No data available 
T2         51.3±16  52.18 (33) 
T1 post 
gadolinium 
561.65 ±70  523±72 
 
Table. 15 Mean segmental T1 and T2 values in the controls 
We established native T1, T1 (post Gadolinium) and T2 relaxation times of myocardium in 
normal subjects and these can be used as baseline reference values in our institution, for low 
precision studies. 
Application of parametric CMRI in myocardial infarction: 
Management of myocardial infarction and ischemic heart disease depends upon viability 
assessment. If more than 50% of the thickness of the myocardium is infarcted, it is less likely to 
benefit or recover functionality after re-vascularization. Conventionally, this is determined by 
assessing the degree of transmurality on the late Gadolinium enhancement images. 
We included 40 patients with myocardial infarction in the study. Based on the final diagnosis on 
the routine cardiac MRI images including assessment of regional wall motion abnormality and 
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the transmurality of the late gadoliniumlium enhancement images, all subjects included in the 
study were categorized as follows, for further statistical analysis -  
Category 0: healthy normal control.  
Category 1:  normal segments in MI patients (no LGE or wall motion abnormality).  
Category 2: hibernating myocardium (wall motion abnormality with no LGE). 
Category 3: Infarct with residual viable myocardium (wall motion abnormality with LGE in 1 - 
24%thickness of myocardium). 
Category 4: Infarct with residual viable myocardium (wall motion abnormality with LGE in 26-
49% thickness of myocardium). 
Category 5: Infarct with no significant residual viable myocardium (wall motion abnormality 
with LGE in 50-74% thickness of myocardium). 
Category 6: Infarct with no residual viable myocardium (wall motion abnormality with LGE in 
>75% thickness of myocardium or transmural infarct). 
These categories were assigned at a later stage and at the time of recording the T1 and T2 
values, the principal investigator was blinded to the categories. Segments with LGE <50% were 
considered viable and more than 50% were considered as non-viable. Total number of 
myocardial segments analyzed was 1731. Number of segments analyzed in patients was 58% 
(1000) and controls were 42% (731). 
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T1, T2 and T1 post Gadolinium values obtained from Myomaps were compared with LGE 
viability. Native T1 has high diagnostic potential in the differentiation of normal, non-viable and 
viable myocardium.  












4 < 50% of 
myocardial 
ms 
5 < 75% of 
transmural 
ms 
6 - > 75% 
transmural 
ms 
T1 short 956.57 ± 65.6 993.70± 62.9 1066.56± 600 1042.94±66.7 983.7 ±137 1018.32±106 1037.46±112 
T1 long 1040.47±74 1077.90 ±75.5 1101.56±74.5 1149.09±97.5 1082±73 1115.78±104 1125±17 
T2 51.3±16 53.21±5.6 53.2± 5.1 56±6.3 52.6±5 55.4± 7 58.11±8 
T1 post 
gadolinium 
561.65 ±70 516.05± 89 513.86±86 570.83±72 488.7±65 427.6±114 420.9±113 
 
Table. 16. Mean segmental T1 and T2 values in the category 0 to 6 
The values obtained in our study were in correlation with the mean segmental T1 values for 
different grades of myocardial infarction in comparison to study done by Dastidar et al (57) in 
viability assessment of chronic MI. 
In their study, they used a scale of 0-4 (0=no scar, 1=1to24%, 2=25to49%, 3=50to74%, 4>75% 













4 < 50% of 
myocardial 
Ms 
5 < 75% of 
transmural 
ms 
6 - > 75% 
transmural 
Ms 
T1 NIL 1031±31 NIL 1070±33  1103±32 1164±58 1206±118  
T2 NIL 52±4 NIL 55±4  58±5  59±8 66±9  
 
Table. 17  Values obtained in a study by Dastidar et al (57) 
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The threshold values in our study were as follows: 
Threshold native T1 value of 1091ms, calculated by T1 long method differentiated viable and 
non-viable myocardium with sensitivity of 51.7% and specificity of 62.2%, in comparison to 
threshold T1 of 1090 ms which best differentiated viable from non-viable segments with 
sensitivity of 90% in the study by Dastidar et al(57). 
Similarly, threshold value of 1086 ms on T1 short method best differentiated viable and non–
viable myocardium with sensitivity of 91.4% and specificity of 29.3%.   
T1 short threshold of 979 ms best differentiated normal and infarcted myocardium with 
sensitivity of 67.14% and specificity of 67.025%. A T1 long threshold of 1099 ms differentiated 
normal and infarcted myocardium with sensitivity of 47.05% and specificity of 84.8%. 
Native T1, T2 values were more in all categories of patients as compared to the controls and this 
was statistically significant with p<0.05 and with 95% confidence intervals. This suggests that 
parametric T1 and T2 mapping of the myocardium has high diagnostic potential in the 
differentiation of normal, non-viable and viable myocardium. Even the seemingly normal 
segments in patients with myocardial infarction, are actually abnormal, which may be related to 
remodeling of LV and adverse cardiac event possibly causes increase in the native T1 in remote 
areas of the heart. 
Native T1 shows significant relation of the degree of myocardial damage assessed by late 
gadolinium enhancement.  Myocardial segments with <50% infarction are considered viable.T1 
values can potentially be used to predict the functional recovery after MI. Mean T1 long 
1082±73 ms of group 4 can be taken as cut-off to differentiate viable and non-viable 
myocardium. 
P a g e  | 89 
 
Combined graphs of show that native T1 (long and short) has better diagnostic accuracy to 
detect different groups of myocardial infarction as compared to T2 values. 
 T2 maps can differentiate acute and chronic infarction based on the presence or absence of 
myocardial edema which usually resolves six months after acute insult. Since most of our 
patients had chronic infarct, T2 mapping was not particularly helpful. 
Post gadolinium T1 values show significant reduction in non-viable infarction (> 50% thickness 
of LGE). Post contrast T1 values were more accurate in the detection of non-viable infarction.  
Factors that influence post contrast T1 values are contrast dose, time and type of contrast.  
Significance of post contrast T1 is reduced due to the above factors. So native T1 mapping 
(without contrast) is preferred to quantify myocardial infarction. 
Nephrogenic systemic fibrosis, a systemic fatal scleroderma like illness with gadolinium 
develops in patients with moderate /severe kidney failure. So non-contrast T1 mapping can 
potentially replace gadolinium in patients with renal failure, to assess the myocardial infarction 
and viability.   
Focal scarring is seen on LGE due to visual difference in the signal intensity between the area of 
focal scarring and normal myocardium.  Interstitial fibrosis or diffuse fibrosis is not seen on 
LGE as it lacks the difference in signal intensity to be visually appreciated. An inversion pulse 
with LGE uniformly suppresses the entire myocardium despite retention of contrast. By 
measuring the intrinsic T1 time, T1 mapping overcomes this limitation. So T1 mapping is the 
imaging technique in the identification of diffuse myocardial fibrosis. 
 
 




Cardiac MRI with its excellent spatial resolution is a gold standard in the evaluation of cardiac 
anatomy and function.  
 
We set up the practice of performing T1 and T2 mapping in our institution and established 
native T1, T2 relaxation times and post contrast T1 values of myocardium in normal subjects 
which can be used as baseline reference values in our institution. Normal T1 values in our 
institution are 1040.47±74 ms (native) and 561.65 ±70 ms (post contrast). Normal T2 value is 
51.3±16 ms.  
 
T1 values were higher in all categories of segments in patients with myocardial infarcts as 
compared to the controls which was statistically significant with p value of <0.05 and 95% 
confidence interval.  The native T1 values showed an increasing trend with increasing degree of 
infarct, while the post contrast T1 values showed a decreasing trend. T2 values were not 
significantly different across categories. This is probably because all the patients in our study 
had chronic myocardial infarction. 
 
Apparently normal segments in patients with myocardial infarction are probably actually 
abnormal, as even these segments showed higher native T1 values than controls which may be 
related to remodeling of left ventricle. This could not be detected by conventional late 
gadolinium enhancement imaging.  
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T1 mapping has great potential in differentiating normal from infarcted myocardium and also 
viable (infarct involving <50% thickness of myocardium) from non-viable (infarct involving 
>50% thickness of myocardium) segments. Threshold native T1 value of 1091 ms differentiated 
viable from non-viable myocardium with sensitivity of 51.7% and specificity of 62.2%.  
Native T1 mapping can thus, potentially replace post gadolinium studies in the evaluation of 



















1. Manually drawn ROIs are subject to partial volume from extra cardiac tissue and adjacent 
blood. Software package for analysis with automatically generated ROIs will standardize the 
analysis and reduce manual effort. 
2. In a segment with partial involvement, the ROIs were not restricted to the region of 
involvement. Instead, the entire segment was included. 
3. Baseline reference values of high precision (small magnitude biological changes) studies 
required recruitment of 50 healthy normal controls. 20 more studies need to be included in the 
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WRITTEN INFORMED CONSENT FORM 
For normal population        Date: 
Study title: T1 and T2 mapping of the myocardium 
It has been explained to me by the investigator in the language that I understand that this study is being 
carried out as extra imaging in addition to the regular MRI that I will be undergoing. By this technique, 
they are trying to study two properties of heart muscle called T1 and T2 relaxation times, and finding the 
normal range of values in Indian population in this MRI machine. 
It has been explained to me that no extra drugs / extra charges  and there is no risk involved in this study 
It has also been explained that I am free to withdraw from the study any time I want and this will not in 
any way compromise my treatment. I understand that my identity and participation will not be revealed 
in any information released to third parties.  
No Extra Charges 
Subjects’ Name :                                     
Date of Birth/ Age: 
 I confirm that I have read and understood the information sheet for the above study and have 
had the opportunity to ask questions 
 I understand my participation is purely voluntary and that I can withdraw from the study 
anytime, without any reason, without my medical care being affected. 
 I understand that my identity will not be revealed in any information. 
I agree to take part in the above study. 
Signature of subject                                                                     Date 
Name of the subject      Thumb Impression 
Signature of the investigator                                                         Date 
Name of the investigator 
Signature of the witness                                                                Date     
Name of the witness      Thumb Impression 
Contract address: 
 
Dr. Grace Rebecca, PG Registrar, Department of Radiology, Christian Medical College and Hospital, 
Vellore – 632 004, Tamil Nadu, Mobile No :9442249535 
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ͧलखा सूͬचत सहमǓत फॉम[ 
आम जनता के ͧलए       तारȣख:    
अÚययन का शीष[क : T1 और T 2 मायोकाͫड [यम के मानͬचğण 
अÛवेषक ɮवारा मुझे समझाया गया है ͩक मɇ समझता हू ँͩक इस अÚययन Ǔनयͧमत एमआरआई ͩक दौर से गुजर 
रहा होगा के अलावा अǓतǐरÈत इमेिजंग के Ǿप मɅ ͩकया जा रहा है | इस तकनीक के ɮवारा, वे T2 छूट बार T1 
बुलाया ǿदय कȧ मांसपेशी के दो गुण और अÚययन करने के ͧलए कोͧशश कर रहे हɇ, और इस एमआरआई मशीन 
मɅ भारतीय आबादȣ मɅ मूãयɉ के सामाÛय Įेणी खोजने कोͧशश कर रहे हɇ | 
यह मुझे समझाया गया है ͩक ǒबना ͩकसी अǓतǐरÈत दवाओ ंका इèतेमाल कर रहे हɇ और इस अÚययन मɅ कोई 
खतरा शाͧमल नहȣ ंहै | यह भी बताया गया है ͩक मɇ ͩकसी भी समय अÚययन से वापस लेने के ͧलए èवतंğ हू ँऔर 
मɇ चाहता हू ँयह ͩकसी भी तरह से मेरे इलाज समझौता नहȣ ंकरɅगे | मɇ समझता हू ँͩक मेरȣ पहचान और भागीदारȣ 
तीसरे प¢ के ͧलए जारȣ ͩकया गया कोई भी जानकारȣ मɅ खुलासा नहȣं ͩकया जाएगा |  
 
No Extra Charges 
 
åयिÈत का नाम:  
जÛम / आय ुǑदनांक : 
• मɇ इस बात कȧ पुिçट है ͩक मɇने पढ़ा है और ऊपर के अÚययन के ͧलए जानकारȣ शीट को समझा और 
सवाल पूछने का मौका ͧमला है | 
 • मɇ समझता हू ँͩक मेरȣ भागीदारȣ पूरȣ तरह èवैिÍछक है और मɇ ͩकसी भी कारण के ǒबना, मेरे 
ͬचͩक×सा, देखभाल Ĥभाͪवत ͩकया ǒबना अÚययन ͩकसी भी समय  वापस ले सकता हू ँ|  
 • मɇ समझता हू ँͩक मेरȣ पहचान कोई भी जानकारȣ मɅ पता नहȣ ंͩकया जाएगा। मɇ ऊपर अÚययन मɅ 
भाग लेने के ͧलए सहमत हू ँ। 
 
åयिÈत के हèता¢र       Ǒदनांक 
åयिÈत का नाम       
 
åयिÈत के हèता¢र       Ǒदनांक 
åयिÈत का नाम 
 
åयिÈत के हèता¢र       Ǒदनांक 
åयिÈत का नाम       
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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               িলিখত অবিহত সɖিত ফমŪ                    তািরখ: 
 গেবষণার িশেরানাম: myocardium এর T1 এবং T2 মƟািপং 
এটা ভাষা ĺয আিম বুঝেত পাির ĺয এই গেবষণায় অিতিরǏ পরীǘা সɑȵ হেǱ তদȭকারী ʸারা আমােক বƟাখƟা করা 
হেয়েছ | T1 এর মƟািপং, তাড়াতািড় ĺরাগ শনাǏ, ĺরােগর তীƷতা িনণŪয় এবং িনিদŪɳ অবʆার মেধƟ ĺরােগরগিতিনেদŪশক 
অȭŪদৃিɳ Ƶদান করার Ƶিত˟িত এটা | আমার কােছ বƟাখƟা করা হেয়েছ ĺয ĺকান অিতিরǏ ওষুধ বƟবহার করা হয় না 
এবং ĺকান ঝঁুিক তার ĺনই এই গেবষণায় | এǅ বƟাখƟা করা হেয়েছ ĺয আিম গেবষণা ĺথেক ĺয ĺকান সময় আিম  নাম  
ƵতƟাহার করার িবষয় মুǏ  এবং এই ছিবǅ ĺকানভােবই আমার িচিক̘সা িনেয় সমেঝাতা করেব না | আিম বুেঝিছ ĺয 
আমার পিরচয় এবং অংশƣহণ তৃতীয় পেǘর কােছ ĺকােনা তথƟ Ƶকাশ করা হেব না. 
No Extra Charges 
Ƶজা 'নাম 
জȶ / বয়স তািরখ: 
i) আিম িনিɩত করিছ ĺয আিম পেড়িছ এবং উপের অধƟয়েনর জনƟ তথƟ শীট বুেঝিছ এবং Ƶɬ িজǷাসা করার সুেযাগ 
িছল 
ii) আিম বুেঝিছ আমার অংশƣহণ িব˝ȝ˚েপ ĺ˰Ǳােসবামূলক এবং আিম ĺকান কারণ ছাড়াই, অধƟয়ন ĺয ĺকােনা সময় 
ĺথেক নাম ƵতƟাহার করেত পাির, আমার িচিকৎসা  ǘিতƣʅ না কের | 
iii) আিম বুেঝিছ ĺয আমার পিরচয় ĺকান তথƟ Ƶকাশ করা হেব না. 
iv) আিম উপের গেবষণায় অংশ িনেত সɖত হন. 
িবষয় এর ˰াǘর                                                                          তািরখ 
িবষয় এর নাম      Thumb Impression 
তদȭকারীর  ˰াǘর                                                                     তািরখ     
তদȭকারী র নাম 
সাǘীর ˰াǘর                                                                             তািরখ   
সাǘীর নাম      Thumb Impression  
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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WRITTEN INFORMED CONSENT FORM 
Date: 
Study title: T1 and T2 mapping of the myocardium 
It has been explained to me by the investigator in the language that I understand that this study is being 
carried out as extra test. T1 mapping promises to detect early disease, quantify disease severity and 
provide prognostic insights into certain conditions. It has been explained to me that no extra drugs/ extra 
charge and there is no risk involved in this study It has also been explained that I am free to withdraw 
from the study any time I want and this will not in any way compromise my treatment. I understand that 
my identity and participation will not be revealed in any information released to third parties.  
No Extra Charges 
Subjects’ Name                                      
Date of Birth/ Age: 
 I confirm that I have read and understood the information sheet for the above study and have 
had the opportunity to ask questions 
 I understand my participation is purely voluntary and that I can withdraw from the study 
anytime, without any reason, without my medical care being affected. 
 I understand that my identity will not be revealed in any information. 
 I agree to take part in the above study. 
 
Signature of subject                                                                       Date 
Name of the subject      Thumb impression 
Signature of the investigator                                                        Date 
Name of the investigator 
Signature of the witness                                                                Date     




For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535; Tamil Nadu 
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ͧलखा सूͬचत सहमǓत फॉम[ 
अÚययन का शीष[क : T1 और T 2 मायोकाͫड [यम के मानͬचğण               तारȣख: 
 
यह अÛवेषक ने मुझे समझाया है मɇ समझता हू ँͩक इस अÚययन अǓतǐरÈत परȣ¢ण के Ǿप मɅ ͩकया जा रहा है ।  
T1 मानͬचğण जãदȣ बीमारȣ का पता लगाने का वादा ͩकया, रोग कȧ गंभीरता यɉ और कुछ शतɟ मɅ शकुन 
अंतǺ[िçट Ĥदान |  
यह मुझे समझाया गया है ͩक ǒबना ͩकसी अǓतǐरÈत दवाओ ंका इèतेमाल कर रहे हɇ और वहा ँकोई खतरा नहȣ ंइस 
अÚययन मɅ शाͧमल है | यह भी बताया गया है ͩक मɇ अÚययन से ͩकसी भी समय मɇ वापस लेने के ͧलए èवतंğ हू ँ
और यह ͩकसी भी तरह से मेरे इलाज मɅ समझौता नहȣ ंकरɅगे | मɇ समझता हू ँͩक मेरȣ पहचान और भागीदारȣ तीसरे 
प¢ के ͧलए जारȣ ͩकया गया कोई भी जानकारȣ मɅ खुलासा नहȣ ंͩकया जाएगा | 
 
No Extra Charges 
 
åयिÈत का नाम:  
जÛम / आय ुǑदनांक : 
 
1) मɇ इस बात कȧ पुिçट है ͩक मɇने पढ़ा है और ऊपर के अÚययन के ͧलए जानकारȣ शीट को समझा और 
सवाल पूछने का मौका ͧमला है | 
2) मुझे समझ मɅ मेरȣ भागीदारȣ पूरȣ तरह èवैिÍछक है और मɇ ͩकसी भी कारण के ǒबना , अÚययन ͩकसी भी 
समय  मेरे ͬचͩक×सा देखभाल Ĥभाͪवत ͩकए ǒबना वापस ले सकता  हू ँ। 
3) मɇ समझता हू ँͩक मेरȣ पहचान कोई भी जानकारȣ मɅ पता नहȣ ंͩकया जाएगा। 
4) मɇ उपरोÈत अÚययन मɅ भाग लेने के ͧलए सहमत हɇ। 
 
åयिÈत के हèता¢र       Ǒदनांक 
åयिÈत का नाम       
       Thumb Impression 
अÛवेषक के हèता¢र       Ǒदनांक 
अÛवेषक के हèता¢र       Ǒदनांक 
गवाह के हèता¢र        Ǒदनांक 
 
गवाह का नाम      Thumb Impression 
 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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ேமேல ெசால~பy இ¯t ஆராvசி ஆவ பuேகபத நuக 
அைழtக~பகிறƫக.  
பuேகக நuக சமதிt «}, ப}வ¯வன பறி உuக¶t ஆவாளƫ 
ெதƬவtt ேவz:  
i. ேநாtக, ெச«ைறக, ம² ஆராvசிய} கால அளº; 
ii. ேசாதைனகள பய}ப{த~பபைவயாக இ¯t ெச«ைறக;  
iii. ஏேத§ நியாயமாக எதிƫபாƫtகt ய அபாயuக அல¢ 
அெசௗகƬயuக; 
iv. ஆராvசி} ஏேத§ உளாƫ|த பல}க;  
v. ஏேத§ மா² ெச«ைறக அல¢ சிகிvைசக; ம²  
vi. இரகசிய{த}ைம எவா² பா¢காtக~ப. 
ெபா¯|¢ இடuகள, ப}வ¯வன பறி­ ஆவாளƫ உuக¶t{ 
ெதƬவtக ேவz:  
i. காய ஏபyடா இ¯tகி}ற ஏேத§ இழ~ப அல¢ ம¯{¢வ 
சிகிvைச;  
ii. எதிƫபாராத அபாயuக¶tகான சா{திய;  
iii. ஆவாளƫ உuக பuேகைப நி²{தt ய நிைலக;  
iv. உuக¶t ஆ ஏேத§ த ெசலºக;  
v. பuேகபைத நி²{த நuக «º ெசதா எ}ன நடt;  
vi. பuேக உuக வ¯~ப{ைத பாதிtகt ய ©திய 
கzப~©க பறி உuக¶t எ~ேபா¢ ெசால~ப; ம²  
vii. ஆவ எ{தைன ேபƫ பuேகபாƫக. 
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No Extra Charges 
பuேகக நuக சமதி{தா, இ|த ஆவண{தி ைகெய¸{திட~பyட நக 
ஒ}², ஆராvசி பறிய எ¸{தªƫவமான ெதா~©ைர ஒ}² உuக¶t 
ெகாtக~பட ேவz. 
ஆராvசி பறி உuக¶t ேகவக இ¯|தா எ|த சமய{தி´ __(Name of 
Principal Investigator)__ அவƫகைள ___(Contact Details)___ - நuக ெதாடƫ© 
ெகாளலா. 
ஆராvசிய} ேபா¢  நuக காயபyடா உuகள¢ ஆவாளƫ, __(Name of 
Principal Investigator)__  அவƫகைள  ___(Contact Details)___ - நuக ெதாடƫ© 
ெகாளலா. 
 
றி~©: அைன{¢ ஆºக¶t, தயº ெச¢ ைற|தபyச உuக 
ம¯{¢வமைனய} ெதாைலேபசி எzைண றி~படº. ேம´ அதிக பyச 
ஆப{தான ஆºக¶t, ம¯{¢வமைனய} ெதாைலேபசி எz ம²மி}றி 
உuகள¢  
ஆவாளƫ  அல¢ ஆº வழிநட{¢னƫ  ெதாைலேபசி எzைண 
றி~படº. [தயº ெச¢ ப{த ப}னƫ இ|த றி~ைப நtகº.] 
 
நuக ஒ¯ ஆராvசி பuேகபாளராக, உuக உƬைமகைள பறி ஒ¯ 
த|திரமான க¯{¢ ேவz எ}² வ¯பனா, நuக NHG Domain Specific 
Review Board-ைடய  ெசயலக{¢t 6471-3266-  ெதாடƫ© ெகாளலா. 
இ|த ஆராvசிய உuக பuேக© யவ¯~பமா. நuகள பuேகக  
ம²{தா அல¢ நி²{த «º ெசதா,  நuக தztக~பட மாyƫக 
அல¢ பல}கைள இழtக மாyƫக.  
ேம´ள தகவக உளy ஆராvசி  ஆவான¢ உuக¶t 
வாவழியாக  வளtக~பy¯tகிற¢ ம² பuேகபத நuக 
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___________________________ ________________________________ ________________ 

































ஆவாளƫ ெபயƫ  ஆவாளƫ ைகெய¸{¢  ேததி     
 
        Thumb Impression 
 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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                                     PATIENT INFORMATION SHEET 
Study title: T1 and T2 mapping of the myocardium  
The following information is provided to inform you about this study and your participation in it. Please 
read the information carefully and you are free to ask any questions regarding the study and the 
information given. The participation in this study is purely voluntary and you are free to withdraw from 
the study anytime. 
Purpose of the study: 
A cardiac MRI T1 and T2 myocardial mapping technique is a non –invasive study, enabling direct 
visualisation of properties and healthiness of heart muscle. By this technique, we are trying to study two 
properties of heart muscle called T1 and T2 relaxation times, by doing some extra imaging, in addition 
to the regular MRI that you will be undergoing. 
T1 mapping promises to detect early disease, quantify disease severity and provide prognostic insights 
into certain conditions. 
No Extra charge  
Method to be followed: 
Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
Intravenous (IV) cannula (usually 20G) will be placed. 
Baseline blood pressure will be checked. 
During the test: 
Standard MRI sequences including post Gadolinium studies will be obtained as requested by your 
treating doctor.  
In addition, extra sequences will be done including native T1 andT2 mapping and post contrast T1 
mapping of myocardium is done which takes additional 1 minute 
Confidentiality: 
The participation in the study will remain confidential and shall be known only to the investigators.  
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Withdrawal from the study: 
Participation in this study is purely voluntary and you can withdraw from the study anytime without any 
reason. It will not compromise your treatment in any way. There are no potential risks involved in this 
study and you need not pay any extra money for the test. 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
Detailed information about the Procedure 
What is cardiac MRI T1 and T2 mapping technique?  
The magnetic resonance imaging (MRI) machine is a tube with a centre opening that is about three feet 
wide. 
 A table slides into the central opening and the patient lies on the table. Pictures of the heart are created 
using a magnetic field, radio waves and computers. 
No X-rays are used to create the images.  
The images made by the MRI will allow your doctor to look at the anatomy and functioning of your 
heart.  
In addition, by using doing T1 and T2 mapping of the heart, we will try to see the abnormality of the 
heart muscle from another perspective.  
What are the benefits and risks of the stress test? 
There is absolute no risk involved in the study. You will just have to be within the scanner for an 
additional minute or so. 
This test can potentially help us to detect the disease earlier. 
 It can also helps us to know amount of disease in the heart. 
Before the test: 
 • You cannot have anything to eat or drink for 4 hours before your test. 
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 • Take your medications as instructed by your doctor 
On day of the test  
Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
A needle {Intravenous (IV) cannula (usually 20G)} will be placed in your hand or elbow region. 
Baseline blood pressure will be checked. 
• Before the test starts, you will be asked questions about your medical history and the medication(s) 
you are taking and also to make sure it is safe for you to have an MRI scan. 
During the test:  
Standard MRI sequences including post Gadolinium studies are obtained.  
Native T1 andT2 mapping and post contrast T1 mapping of myocardium is done which takes additional 
1 minute 
• During the test, you will hear knocking sounds as the machine takes the pictures. We will also prompt 
you with instructions. For example, we may ask you to hold your breath for 8 to 10 seconds 
• It is important for you to stay as still as possible because movements can create glitches in the pictures. 
 • At the end of the procedure, your IV canula (needle) will be removed. 
After the test  
• You may resume your normal activity unless your doctor tells you differently. 
 • Take your regular medications as directed unless your doctor tells you differently. 
 • By the following day, the test results will be sent to the doctor who ordered the test. You will need to 
contact your doctor to discuss the results of your test. 
 • Keep any scheduled follow-up appointments with your primary doctor 
  For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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ĸĆĦ సమĨర పతƔమ 
అధŪయన౦ ĳÐర : T1 and T2 మŪĳింȣ ఆȶ İ మȂĥాĸŝయȹ 
ఈ అధŪయన౦లĐ Ƿాలþœ నడం గĸంǩ ఈ ĥƘంİ సమĨరం Ǿక¡ ĮెȃయĨేయడĶ¸Ûనİ. İǵǵ జగƘతŠ Ħా చİȇ ఈ 
సమĨరంలĐ Ǿక¡ ఏĺ±ౖĲ సంİేȏల¡ ఉనŤķ¹డల ĽÐŵచŖĦ  ాఅడగగలర . ఈ పĸĻĒధనలĐ Ƿాలþœ నడం ప®ĸ ŠĦ  ాĲ 
ǵరşయమǵ, ఏ ĥారణం లÌక¡ంĬ ఈ అధŪయన౦ నుంĬ ȇరǽంచుĥóనవచŖǵ Ĳక¡ ĮెȃయĨేయడĶ¸Ûనİ.  
అధŪయన౦ ఉİే Ţశం:  
ĥాĸ ŝయȡ MRI T1 and T2 మȂĥాĸŝయȽ మŪĳింȣ అనునİ సురǘతĶ¸Ûన, గంĬ ెకండĸాల పǵతనం గĸంǩ 
అధŪయన౦ Ĩేయ ఒక  పదŢǳ. ఈ పదŢǳ İŵĸా Ǿ గంĬ ెకండĸాలక¡ సంబంıంǩన ĸ²ండ¦ ȇషయల (T1 and T2) 
సడȃంప­ సమయలను Ȏాıరణ MRI ȎాŐǵంȣ ĮČ Ƿాట ఎĥాƟƫƔ ఇĶÉǭంȣ İŵĸా Ĩేయబడ¦ను. ఈ పĸȌలన İŵర 
Ǿ గంĬె కండĸాలక¡ సంబంıంǩన ĸ²ండ¦ ȇషయల (T1 and T2) సడȃంప­ సమయలĮČ ఇంĬయ İేశ ĺాసుల 
సడȃంప­ సమయలĮČ సĸచూĨెదర . 
No Extra Charges 
అధŪయన౦ Ĩేయ పదŢǳ:  
ĸĆĦ తనక¡ ǵరşķంǩన సమయǵకĲŤ ఒక గంట మందుĦా MRI ȎాŐǵంȣ ర¤మ 8 ĥ ĸావల»ను.  
ȏĽిťటȽ ĺార  ఇĨేŖ దుసుŠ లను ĳÐļ¿ంȫ ధĸంǩ బంĦార  ఆభరణల¡, ĳ¿టś డ¦ పళ¨Ŵ మĸయ ȇǵĥĬĥ సంబంǩన 
ఇతరĶ¸Ûనĺాటǵ ǴĽిĺÂయవల»ను.  
డయబ·టɂ లÌİ గంĬెక¡ సంబంıంǩన ఇతర సమసŪలక¡ ప®రŵం గరķĲĸాఅǵ Įెల¡సుĥóǵ పƔసుŠ త బų ȭ ĳ¿ƔషȻ 
Ĩెȡ ĨేĽ¿దర . 
అధŪయన సమయంలĐ:  Ǿక¡ ǩĥతŸ ĨేĽÐ Ĭకśర Ħార  అĬĦన ȇధంĦా Ȏśా ండȻŝ MRI Ĩేయబడ¦ను.  
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ECG ల»డ¦ų  Ǿ శĸĸాǵĥ అమĸŖ Ǿ గంĬ ెȁకŐ పǵȇıĲǵŤ, ĥóǵŤ cine ఇĶÉȨ లను మĸయ ĲÂటȿ T1 and 
T2 మŪĳింȣ ĨేĽ¿దర . 
T1 and T2 మŪĳింȣ Ĩేయటక¡ ఒక ǵǽషం అలĦÃ cine ఇĶÉȨ లను Ǵయటక¡ 3-4 ǵǽషమల¡ అవ­ను.  
ĥాǵŦĬెǵŷయȽ: Ǿర  ఈ అధŪయన౦లĐ Ƿాలþœ ĲÂ ȇషయం పĸĻĒధక¡ǵĥ ĥాక¡ంĬ ఇతర లక¡ Įెȃయక¡ంĬ ĦĆపŪంĦా 
ఉంĨెదర .   
అధŪయనం నుంĬ ఉపసంహరణ : 
ఈ అధŪయనంలĐ ǷాĸśĽిĳÐషȴ ప®ĸ ŠĦ  ాసŵచŗంద మĸయ Ǿర  ఏ ĥారణం లÌక¡ంĬ ఎప­ťĬైĲ అధŪయనం నుంĬ 
ĺ±నĥŐ ǴసుĥąవచుŖ. ఇİ ఏ ȇధంĦా Ǿ ǩĥతŸ ĸాǮ ఉండదు. ఈ అధŪయనంలĐ పƔĶÉయం ఏ సంĵవŪ పƔమİల 
ఉĲŤķ మĸయ Ǿర  పĸǖ ĥąసం ఏ అదనప­ డబŧ ĨెȃųȎ Šా ర  పǵలÌదు. 
ఏ పƔశŤల¡ ĥąసం , దయĨేĽ ిĬకśȻ ĦÃƘɂ ĸ²బ·ĥాŐ ĳీǮ ĸǭȎśా ƿ Ȼ Ļాఖ ĸÃĬయలǮ , ĽిఎంĽ ిĺ±ల¥ų ర  contact- . ǿబ·ౖȽ + 
9442249535 
ȇıనమ గĸంǩ ȇవరĶ¸Ûన సమĨరం 
ĥాĸ ŝయȡ MRI T1 మĸయ T2 మŪĳింȣ ట½ĥŤȡ ఏǽట ? 
 
అయȎాŐంత పƔǳధŵǵ ఇĶÉǭంȣ (MRI ) యంతƔం గĸంǩ మ¢డ¦ అడ¦గల ĺ±డల¡ť ఉంİ ఓĳ¿ǵంȣ ĥÃందƔం Ħôటśం. 
 ఒక పట śక ĥÃందƔ ǷƔా రంభ లĐĥ మǵĦ మĸయ ĸĆĦ పట śక ఉంİ. గంĬ ెȁకŐ ǩĮƔ ల¡ ర¤Ƿû ంİంǩ ఒక ఐȎాŐంత , 
ĸÃĬȂ తరంĦాల¡ మĸయ కంప®Ūటర ų  సృļి ś ంచబడĮķ. 
ĮČబటś వ­ల ఎĥÃƟɖలను ǩĮƔ ల¡ సృļి ś ంచĬǵĥ ఉపȂĦȎ Šా ర . 
MRI ĨేĽిన ǩĮƔ ల¡ Ǿ గంĬ ెȁకŐ ǵĸాũణం మĸయ పǵǴర ను చూడంĬ అనుమǳసుŠ ంİ. 
Ĩేయడం T1 మĸయ గంĬ ెȁకŐ T2 మŪĳింȣ ఉపȂĦంǩ , ĶÉమ ఈ MRI Ķ¸ļీȴ ĥąసం మన జĲĵలĐ 
గంĬ ెకండĸాల Ȏాıరణ ȇల¡వల¡ ఏĸాťట పƔయǳŤసుŠ ంİ. 
ఒǳŠĬ పĸǖ ȁకŐ పƔȂజĲల¡ మĸయ నȍśా ల¡ ఏǽట ? 
అధŪయనంలĐ Ƿాలþœ నŤ సంప®రş ఏ పƔమదం ఉంİ. Ǿర  ĥÃవలం ఒక అదనప­ 4-5minutes లÌİ ĥąసం ȎాŐనȻ 
లĐపల ఉంటంİ . 
ఈ పĸǖ సమరšవంతంĦా మనుపట ĺాŪı గĸ Šంచడం మక¡ సȏయపడ¦త§ంİ. 
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 ఇİ క¥Ĭ మక¡ హృదయ ĺాŪı ǿతŠం Įెల¡సు సȏయపడ¦త§ంİ ĨేయవచుŖ . 
 
పĸǖ మందు: 
• Ǿ ĺ±ౖదుŪడ¦ సూǩంǩన ȇధంĦా Ǿ మందుల¡ ǴసుĥąంĬ 
పĸǖ ĸĆǯన: 
ĸĆĦ MRI ర¤ȹ 8, ఒక గంట ļ¿డూŪȽ పĸǖ సమయం మందు వదŢక¡ ఉంİ. 
ĸĆĦ ఆసుపǳƔలĐ ĦĖను లĐĥ మరŖĬǵĥ మĸయ అǵŤ ఆభరణల¡ , దంĮల¡ మĸయ ȇǵĥĬ ĮúలĦంచĬǵĥ 
అడగబడĮర . 
బÈĽ¿à ų ȴ రకŠǷč ట తǵǤ Ĩేయబడ¦త§ంİ . 
• పĸǖ ǿదలవ­త§ంİ మందు, Ǿర  Ǿ ĺ±ౖదŪ చĸతƔ మĸయ మందుల (ల¡ ) Ǿర  ఒక MRI ȎాŐȴ కȃĦ 
ఖǩŖతంĦా సురǘతమǵ ĨేయĬǵĥ క¥Ĭ Ǵసుĥóǵ మĸయ గĸంǩ పƔశŤల¡ అడ¦గĮర  . 
 
పĸǖ సమయంలĐ: 
ĥąరడం జĸĦంİ ĸ²గŪలȻ MRI ప®ĸ Š అవ­త§ంİ. 
ĥాķȽŸ మర ťల¡ ఉండవచుŖ మĸయ ECG ȄȭŸ పĸషŐĸంచబడ¦త§ంİ. మȂĥాĸŝయంక¡ Ȏšా ǵక T1 and T2 
మŪĳింȣ అదనప­ 1 ǵǽషం పడ¦త§ంİ ఇİ జర గత§ంİ. ĽిǶ ĥాĸ ŝయȡ MRI సǵŤĺÂĻాల¡ మĸంత 3-4min 
పటśవచుŖ ప®ĸ Š ĨేȎార . 
• పĸǖ సందరŨంĦా , Ǿర  యంతƔం ǩĮƔ ల¡ పడ¦త§ంİ తలĥƘందుల¡ శబŢ ల¡ ȇనవచుŖ. ĶÉమ క¥Ĭ సూచనలĮČ 
Ǿర  అడ¦గత§ంİ. ఉİహరణక¡ , ĶÉమ 8 నుంǩ 10 Ľ¿కనų  Ǿ Ļాŵసను ĲùĥŐ Ǿర  అడగవచుŖ 
• ఇİ ఉదŪమల¡ ǩĮƔ ల¡ అĺాంతĸాల¡ సృļి ś ంచవచుŖ ఎందుకంటÎ Ǿర  ఇపťటĥ ȎాధŪĶ¸Ûనంత ఉండĬǵĥ 
మఖŪం. 
పĸǖ తĸాŵత 
• Ǿ ĬకśȻ ǻనŤంĦా Ǿర  Ĩెబత§ంİ తపť Ǿర  Ǿ Ȏాıరణ ĥారŪకలǷాల¡ ĸ²సూŪȹ ఉండవచుŖ. 
 • Ǿ ĬకśȻ ǻనŤంĦా Ǿర  Ĩెబత§ంİ తపť దరŶకతŵం Ǿ Ȏాıరణ మందుల¡ ǴసుĥąంĬ. 
 • తర ĺాǳ ĸĆǯ İŵĸా, పĸǘ ఫȃĮల¡ పĸǖ ఆİేȋంĨడ¦ ĬకśȻ పంపబడ¦ను . Ǿర  Ǿ పĸǖ ఫȃĮల¡ 
చĸŖంచĬǵĥ Ǿ ĺ±ౖదుŪడ¦ సంపƔİంచĬǵĥ అవసరం. 
 • Ǿ ǷƔా ధǽక ĺ±ౖదుŪడ¦ ఏ ļ¿డూŪȽ, ǵయమĥాల¡ అనుసĸంచంĬ. 
 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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रोगी सूचना शीट 
अÚययन शीष[क: मायोकाͫड [यम के T1 और T 2 मानͬचğण 
Ǔनàन जानकारȣ इस अÚययन और उस मɅ अपनी भागीदारȣ के बारे मɅ सूͬचत करने के ͧलए Ĥदान कȧ जाती है । 
कृपया जानकारȣ Úयान से पढ़Ʌ  और आप अÚययन और दȣ गई जानकारȣ के बारे मɅ ͩकसी भी सवाल पूछने के ͧलए 
èवतंğ हɇ ।  
इस अÚययन मɅ भागीदारȣ पूरȣ तरह èवैिÍछक है और आप कभी भी अÚययन से वापस लेने के ͧलए èवतंğ हɇ। 
 
अÚययन का उƧेæय: 
एक ǿदय एमआरआई T1 और T2 दौरे मानͬचğण तकनीक एक गैर इनवेͧसव अÚययन है, ǿदय कȧ मांसपेशी के 
गुणɉ के Ĥ×य¢ Ǻæय स¢म है। इस तकनीक के ɮवारा, हम ǿदय कȧ मांसपेशी के दो गुणɉ का अÚययन करने के 
ͧलए कोͧशश कर रहे हɇ 
कहा जाता है T1 और T 2 relaxation time, कुछ अǓतǐरÈत इमेिजंग कर रहȣ है, Ǔनयͧमत Ǿप से एमआरआई ͩक 
दौर से गुजर जाएगा।  
ऐसा करके , हम इस एमआरआई मशीन मɅ भारतीय आबादȣ मɅ मूãयɉ के सामाÛय Įेणी èथाͪपत करना चाहते हɇ । 
 
No Extra Charges 
 
ͪवͬध का पालन ͩकया जाना है: 
रोगी एमआरआई कमरे 8, एक घंटे के ͧलए Ǔनधा[ǐरत परȣ¢ा का समय से पहले आ रहा है । 
मरȣज को एक अèपताल का गाउन मɅ बदलने के ͧलए और सभी के आभूषण, डेÛचर और सुनने के सामान को दूर 
करने के ͧलए कहा जाएगा। 
आधारभूत रÈतचाप कȧ जाँच कȧ जाएगी और यह सुǓनिæचत ͩकया जाएगा मधुमेह या Ǒदल कȧ बीमारȣ के ͩकसी 
भी अÛय सुͪवधाओ ंका कोई इǓतहास नहȣ ंहै। 
 
जांच के दौरान: 
èटɇडड[ एमआरआई के Ǿप मɅ अपने इलाज ͬचͩक×सक ɮवारा अनुरोध ĤाÜत ͩकया जाएगा। 
इसके अलावा, ईसीजी सुराग अपने शरȣर पर तय ͩकया जाएगा और अǓतǐरÈत Ǻæयɉ कुछ ͧसने छͪवयɉ और देशी 
T1 और T 2 मानͬचğण सǑहत Ǒदल के ͧलए ͩकया जाएगा। 
यह T1 और T 2 मानͬचğण और ͧसने छͪवयɉ के ͧलए 3-4 min के ͧलए अǓतǐरÈत 1 ͧमनट लगते हɇ । 
 
गोपनीयता: 
अÚययन मɅ भाग लेने के गोपनीय रहेगा और केवल जांचकता[ओ ंके ͧलए जाना जाएगा । 
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अÚययन से Ǔनकासी: 
इस अÚययन मɅ भागीदारȣ पूरȣ तरह èवैिÍछक है और आप ͩकसी भी कारण के ǒबना कभी भी अÚययन से वापस 
ले सकते हɇ । यह ͩकसी भी तरह से अपने इलाज समझौता नहȣ ंकरɅगे। कोई संभाͪवत इस अÚययन मɅ शाͧमल 
जोͨखम भी हɇ और आप परȣ¢ण के ͧलए ͩकसी भी अǓतǐरÈत पैसे का भुगतान नहȣ ंकȧ जǾरत है । ͩकसी भी Ĥæन 
के ͧलए, कृपया contact- डॉ. Grace Rebecca, पीजी रिजèĚार, रेͫडयोलॉजी ͪवभाग, सीएमसी वेãलोर। मोबाइल- 
+9442249535. 
 
ĤͩĐया के बारे मɅ ͪवèतृत जानकारȣ 
ǿदय एमआरआई T1 और T 2 मानͬचğण तकनीक Èया है? 
 
चु ंबकȧय अनुनाद इमेिजंग ( एमआरआई) मशीन एक कɅ ġ खोलने कȧ है ͩक लगभग तीन फȧट चौड़ा है के साथ एक 
ɪयूब है। 
एक मेज कɅ ġȣय उɮघाटन मɅ èलाइड और रोगी कȧ मेज पर िèथत है। Ǒदल का ͬचğ एक चु ंबकȧय ¢ेğ , रेͫडयो तरंगɉ 
और कंÜयूटर का उपयोग कर बनाई गई हɇ । 
कोई एÈस रे ͬचğ बनाने के ͧलए इèतेमाल नहȣ ंकर रहे हɇ । 
एमआरआई ɮवारा बनाई गई छͪवयɉ हमɅ शारȣǐरक रचना और अपने Ǒदल के कामकाज को देखने के ͧलए अनुमǓत 
देगा। 
इसका उपयोग कर T1 और Ǒदल कȧ T2 मानͬचğण करने से, हम इस एमआरआई मशीन के ͧलए हमारȣ आबादȣ 
मɅ ǿदय कȧ मांसपेͧशयɉ के ͧलए सामाÛय मूãयɉ कȧ èथापना करने कȧ कोͧशश करɅगे | 
 
लाभ और तनाव परȣ¢ण के जोͨखम Èया हɇ? 
वहा ँकोई खतरा अÚययन मɅ शाͧमल नहȣ ंहै। आपको बस एक अǓतǐरÈत 4-5minutes या ऐसा करने के ͧलए 
èकैनर के भीतर करना होगा | 
इस परȣ¢ा मɅ संभाͪवत रोग पहले पता लगाने के ͧलए हमारȣ मदद कर सकते हɇ। 
यह हमɅ Ǒदल मɅ रोग कȧ राͧश पता करने के ͧलए मदद कर सकते है। 
 
 
परȣ¢ण से पहले: 
 
•अपने ͬचͩक×सक ɮवारा Ǔनदȶश Ǒदए अपनी दवा ले| 
 
 
परȣ¢ा के Ǒदन: 
P a g e  | 114 
 
रोगी एमआरआई कमरे 8, एक घंटे के ͧलए Ǔनधा[ǐरत परȣ¢ा का समय से पहले आ रहा है । मरȣज को एक 
अèपताल का गाउन मɅ बदलने के ͧलए और सभी के आभूषण , डेÛचर और सुनने के सामान को दूर करने के ͧलए 
कहा जाएगा। आधारभूत रÈतचाप कȧ जाँच कȧ जाएगी । इससे पहले परȣ¢ण शुǾ होता है, आप को अपनी 
ͬचͩक×सा के इǓतहास और दवाओ ंके बारे मɅ सवाल पूछा जाएगा, आप यह भी सुǓनिæचत रहे एमआरआई èकैन 
सुरͯ¢त है। 
 
जांच के दौरान: 
Ǔनयͧमत Ǿप से अनुरोध ͩकया गया एमआरआई ͩकया जाएगा। 
Coils पǐरवत[न हो सकता है और ईसीजी सुराग तय हो जाएगा। मायोकाͫड [यम के मूल Ǔनवासी T1 और T 2 मैͪप ंग 
हो जो अǓतǐरÈत 1 ͧमनट लगते है। ͧसने ǿदय एमआरआई Ǻæयɉ ͩकया जाता है जो 3-4min अͬधक समय लग 
सकता है । 
परȣ¢ण के दौरान, आप दèतक ÚवǓनयɉ के Ǿप मɅ मशीन तèवीरɅ  लेता सुना होगा। यह भी Ǔनदȶश के साथ संकेत 
होगा। उदाहरण के ͧलए, हम 8 से 10 सेकंड के ͧलए अपनी सांस रोक के ͧलए आप पूछ सकते हɇ | 
• यह आप के Ǿप मɅ अभी भी संभव के Ǿप मɅ रहने के ͧलए है Èयɉͩक आंदोलनɉ ͬचğɉ मɅ glitches बना सकते हɇ 
मह×वपूण[ है। 
 
परȣ¢ण के बाद 
जब तक आप अपने डॉÈटर से अलग ढंग से बताता है ͩक आप अपने सामाÛय गǓतͪवͬध ͩफर से शुǾ हो सकती है। 
• Ǔनदȶशन के Ǿप मɅ जब तक आप अपने डॉÈटर से अलग ढंग से बताता है ͩक अपने Ǔनयͧमत Ǿप से दवा लेने । 
 
• अगले Ǒदन तक, परȣ¢ण के पǐरणाम डॉÈटर जो परȣ¢ण का आदेश Ǒदया करने के ͧलए भेजा जाएगा। आप अपने 
परȣ¢ण के पǐरणामɉ पर चचा[ करने के ͧलए अपने डॉÈटर से संपक[  करने कȧ आवæयकता होगी । 
• अपनी Ĥाथͧमक ͬचͩक×सक के साथ ͩकसी भी अनुसूͬचत अनुवतȸ ǓनयुिÈतयɉ रखɅ 
 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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PATIENT INFORMATION SHEET 
 
Study title: T1 and T2 mapping of the myocardium  
The following information is provided to inform you about this study and your participation in it. Please 
read the information carefully and you are free to ask any questions regarding the study and the 
information given. The participation in this study is purely voluntary and you are free to withdraw from 
the study anytime. 
Purpose of the study: 
A cardiac MRI T1 and T2 myocardial mapping technique is a non –invasive study, enabling direct 
visualisation of properties of heart muscle. By this technique, we are trying to study two properties of 
heart muscle called T1 and T2 relaxation times, by doing some extra imaging, in addition to the regular 
MRI that you will be undergoing. 
By doing this, we wish to establish the normal range of values in Indian population in this MRI machine. 
 
No extra money will be charged for the patient for T1 and T2 mapping  
  
Method to be followed: 
 
Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
Baseline blood pressure will be checked and it will be ensured that there is no history of diabetes or any 
other features of heart disease. 
During the test: 
Standard MRI will be obtained as requested by your treating doctor.  
In addition, ECG leads will be fixed on your body and extra sequences will be done for the heart 
including some cine images and native T1 andT2 mapping.  
It takes additional 1 minute for the T1 and T2 mapping and 3-4min for the cine images. 
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Confidentiality: 
The participation in the study will remain confidential and shall be known only to the investigators.  
Withdrawal from the study: 
Participation in this study is purely voluntary and you can withdraw from the study anytime without any 
reason. It will not compromise your treatment in any way. There are no potential risks involved in this 
study and you need not pay any extra money for the test. 
Detailed information about the Procedure 
What is cardiac MRI T1 and T2 mapping technique?  
The magnetic resonance imaging (MRI) machine is a tube with a centre opening that is about three feet 
wide. 
 A table slides into the central opening and the patient lies on the table. Pictures of the heart are created 
using a magnetic field, radio waves and computers. 
No X-rays are used to create the images.  
The images made by the MRI will allow us to look at the anatomy and functioning of your heart.  
By using doing T1 and T2 mapping of the heart, we will try to establish normal values for heart muscle 
in our population for this MRI machine.  
What are the benefits and risks of the stress test? 
There is absolute no risk involved in the study. You will just have to be within the scanner for an 
additional 4-5minutes or so. 
This test can potentially help us to detect the disease earlier. 
 It can also helps us to know amount of disease in the heart. 
Before the test: 
• Take your medications as instructed by your doctor 
On day of the test  
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Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
Baseline blood pressure will be checked. 
• Before the test starts, you will be asked questions about your medical history and the medication(s) 
you are taking and also to make sure it is safe for you to have an MRI scan. 
During the test:  
Regular MRI that has been requested will be done. 
Coils may be changes and ECG leads will be fixed. Native T1 andT2 mapping of myocardium is done 
which takes additional 1 minute. Cine cardiac MRI sequences are done which may take 3-4min more. 
• During the test, you will hear knocking sounds as the machine takes the pictures. We will also prompt 
you with instructions. For example, we may ask you to hold your breath for 8 to 10 seconds 
• It is important for you to stay as still as possible because movements can create glitches in the pictures. 
After the test  
• You may resume your normal activity unless your doctor tells you differently. 
 • Take your regular medications as directed unless your doctor tells you differently. 
 • By the following day, the test results will be sent to the doctor who ordered the test. You will need to 
contact your doctor to discuss the results of your test. 
 • Keep any scheduled follow-up appointments with your primary doctor 
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ேநாயாள தகவ தா 
ஆº தைல~©: ைமேயாகாƫய எ}ற «த T1 ம²  2 ேம~பu 
 
ப}வ¯ தகவகைள இ|த ஆº ம² அ¢ உuக பu பறி 
ெதƬவtக வழuக~பகிற¢. தகவ கவனமாக~ பtகº ம² நuக 
ஆº ம² ெகாtக~பyட தகவ ெதாடƫபாக எ|த ேகவக ேகyக 
இலவச உளன. இ|த ஆவ பu «றி´ த}னாƫவ ம² நuக 
ஆº எ~ேபா¢ இ¯|¢ தி¯ப இலவச இ¯tகிறƫக . 
 
ஆவ} ேநாtக : 
 
ஒ¯ இதய எஆƫஐ T1 ம² T2 இதய ேம~பu ¤yப இதய தைச பz©க 
ேநர~ பாƫைவt ெசயப{த , ஒ¯ அலாத -invasive கவயா. இ|த 
ெதாழி ¤yப ¬ல, நuக அ§பவ{¢ எ}² வழtகமான எஆƫஐ 
தலாக , சில த இேமஜிu ெச¢ , இதய தைச இரz பz©க T1 
ம² T2 தளƫº «ைற எ}² பtக «யசி . 
இைத ெசவத} ¬ல, நா இ|த எஆƫஐ இய|திர இ|திய மtக 
ெதாைகய மதி~©க சாதாரண வரப அைமtக வ¯©கிற¢. 
 
No Extra Charges 
 
«ைற ப}பற~பட ேவz : 
 
ேநாயாள ஒ¯ மண ேநர திyடமிட~பyள¢ ேசாதைன ேநர «} 
எஆƫஐ அைற 8 மணt வ|¢ உள¢ . 
ேநாயாள ஒ¯ ம¯{¢வமைனய கº} மாற ம² அைன{¢ நைகக , 
ெபா~பக ம² வசாரைண எy நtக ேகyக~ப. 
ேபைல} இர{த அ¸{த ேசாதிtக~பட ேவz ம² அ¢ நƬழிº 
அல¢ இதய ேநா ேவ² எ|த அசuக பறிய வரலா² எ¢º எ}² 
உ²தி ெசய~ப.  
 
ேசாதைனய} ேபா¢ : 
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உuக சிகிvைச ம¯{¢வƫ ¬ல ேகy டாzடƫy எஆƫஐ 
ெபறºள¢. 
தலாக, ஈசிஜி தடuக உuக உடலி ெசய~ப ம² சில சின 
படuக ம² ெசா|த «த T1 ம²  2 ேம~பu உyபட இதய த 
காyசிகைள ெசய~ப. 






ஆவ பu ரகசியமாக இ¯t ம² மyேம வசாரைண ெதƬயவ¯ 
எ}றாƫக. 
 
ஆவ இ¯|¢ ப}வாu : 
 
இ|த ஆவ பuேக© «றி´ த}னாƫவ ம² நuக எ|த காரண« 
இலாம எ~ேபா¢ ஆº இ¯|¢ தி¯ப «­ . அ¢ எ|த வழிய 
உuக சிகிvைச வytெகாtகமாyேடா. இ|த ஆவ ஈபyள எ|த 
அபாயuக உளன நuக ேசாதைன எ|த த பண ெச´{த{ 
ேதைவயைல. 
எ|த ேகவக¶t, தயºெச¢ டாtடƫ கிேர ெரேபtகா , தu பதிவாளƫ 
, கதிƬயtகவய ¢ைற , சி.எ.சி. ேவµƫ contact- . Mobile- + 9442249535 
 
நைட«ைற பறி வƬவான தகவகைள 
 
இதய எஆƫஐ T1 ம² T2 ேம~பu ¤yப எ}ன? 
 
கா|த ஒ{ததிƫº படெம{த (MRI) இய|திர{ைத எ}² மாƫ ¬}² அ 
அகல திற|¢ ஒ¯ ைமய{தி ஒ¯ ழா ஆ. 
 ஒ¯ அyடவைண ம{திய திற~© ைலக ம² ேநாயாள அyடவைண 
அைம|¢ள¢. இதய படuக ஒ¯ கா|த, ேரேயா அைலக ம² 
கணனக பய}ப{தி உ¯வாtக~பகி}றன. 
இைல எt கதிƫக படuகைள உ¯வாtக பய}ப{த~பகி}றன. 
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எஆƫஐ ¬ல படuகைள எuக¶t உuக இதய உடறிய ம² 
ெசயபாyைட பாƫtக அ§மதிt. 
ெச¢ T1 ம² இதய  2 ேம~பu பய}ப{தி, நா இ|த எஆƫஐ 
இய|திர இதய தைச சாதாரண மதி~©க எuக மtக ெதாைகய நி²வ 
«யசி. 
கா|த ஒ{ததிƫº படெம{த (MRI) இய|திர{ைத எ}² மாƫ ¬}² அ 
அகல திற|¢ ஒ¯ ைமய{தி ஒ¯ ழா ஆ. 
 ஒ¯ அyடவைண ம{திய திற~© ைலக ம² ேநாயாள அyடவைண 
அைம|¢ள¢. இதய படuக ஒ¯ கா|த, ேரேயா அைலக ம² 
கணனக பய}ப{தி உ¯வாtக~பகி}றன. 
இைல எt கதிƫக படuகைள உ¯வாtக பய}ப{த~பகி}றன. 
எஆƫஐ ¬ல படuகைள எuக¶t உuக இதய உடறிய ம² 
ெசயபாyைட பாƫtக அ§மதிt. 
ெச¢ T1 ம² இதய  2 ேம~பu பய}ப{தி, நா இ|த எஆƫஐ 
இய|திர இதய தைச சாதாரண மதி~©க எuக மtக ெதாைகய நி²வ 
«யசி. 
 
அ¸{த ேசாதைன உள ந}ைமக ம² ஆப{¢க எ}ன? 
 
ஈபy ஒ¯ த 4-5minutes அல¢ ஐ|¢ ேகனƫ t இ¯tக 
ேவz «¸ைமயான எ|த ஆப{¢ உள¢ . இ|த ேசாதைன சா{திய«ள 
«|ைதய ேநா கzடறிய எuக¶t உதவ «­.  இ¢ எuக¶t இதய 
ேநா அளº ெதƬ­ உதºகிற¢ «­ . 
 
ேசாதைன «} : 
உuக ம¯{¢வƫ றி~பyள¢ உuக ம¯|¢கைள எ{¢ 
ேசாதைன நாள 
ேநாயாள ஒ¯ மண ேநர திyடமிட~பyள¢ ேசாதைன ேநர «} 
எஆƫஐ அைற 8 மணt வ|¢ உள¢ . ேநாயாள ஒ¯ ம¯{¢வமைனய 
கº} மாற ம² அைன{¢ நைகக , ெபா~பக ம² வசாரைண 
எy நtக ேகyக~ப. ேபைல} இர{த அ¸{த ேசாதைன 
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ெசய~ப.  ேசாதைன ¢வtவத «}, உuக ம¯{¢வ வரலா² 
ம² ம¯|¢ (க) நuக எஆƫஐ ேக} ேவz உ²தி அ¢ 
பா¢கா~பான¢ ெசய ட எ{¢ ஏ} பறிய ேகவக ேகyக~ப. 
 
ேசாதைனய} ேபா¢ : 
ேகyக~பyள¢ எ}² வழtகமான எஆƫஐ ெசய~ப. 
¯க மாறuக இ¯tகலா ம² ஈசிஜி தடuக சƬ ெசய~ப. 
ைமேயாகாƫய ªƫவ  க «த T1 ம²  2 ேம~பu த 1 நிமிட 
எt எ|த ெசய~பகிற¢. சின இதய எஆƫஐ காyசிகைள எ|த ேம´ 
3-4min ஆகலா ெசய~பகி}றன.  ேசாதைன ேபா¢, நuக இய|திர 
படuக எt என தy ச{த ேகyக ேவz. நாuக வழி«ைறகைள 
நuக ேகy. உதாரணமாக, நா 8 «த 10 வநாக ¬vைச நuக 
ேகyகலா. இ¢ இயtகuக படuகைள ைறபாக உ¯வாtக «­ 
எ}பதா, நuக இ}§ «|தவைர தuக «tகியமான உள¢. 
 
ேசாதைனt பற 
• உuக ம¯{¢வƫ வ{தியாசமாக நuக ெசாகிற¢ தவர நuக உuக 
சாதாரண ெசயபா மz  . 
 உuக ம¯{¢வƫ வ{தியாசமாக நuக ெசாகிற¢ வைர இயtகிய • உuக 
வழtகமான ம¯|¢கைள எ{¢. 
 • அ{த நா ¬ல, ேசாதைன «º ேசாதைன உ{தரவyடாƫ 
ம¯{¢வƬட அ§~ப ைவtக~ப. நuக உuக ேசாதைன «ºகைள 
வவாதிtக உuக ம¯{¢வƫ ெதாடƫ© ெகாள ேவz . 
 • உuக «த}ைம ம¯{¢வƫ எ|த திyடமிட~பyள¢ ப}ெதாடƫ 
நியமனuக ைவ{¢ 
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ĸĆĦ సమĨర పతƔమ 
అధŪయన౦ ĳÐర : T1 and T2 మŪĳింȣ ఆȶ İ మȂĥాĸŝయȹ 
ఈ అధŪయన౦లĐ Ƿాలþœ నడం గĸంǩ ఈ ĥƘంİ సమĨరం Ǿక¡ ĮెȃయĨేయడĶ¸Ûనİ. İǵǵ జగƘతŠ Ħా చİȇ ఈ 
సమĨరంలĐ Ǿక¡ ఏĺ±ౖĲ సంİేȏల¡ ఉనŤķ¹డల ĽÐŵచŖĦ  ాఅడగగలర . ఈ పĸĻĒధనలĐ Ƿాలþœ నడం ప®ĸ ŠĦ  ాĲ 
ǵరşయమǵ, ఏ ĥారణం లÌక¡ంĬ ఈ అధŪయన౦ నుంĬ ȇరǽంచుĥóనవచŖǵ Ĳక¡ ĮెȃయĨేయడĶ¸Ûనİ.  
అధŪయన౦ ఉİే Ţశం:  
ĥాĸ ŝయȡ MRI T1 and T2 మȂĥాĸŝయȽ మŪĳింȣ అనునİ సురǘతĶ¸Ûన, గంĬ ెకండĸాల పǵతనం గĸంǩ 
అధŪయన౦ Ĩేయ ఒక  పదŢǳ. ఈ పదŢǳ İŵĸా Ǿ గంĬ ెకండĸాలక¡ సంబంıంǩన ĸ²ండ¦ ȇషయల (T1 and T2) 
సడȃంప­ సమయలను Ǿక¡ ĨేĽÐ Ȏాıరణ MRI ȎాŐǵంȣ ĮČ Ƿాట ఎĥాƟƫƔ ఇĶÉǭంȣ İŵĸా Ĩేయబడ¦ను.  
T1 మŪĳింȣ Ĩేయట వలన గంĬె ĺాŪı ǷƔా రంభ లǖణలను, ĺాŪı ȁకŐ ǴవƔతను మĸయ ఇతర లĐగటś  
ȇషయలను Įెల¡సుĥóనుటక¡ ȎాధŪపడ¦ను.  
No Extra Charges 
అధŪయన౦ Ĩేయ పదŢǳ:  
ĸĆĦ తనక¡ ǵరşķంǩన సమయǵకĲŤ ఒక గంట మందుĦా MRI ȎాŐǵంȣ ర¤మ 8 ĥ ĸావల»ను.  
ȏĽిťటȽ ĺార  ఇĨేŖ దుసుŠ లను ĳÐļ¿ంȫ ధĸంǩ బంĦార  ఆభరణల¡, ĳ¿టś డ¦ పళ¨Ŵ మĸయ ȇǵĥĬĥ సంబంǩన 
ఇతరĶ¸Ûనĺాటǵ ǴĽిĺÂయవల»ను.  
ఇంటƔȈనɂ (IV) ĥానుŪల (ȎాధరణంĦా 20 ĦƘా మల¡) ఉంĨెదర .   
పƔసుŠ త బų ȭ ĳ¿ƔషȻ Ĩెȡ ĨేĽ¿దర . 
అధŪయన సమయంలĐ:  
Ǿక¡ ǩĥతŸ ĨేĽÐ Ĭకśర Ħార  అĬĦన ȇధంĦా Ȏśా ండȻŝ MRI ĮČǷాట Ƿč ɂś  గĬోȃǵయం అıŪయĲల¡ Ĩేయబడ¦ను.  
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ĲÂటȿ T1 and T2 మŪĳింȣ అలĦÃ Ƿč ɂś  ĥాంటƔ ɂś  T1 మŪĳింȣ ఆȶ మȂĥాĸŝయȹ ĨేĽ¿దర . İǵĥ అదనంĦా ఒక 
ǵǽషం ఎక¡Őవ అవ­ను.  
ĥాǵŦĬెǵŷయȽ: Ǿర  ఈ అధŪయన౦లĐ Ƿాలþœ ĲÂ ȇషయం పĸĻĒధక¡ǵĥ ĥాక¡ంĬ ఇతర లక¡ Įెȃయక¡ంĬ ĦĆపŪంĦా 
ఉంĨెదర .   
అధŪయనం నుంĬ ఉపసంహరణ : 
ఈ అధŪయనంలĐ ǷాĸśĽిĳÐషȴ ప®ĸ ŠĦ  ాసŵచŗంద మĸయ Ǿర  ఏ ĥారణం లÌక¡ంĬ ఎప­ťĬైĲ అధŪయనం నుంĬ 
ĺ±నĥŐ ǴసుĥąవచుŖ. ఇİ ఏ ȇధంĦా Ǿ ǩĥతŸ ĸాǮ ఉండదు. ఈ అధŪయనంలĐ పƔĶÉయం ఏ సంĵవŪ పƔమİల 
ఉĲŤķ మĸయ Ǿర  పĸǖ ĥąసం ఏ అదనప­ డబŧ ĨెȃųȎ Šా ర  పǵలÌదు. 
ఏ పƔశŤల¡ ĥąసం , దయĨేĽ ిĬకśȻ ĦÃƘɂ ĸ²బ·ĥాŐ ĳీǮ ĸǭȎśా ƿ Ȼ Ļాఖ ĸÃĬయలǮ , ĽిఎంĽ ిĺ±ల¥ų ర  contact- . ǿబ·ౖȽ + 
9442249535 
 
ȇıనమ గĸంǩ ȇవరĶ¸Ûన సమĨరం 
ĥాĸ ŝయȡ MRI T1 మĸయ T2 మŪĳింȣ ట½ĥŤȡ ఏǽట ? 
 
అయȎాŐంత పƔǳధŵǵ ఇĶÉǭంȣ (MRI ) యంతƔం గĸంǩ మ¢డ¦ అడ¦గల ĺ±డల¡ť ఉంİ ఓĳ¿ǵంȣ ĥÃందƔం Ħôటśం. 
 ఒక పట śక ĥÃందƔ ǷƔా రంభ లĐĥ మǵĦ మĸయ ĸĆĦ పట śక ఉంİ. గంĬ ెȁకŐ ǩĮƔ ల¡ ర¤Ƿû ంİంǩ ఒక ఐȎాŐంత , 
ĸÃĬȂ తరంĦాల¡ మĸయ కంప®Ūటర ų  సృļి ś ంచబడĮķ. 
ĮČబటś వ­ల ఎĥÃƟɖలను ǩĮƔ ల¡ సృļి ś ంచĬǵĥ ఉపȂĦȎ Šా ర . 
MRI ĨేĽిన ǩĮƔ ల¡ Ǿ ĬకśȻ Ǿ గంĬ ెȁకŐ ǵĸాũణం మĸయ పǵǴర ను చూడంĬ అనుమǳసుŠ ంİ. 
అదనంĦా , Ĩేయడం T1 మĸయ గంĬె ȁకŐ T2 మŪĳింȣ ఉపȂĦంǩ , ĶÉమ మĸôక ĥąణం నుంĬ గంĬె 
కండĸాల¡ అȎాıరణత చూడటǵĥ పƔయǳŤంచంĬ. 
Ǿర  ǳనĬǵĥ లÌİ Ǿ పĸǖ మందు 4 గంటల ĮƔ గĬǵĥ ఏİైĲ ఉండక¥డదు. 
 • Ǿ ĺ±ౖదుŪడ¦ సూǩంǩన ȇధంĦా Ǿ మందుల¡ ǴసుĥąంĬ 
పĸǖ ĸĆǯన: 
ĸĆĦ MRI ర¤ȹ 8, ఒక గంట ļ¿డూŪȽ పĸǖ సమయం మందు వదŢక¡ ఉంİ. 
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ĸĆĦ ఆసుపǳƔలĐ ĦĖను లĐĥ మరŖĬǵĥ మĸయ అǵŤ ఆభరణల¡, దంĮల¡ మĸయ ȇǵĥĬ ĮúలĦంచĬǵĥ 
అడగబడĮర . 
ఒక సూİ {ఇంటƔ Ȉనɂ (IV) ĥానుŪల (ȎాıరణంĦా 20G)} Ǿ Ĩేǳ లÌİ ȀĨేķ ǷƔా ంతంలĐ ĳ¿టśబడ¦త§ంİ. 
బÈĽ¿à ų ȴ రకŠǷč ట తǵǤ Ĩేయబడ¦త§ంİ. 
• పĸǖ ǿదలవ­త§ంİ మందు, Ǿర  Ǿ ĺ±ౖదŪ చĸతƔ మĸయ మందుల (ల¡) Ǿర  ఒక MRI ȎాŐȴ కȃĦ 
ఖǩŖతంĦా సురǘతమǵ ĨేయĬǵĥ క¥Ĭ Ǵసుĥóǵ మĸయ గĸంǩ పƔశŤల¡ అడ¦గĮర . 
పĸǖ సమయంలĐ: 
Ƿč ɂś  ĬోȄǵయȹ అధŪయĲల¡ సȏ ǷƔా మణక MRI సǵŤĺÂĻాల¡ ǴȎ Šా ర . 
Ȏšా ǵక T1 and T2 మŪĳింȣ మĸయ Ƿč ɂś  ȇర దţ ంĦా మȂĥాĸŝయంక¡ ȁకŐ T1 మŪĳింȣ అదనప­ 1 ǵǽషం 
పడ¦త§ంİ ఇİ జర గత§ంİ 
• పĸǖ సందరŨంĦా, Ǿర  యంతƔం ǩĮƔ ల¡ పడ¦త§ంİ తలĥƘందుల¡ శబŢ ల¡ ȇనవచుŖ. ĶÉమ క¥Ĭ సూచనలĮČ 
Ǿర  అడ¦గత§ంİ. ఉİహరణక¡, ĶÉమ 8 నుంǩ 10 Ľ¿కనų  Ǿ Ļాŵసను ĲùĥŐ Ǿర  అడగవచుŖ 
• ఇİ ఉదŪమల¡ ǩĮƔ ల¡ అĺాంతĸాల¡ సృļి ś ంచవచుŖ ఎందుకంటÎ Ǿర  ఇపťటĥ ȎాధŪĶ¸Ûనంత ఉండĬǵĥ 
మఖŪం. 
 • పƔĥƘయ ȁకŐ మĦంప­లĐ, Ǿ IV İǵǾద Įúడ¦గ (సూİ) ĮúలĦంచబడ¦త§ంİ. 
పĸǖ తĸాŵత 
• Ǿ ĬకśȻ ǻనŤంĦా Ǿర  Ĩెబత§ంİ తపť Ǿర  Ǿ Ȏాıరణ ĥారŪకలǷాల¡ ĸ²సూŪȹ ఉండవచుŖ. 
 • Ǿ ĬకśȻ ǻనŤంĦా Ǿర  Ĩెబత§ంİ తపť దరŶకతŵం Ǿ Ȏాıరణ మందుల¡ ǴసుĥąంĬ. 
 • తర ĺాǳ ĸĆǯ İŵĸా, పĸǘ ఫȃĮల¡ పĸǖ ఆİేȋంĨడ¦ ĬకśȻ పంపబడ¦ను. Ǿర  Ǿ పĸǖ ఫȃĮల¡ 
చĸŖంచĬǵĥ Ǿ ĺ±ౖదుŪడ¦ సంపƔİంచĬǵĥ అవసరం. 
 • Ǿ ǷƔా ధǽక ĺ±ౖదుŪడ¦  ļ¿డూŪȽ, ǵయమĥాల¡ అనుసĸంచంĬ. 
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रोगी सूचना शीट 
अÚययन शीष[क: मायोकाͫड [यम के T1 और T2 मानͬचğण 
Ǔनàन जानकारȣ इस अÚययन और उस मɅ अपनी भागीदारȣ के बारे मɅ सूͬचत करने के ͧलए Ĥदान कȧ जाती है । 
कृपया जानकारȣ Úयान से पढ़Ʌ  और आप अÚययन और दȣ गई जानकारȣ के बारे मɅ ͩकसी भी सवाल पूछने के ͧलए 
èवतंğ हɇ| इस अÚययन मɅ भागीदारȣ पूरȣ तरह èवैिÍछक है और आप कभी भी अÚययन से वापस लेने के ͧलए 
èवतंğ हɇ। 
अÚययन का उƧेæय: 
एक ǿदय एमआरआई T1 और T2 दौरे मानͬचğण तकनीक एक गैर इनवेͧसव अÚययन है, ǿदय कȧ मांसपेशी के 
गुणɉ के Ĥ×य¢ Ǻæय स¢म है। इस तकनीक के ɮवारा, हम ǿदय कȧ मांसपेशी के दो गुणɉ का अÚययन करने के 
ͧलए कोͧशश कर रहे हɇ| कहा जाता है T1 और T 2 relaxation time, कुछ अǓतǐरÈत इमेिजंग कर रहȣ है, Ǔनयͧमत 
Ǿप से एमआरआई ͩक दौर से गुजर जाएगा। 
T1 मानͬचğण जãदȣ बीमारȣ का पता लगाने का वादा करता है, रोग कȧ गंभीरता यɉ और कुछ शतɟ मɅ शकुन 
अंतǺ[िçट Ĥदान करते हɇ। 
ͪवͬध का पालन ͩकया जाना है: 
रोगी एमआरआई कमरे 8, एक घंटे के ͧलए Ǔनधा[ǐरत परȣ¢ा का समय से पहले आ रहा है । 
मरȣज को एक अèपताल का गाउन मɅ बदलने के ͧलए और सभी के आभूषण, डेÛचर और सुनने के सामान को दूर 
करने के ͧलए कहा जाएगा। 
अंतःͧशरा (चतुथ[) Ĥवेशनी (आमतौर पर 20 Ēाम) रखा जाएगा। 
आधारभूत रÈतचाप कȧ जाचँ कȧ जाएगी| 
जांच के दौरान: 
पोèट gadolinium अÚययन सǑहत èटɇडड[ एमआरआई Ǻæयɉ के Ǿप मɅ अपने इलाज ͬचͩक×सक ɮवारा अनुरोध 
ĤाÜत ͩकया जाएगा। 
इसके अलावा, अǓतǐरÈत Ǻæयɉ मूल Ǔनवासी टȣ 1 और मायोकाͫड [यम ͩकया जाता है जो अǓतǐरÈत 1 ͧमनट लगते 
हɇ कȧ टȣ 2 मानͬचğण और पोèट ͪवपरȣत T1 मानͬचğण सǑहत ͩकया जाएगा। 
गोपनीयता: 
अÚययन मɅ भाग लेने के गोपनीय रहेगा और केवल जांचकता[ओ ंके ͧलए जाना जाएगा । 
अÚययन से Ǔनकासी:  
इस अÚययन मɅ भागीदारȣ पूरȣ तरह èवैिÍछक है और आप ͩकसी भी कारण के ǒबना कभी भी अÚययन से वापस 
ले सकते हɇ । यह ͩकसी भी तरह से अपने इलाज समझौता नहȣ ंकरɅगे। कोई संभाͪवत इस अÚययन मɅ शाͧमल 
जोͨखम भी हɇ और आप परȣ¢ण के ͧलए ͩकसी भी अǓतǐरÈत पैसे का भुगतान नहȣ ंकȧ जǾरत है । ͩकसी भी Ĥæन 
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के ͧलए, कृपया contact- डॉ. Grace Rebecca, पीजी रिजèĚार, रेͫडयोलॉजी ͪवभाग, सीएमसी वेãलोर। मोबाइल- 
+9442249535. 
ĤͩĐया के बारे मɅ ͪवèतृत जानकारȣ 
ǿदय एमआरआई T1 और T 2 मानͬचğण तकनीक Èया है? 
चु ंबकȧय अनुनाद इमेिजंग ( एमआरआई) मशीन एक कɅ ġ खोलने कȧ है ͩक लगभग तीन फȧट चौड़ा है के साथ एक 
ɪयूब है। 
एक मेज कɅ ġȣय उɮघाटन मɅ èलाइड और रोगी कȧ मेज पर िèथत है। Ǒदल का ͬचğ एक चु ंबकȧय ¢ेğ , रेͫडयो तरंगɉ 
और कंÜयूटर का उपयोग कर बनाई गई हɇ । 
कोई एÈस रे ͬचğ बनाने के ͧलए इèतेमाल नहȣ ंकर रहे हɇ । 
एमआरआई ɮवारा बनाई गई छͪवयɉ हमɅ शारȣǐरक रचना और अपने Ǒदल के कामकाज को देखने के ͧलए अनुमǓत 
देगा। 
इसका उपयोग कर T1 और Ǒदल कȧ T2 मानͬचğण करने से, हम इस एमआरआई मशीन के ͧलए हमारȣ आबादȣ 
मɅ ǿदय कȧ मांसपेͧशयɉ के ͧलए सामाÛय मूãयɉ कȧ èथापना करने कȧ कोͧशश करɅगे | 
लाभ और तनाव परȣ¢ण के जोͨखम Èया हɇ? 
अÚययन मɅ कोई खतरा शाͧमल नहȣ ंहै । तुम बस एक अǓतǐरÈत ͧमनट या ऐसा करने के ͧलए èकैनर के भीतर 
करना होगा। इस परȣ¢ा मɅ संभाͪवत रोग पहले पता लगाने के ͧलए हमारȣ मदद कर सकते हɇ। 
यह हमɅ Ǒदल मɅ रोग कȧ राͧश पता करने के ͧलए मदद कर सकते है। 
 
No Extra Charges 
 
परȣ¢ण से पहले: 
• आप खाने के ͧलए या अपने परȣ¢ण से पहले 4 घंटे के ͧलए पीने के ͧलए कुछ भी नहȣं कर सकते। 
• अपने ͬचͩक×सक ɮवारा Ǒदए Ǔनदȶश के Ǿप मɅ अपनी दवा ले| 
परȣ¢ा के Ǒदन 
रोगी एमआरआई कमरे 8, एक घंटे के ͧलए Ǔनधा[ǐरत परȣ¢ा का समय से पहले आ रहा है । 
मरȣज को एक अèपताल का गाउन मɅ बदलने के ͧलए और सभी के आभूषण , डेÛचर और सुनने के सामान को दूर 
करने के ͧलए कहा जाएगा। 
एक सुई { अंतःͧशरा (चतुथ[) Ĥवेशनी (आमतौर पर 20 Ēाम) } अपने हाथ या कोहनी ¢ेğ मɅ रखा जाएगा। 
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आधारभूत रÈतचाप कȧ जाँच कȧ जाएगी । 
इससे पहले परȣ¢ण शुǾ होता है, आप को अपनी ͬचͩक×सा के इǓतहास और दवाओ ंके बारे मɅ सवाल पूछा जाएगा, 
आप यह भी सुǓनिæचत रहे एमआरआई èकैन सुरͯ¢त है। 
जांच के दौरान: 
पोèट gadolinium अÚययन सǑहत èटɇडड[ एमआरआई Ǻæयɉ के Ǿप मɅ अपने इलाज ͬचͩक×सक ɮवारा अनुरोध 
ĤाÜत ͩकया जाएगा। 
इसके अलावा, अǓतǐरÈत Ǻæयɉ मूल Ǔनवासी टȣ 1 और मायोकाͫड [यम ͩकया जाता है जो अǓतǐरÈत 1 ͧमनट लगते 
हɇ कȧ टȣ 2 मानͬचğण और पोèट ͪवपरȣत T1 मानͬचğण सǑहत ͩकया जाएगा। 
• परȣ¢ण के दौरान, आप के Ǿप मɅ मशीन तèवीरɅ लेता दèतक आवाज़ सुन जाएगा ।  
हम यह भी Ǔनदȶश के साथ संकेत होगा। उदाहरण के ͧलए, हम 8 से 10 सेकंड के ͧलए अपनी सांस रोक के ͧलए आप 
पूछ सकते हɇ| 
• यह आप के Ǿप मɅ अभी भी संभव के Ǿप मɅ रहने के ͧलए है Èयɉͩक आंदोलनɉ ͬचğɉ मɅ glitches बना सकते हɇ 
मह×वपूण[ है। 
• ĤͩĐया के अंत मɅ, अपने चतुथ[ canula (सुई ) को हटा Ǒदया जाएगा । 
परȣ¢ण के बाद: 
• जब तक अपने डॉÈटर अलग ढंग से बताता नहȣ ंतब तक अपने सामाÛय गǓतͪवͬध ͩफर से शुǾ कर सकते है। 
जब तक अपने डॉÈटर अलग ढंग से बताता नहȣ ं तब तक अपने 
Ǔनयͧमत Ǿप से दवा ले । 
• अगले Ǒदन तक, परȣ¢ण के पǐरणाम डॉÈटर जो परȣ¢ण का आदेश Ǒदया करने के ͧलए भेजा जाएगा। आप अपने 
परȣ¢ण के पǐरणामɉ पर चचा[ करने के ͧलए अपने डॉÈटर से संपक[  करने कȧ आवæयकता होगी । 
• अपनी Ĥाथͧमक ͬचͩक×सक के साथ ͩकसी भी अनुसूͬचत अनुवतȸ ǓनयुिÈतयɉ रखɅ। 
 
 
For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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                                     PATIENT INFORMATION SHEET 
 
Study title: T1 and T2 mapping of the myocardium  
The following information is provided to inform you about this study and your participation in it. Please 
read the information carefully and you are free to ask any questions regarding the study and the 
information given. The participation in this study is purely voluntary and you are free to withdraw from 
the study anytime. 
Purpose of the study: 
A cardiac MRI T1 and T2 myocardial mapping technique is a non –invasive study, enabling direct 
visualisation of properties and healthiness of heart muscle. By this technique, we are trying to study two 
properties of heart muscle called T1 and T2 relaxation times, by doing some extra imaging, in addition 
to the regular MRI that you will be undergoing. 
T1 mapping promises to detect early disease and to know the amount of disease in the heart 
 
No extra money will be charged for T1 Na T2 mapping of the myocardium 
Method to be followed: 
Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
Intravenous (IV) cannula (usually 20G) will be placed. 
Baseline blood pressure will be checked. 
During the test: 
Standard MRI sequences including post Gadolinium studies will be obtained as requested by your 
treating doctor.  
In addition, extra sequences will be done including native T1 andT2 mapping and post contrast T1 
mapping of myocardium is done which takes additional 1 minute 
Confidentiality: 
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The participation in the study will remain confidential and shall be known only to the investigators.  
Withdrawal from the study: 
Participation in this study is purely voluntary and you can withdraw from the study anytime without any 
reason. It will not compromise your treatment in any way. There are no potential risks involved in this 
study and you need not pay any extra money for the test. 
Detailed information about the Procedure 
What is cardiac MRI T1 and T2 mapping technique?  
The magnetic resonance imaging (MRI) machine is a tube with a centre opening that is about three feet 
wide. 
 A table slides into the central opening and the patient lies on the table. Pictures of the heart are created 
using a magnetic field, radio waves and computers. 
No X-rays are used to create the images.  
The images made by the MRI will allow your doctor to look at the anatomy and functioning of your 
heart.  
In addition, by using doing T1 and T2 mapping of the heart, we will try to see the abnormality of the 
heart muscle from another perspective.  
What are the benefits and risks of the test? 
There is absolute no risk involved in the study. You will just have to be within the scanner for an 
additional minute or so. 
This test can potentially help us to detect the disease earlier. 
 It can also helps us to know amount of disease in the heart. 
Before the test: 
 • You cannot have anything to eat or drink for 4 hours before your test. 
 • Take your medications as instructed by your doctor 
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On day of the test  
Patient is to arrive at MRI Room 8, one hour prior to the scheduled test time. 
Patient will be asked to change into a hospital gown and remove all jewellery, dentures and hearing aids.  
A needle {Intravenous (IV) cannula (usually 20G)} will be placed in your hand or elbow region. 
Baseline blood pressure will be checked. 
• Before the test starts, you will be asked questions about your medical history and the medication(s) 
you are taking and also to make sure it is safe for you to have an MRI scan. 
During the test:  
Standard MRI sequences including post Gadolinium studies are obtained.  
Native T1 andT2 mapping and post contrast T1 mapping of myocardium is done which takes additional 
1 minute 
• During the test, you will hear knocking sounds as the machine takes the pictures. We will also prompt 
you with instructions. For example, we may ask you to hold your breath for 8 to 10 seconds 
• It is important for you to stay as still as possible because movements can create glitches in the pictures. 
 • At the end of the procedure, your IV canula (needle) will be removed. 
After the test  
• You may resume your normal activity unless your doctor tells you differently. 
 • Take your regular medications as directed unless your doctor tells you differently. 
 • By the following day, the test results will be sent to the doctor who ordered the test. You will need to 
contact your doctor to discuss the results of your test. 
 • Keep any scheduled follow-up appointments with your primary doctor 
  For any queries, kindly contact- Dr. Grace Rebecca, PG Registrar, Department of Radiology, CMC 
Vellore. Mobile-+9442249535 
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ேநாயாள தகவ தா 
ஆº தைல~©: ைமேயாகாƫய எ}ற «த T1 ம² T2 ேம~பu. 
ப}வ¯ தகவகைள இ|த ஆº ம² அ¢ உuக பu பறி 
ெதƬவtக வழuக~பகிற¢. தகவ கவனமாக~ பtகº ம² நuக 
ஆº ம² ெகாtக~பyட தகவ ெதாடƫபாக எ|த ேகவக ேகyக 
இலவச உளன. இ|த ஆவ பu «றி´ த}னாƫவ ம² நuக 
ஆº எ~ேபா¢ இ¯|¢ தி¯ப இலவச இ¯tகிறƫக . 
 
ஆவ} ேநாtக:  
ஒ¯ இதய எஆƫஐ T1 ம² T2 இதய ேம~பu ¤yப பz©க ம² இதய 
தைச healthiness ேநர~ பாƫைவt ெசயப{த , ஒ¯ அலாத -invasive 
கவயா. இ|த ெதாழி ¤yப ¬ல, நuக அ§பவ{¢ எ}² 
வழtகமான எஆƫஐ தலாக , சில த இேமஜிu ெச¢ , இதய தைச 
இரz பz©க T1 ம² T2 தளƫº «ைற எ}² பtக «யசி . 
«த T1 ேம~பu ஆரப ேநா கzடறிய ேநாய} தவர{த}ைம கணtகிட 
ம² சில நிப|தைனகைள ஒ¯ «}கண~© ¤zணறிº வழuக உ²தி . 
 
No Extra Charges 
 
«ைற ப}பற~பட ேவz : 
ேநாயாள ஒ¯ மண ேநர திyடமிட~பyள¢ ேசாதைன ேநர «} 
எஆƫஐ அைற 8 மணt வ|¢ உள¢ . 
ேநாயாள ஒ¯ ம¯{¢வமைனய கº} மாற ம² அைன{¢ நைகக , 
ெபா~பக ம² வசாரைண எy நtக ேகyக~ப. 
நாளuக (IV) வழா ( வழtகமாக 20g ) ைவtக~ப . 
ேபைல} இர{த அ¸{த ேசாதைன ெசய~ப. 
 
ேசாதைனய} ேபா¢ : 
உuக சிகிvைச ம¯{¢வƫ ¬ல ேகy பதவைய கேடாலினய ஆºக 
உளyட தரநிைல எஆƫஐ காyசிகைள ெபறºள¢. 
தலாக, த காyசிகைள ெசா|த «த T1 ம²  2 ேம~பu ம² 
த 1 நிமிட எt எ|த ைமேயாகாƫய ெசய~பகிற¢ பதவt 
மாறாக «த T1 ேம~பu உyபட ெசய~ப. 




ஆவ பu ரகசியமாக இ¯t ம² மyேம வசாரைண ெதƬயவ¯ 
எ}றாƫக. 
 
ஆவ இ¯|¢ ப}வாu : 
இ|த ஆவ பuேக© «றி´ த}னாƫவ ம² நuக எ|த காரண« 
இலாம எ~ேபா¢ ஆº இ¯|¢ தி¯ப «­ . அ¢ எ|த வழிய 
உuக சிகிvைச வytெகாtகமாyேடா. இ|த ஆவ ஈபyள எ|த 
அபாயuக உளன நuக ேசாதைன எ|த த பண ெச´{த{ 
ேதைவயைல. 
எ|த ேகவக¶t, தயºெச¢ டாtடƫ கிேர ெரேபtகா , தu பதிவாளƫ 
, கதிƬயtகவய ¢ைற , சி.எ.சி. ேவµƫ contact- . Mobile- + 9442249535. 
 
நைட«ைற பறி வƬவான தகவகைள 
 
இதய எஆƫஐ T1 ம² T2 ேம~பu ¤yப எ}ன? 
 
கா|த ஒ{ததிƫº படெம{த (MRI ) இய|திர{ைத எ}² மாƫ ¬}² அ 
அகல திற|¢ ஒ¯ ைமய{தி ஒ¯ ழா ஆ. 
 ஒ¯ அyடவைண ம{திய திற~© ைலக ம² ேநாயாள அyடவைண 
அைம|¢ள¢. இதய படuக ஒ¯ கா|த , ேரேயா அைலக ம² 
கணனக பய}ப{தி உ¯வாtக~பகி}றன. 
இைல எt கதிƫக படuகைள உ¯வாtக பய}ப{த~பகி}றன. 
எஆƫஐ ¬ல படuகைள உuக ம¯{¢வƫ உuக இதய உடறிய 
ம² ெசயபாyைட பாƫtக அ§மதிt. 
தலாக, ெச¢ T1 ம² இதய  2 ேம~பu பய}ப{தி , நா மெறா¯ 
கzேணாyட{தி இதய தைச பறத பாƫtக «யசி . 
 
அ¸{த ேசாதைன உள ந}ைமக ம² ஆப{¢க எ}ன? 
 
ஆவ ஈபyள «¸ைமயான எ|த ஆப{¢ உள¢ . நuக ஒ¯ 
த நிமிட அல¢ ஐ|¢ ேகனƫ t இ¯tக ேவz. 
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இ|த ேசாதைன சா{திய«ள «|ைதய ேநா கzடறிய எuக¶t உதவ 
«­. 
 இ¢ எuக¶t இதய ேநா அளº ெதƬ­ உதவ «­. 
 
ேசாதைன «} : 
• நuக சா~பட அல¢ உuக ேசாதைன «} 4 மண tக எ¢º 
இைல «­. 
 • உuக ம¯{¢வƫ றி~பyள¢ உuக ம¯|¢கைள எ{¢ 
 
ேசாதைன நாள: 
ேநாயாள ஒ¯ மண ேநர திyடமிட~பyள¢ ேசாதைன ேநர «} 
எஆƫஐ அைற 8 மணt வ|¢ உள¢ . 
ேநாயாள ஒ¯ ம¯{¢வமைனய கº} மாற ம² அைன{¢ நைகக , 
ெபா~பக ம² வசாரைண எy நtக ேகyக~ப. 
ஒ¯ ஊசி { நாளuக (IV) வழா ( வழtகமாக 20g ) } உuக ைக அல¢ 
«ழuைக பதிய ைவtக~ப. 
ேபைல} இர{த அ¸{த ேசாதைன ெசய~ப. 
• ேசாதைன ¢வtவத «}, உuக ம¯{¢வ வரலா² ம² ம¯|¢ 
(க) நuக எஆƫஐ ேக} ேவz உ²தி அ¢ பா¢கா~பான¢ ெசய 
ட எ{¢ ஏ} பறிய ேகவக ேகyக~ப. 
 
ேசாதைனய} ேபா¢ : 
பதவைய கேடாலினய ஆºக உளyட தரநிைல எஆƫஐ காyசிகைள 
ெப² வ¯கி}றனƫ. 
ைமேயாகாƫய ªƫவ  க «த T1 ம²  2 ேம~பu ம² ப|ைதய 
மாறாக «த T1 ேம~பu த 1 நிமிட எt எ|த ெசய~பகிற¢ 
• ேசாதைன ேபா¢, நuக இய|திர படuக எt என தy ச{த ேகyக 
ேவz. நாuக வழி«ைறகைள நuக ேகy. உதாரணமாக, நா 8 
«த 10 வநாக ¬vைச நuக ேகyகலா 
• இ¢ இயtகuக படuகைள ைறபாக உ¯வாtக «­ எ}பதா, 
நuக இ}§ «|தவைர தuக «tகியமான உள¢. 
 • நைட«ைற «வ, உuக நா}கா வழா (ஊசி) அகற~ப. 
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ேசாதைனt பற: 
• உuக ம¯{¢வƫ வ{தியாசமாக நuக ெசாகிற¢ தவர நuக உuக 
சாதாரண ெசயபா மz  . 
 உuக ம¯{¢வƫ வ{தியாசமாக நuக ெசாகிற¢ வைர இயtகிய • உuக 
வழtகமான ம¯|¢கைள எ{¢. 
 • அ{த நா ¬ல, ேசாதைன «º ேசாதைன உ{தரவyடாƫ 
ம¯{¢வƬட அ§~ப ைவtக~ப. நuக உuக ேசாதைன «ºகைள 
வவாதிtக உuக ம¯{¢வƫ ெதாடƫ© ெகாள ேவz . 
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Data Sheet
      
T1 short T1 long        T2bat2-T2 T1 - gado     LGELGE Wall mot badiag diag code
920 1038 45 601 0 0 Normal 1
878 914 44 0 0 normal 1
887 1053 48 0 0 NORMAL 1
981 1059 47 678 0 0 normal 1
967 1204 690 0 0 normal 1
847 1004 579 0 0 NORMAL 1
959 1044 62 597 0 0 normal 1
1031 1133 59 0 0 normal 1
943 995 53 420 0 0 normal 1
1039 101 54 491 0 0 normal 1
865 1027 49 451 0 0 normal 1
904 983 47 604 0 0 NORMAL 1
991 1069 50 570 0 0 normal 1
943 1072 44 0 0 normal 1
975 1087 62 544 0 0 normal 1
1004 1044 48 447 0 0 normal 1
951 1014 51 565 0 0 normal 1
963 987 50 520 0 0 NORMAL 1
936 1010 44 552 0 0 NORMAL 1
967 1012 54 475 0 0 NORMAL 1
903 1021 44 521 0 0 Normal 1
954 1043 47 592 0 0 Normal 1
528 997 45 0 0 Normal 1
863 995 44 601 0 0 Normal 1
1005 1110 53 622 0 0 Normal 1
908 1079 50 533 0 0 Normal 1
1036 1059 44 0 0 Normal 1
991 1052 57 523 0 0 Normal 1
999 1081 54 641 0 0 Normal 1
1039 1098 57 579 0 0 Normal 1
951 1060 53 537 0 0 Normal 1
966 1043 44 601 0 0 Normal 1
917 951 47 0 0 normal 1
1071 1115 53 0 0 NORMAL 1
1037 1054 54 690 0 0 normal 1
983 1154 753 0 0 normal 1
935 1043 557 0 0 NORMAL 1
1078 979 589 0 0 normal 1
1019 1044 53 0 0 normal 1
924 1019 52 417 0 0 normal 1
1007 1149 56 476 0 0 normal 1
883 1028 49 460 0 0 normal 1
977 1010 53 596 0 0 NORMAL 1
990 1042 51 567 0 0 normal 1
901 1068 42 0 0 normal 1
967 1064 53 514 0 0 normal 1
889 1044 47 493 0 0 normal 1
973 1079 53 546 0 0 normal 1
939 993 52 512 0 0 NORMAL 1
897 1038 42 565 0 0 NORMAL 1
991 1065 54 481 0 0 NORMAL 1
919 1057 50 530 0 0 Normal 1
925 1046 46 558 0 0 Normal 1
967 983 45 0 0 Normal 1
894 1013 43 585 0 0 Normal 1
976 1140 52 610 0 0 Normal 1
946 1092 45 528 0 0 Normal 1
981 1059 51 0 0 Normal 1
1017 1077 51 547 0 0 Normal 1
987 1083 53 580 0 0 Normal 1
916 1037 61 528 0 0 Normal 1
960 1021 52 534 0 0 Normal 1
960 1038 44 566 0 0 Normal 1
949 946 49 0 0 normal 1
1117 1068 54 0 0 NORMAL 1
1022 1046 51 684 0 0 normal 1
968 1063 725 0 0 normal 1
958 1066 557 0 0 NORMAL 1
968 1069 51 603 0 0 normal 1
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1011 1031 49 0 0 normal 1
926 1039 53 437 0 0 normal 1
1035 1147 53 481 0 0 normal 1
898 1049 47 461 0 0 normal 1
988 1106 50 608 0 0 NORMAL 1
1001 1091 49 555 0 0 normal 1
972 1111 46 0 0 normal 1
1004 1064 53 544 0 0 normal 1
1002 1064 54 478 0 0 normal 1
996 1028 55 551 0 0 normal 1
956 988 55 479 0 0 NORMAL 1
881 997 46 569 0 0 NORMAL 1
980 1039 54 476 0 0 NORMAL 1
908 1015 42 564 0 0 Normal 1
965 1069 46 552 0 0 Normal 1
969 1011 47 0 0 Normal 1
900 1045 49 591 0 0 Normal 1
967 1097 52 614 0 0 Normal 1
941 1022 51 539 0 0 Normal 1
967 996 52 0 0 Normal 1
1014 1075 51 547 0 0 Normal 1
933 1123 56 596 0 0 Normal 1
1001 1065 60 504 0 0 Normal 1
978 1029 51 516 0 0 Normal 1
908 1056 45 590 0 0 Normal 1
865 941 48 0 0 normal 1
1125 1074 53 0 0 NORMAL 1
1009 1038 52 717 0 0 normal 1
1003 1030 603 0 0 normal 1
1001 1021 554 0 0 NORMAL 1
954 1117 50 626 0 0 normal 1
977 1047 50 0 0 normal 1
908 996 52 462 0 0 normal 1
1035 1124 55 500 0 0 normal 1
903 991 47 463 0 0 normal 1
964 1099 49 588 0 0 NORMAL 1
935 1017 48 558 0 0 normal 1
960 1179 38 0 0 normal 1
1016 1160 66 552 0 0 normal 1
959 996 50 412 0 0 normal 1
978 1035 51 557 0 0 normal 1
945 925 50 525 0 0 NORMAL 1
899 959 43 594 0 0 NORMAL 1
960 1003 51 459 0 0 NORMAL 1
922 969 50 523 0 0 Normal 1
915 1056 45 576 0 0 Normal 1
927 984 47 0 0 Normal 1
853 987 42 641 0 0 Normal 1
968 1096 55 609 0 0 Normal 1
973 1102 48 530 0 0 Normal 1
1034 1080 41 0 0 Normal 1
956 1100 49 523 0 0 Normal 1
937 1035 51 518 0 0 Normal 1
947 1018 56 549 0 0 Normal 1
1003 1068 51 536 0 0 Normal 1
946 1042 45 642 0 0 Normal 1
848 929 47 0 0 normal 1
980 1104 60 0 0 NORMAL 1
935 1037 47 616 0 0 normal 1
817 930 715 0 0 normal 1
964 1023 546 0 0 NORMAL 1
972 990 54 604 0 0 normal 1
961 1041 51 0 0 normal 1
933 989 49 0 0 normal 1
1028 1153 53 482 0 0 normal 1
901 1016 47 462 0 0 normal 1
922 1057 49 594 0 0 NORMAL 1
933 1020 44 518 0 0 normal 1
871 1072 42 0 0 normal 1
1028 1110 58 502 0 0 normal 1
910 1089 46 436 0 0 normal 1
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995 1046 50 574 0 0 normal 1
990 942 48 502 0 0 NORMAL 1
880 961 40 574 0 0 NORMAL 1
1061 1011 49 459 0 0 NORMAL 1
920 985 52 598 0 0 Normal 1
954 1091 44 568 0 0 Normal 1
935 1011 46 0 0 Normal 1
886 969 40 619 0 0 Normal 1
948 1074 52 605 0 0 Normal 1
967 1055 48 510 0 0 Normal 1
934 1030 47 0 0 Normal 1
1031 1029 52 574 0 0 Normal 1
973 1071 49 636 0 0 Normal 1
1038 1052 591 0 0 Normal 1
929 1068 49 572 0 0 Normal 1
922 1062 45 641 0 0 Normal 1
855 956 48 0 0 normal 1
829 1084 47 0 0 NORMAL 1
935 1013 44 667 0 0 normal 1
864 982 700 0 0 normal 1
872 1054 566 0 0 NORMAL 1
997 1006 53 610 0 0 normal 1
910 1066 57 0 0 normal 1
928 988 50 0 0 normal 1
1103 1130 53 484 0 0 normal 1
885 968 43 470 0 0 normal 1
894 1030 465 592 0 0 NORMAL 1
932 1124 48 537 0 0 normal 1
839 979 44 0 0 normal 1
990 1063 58 540 0 0 normal 1
924 1065 50 471 0 0 normal 1
995 1052 53 542 0 0 normal 1
936 964 49 497 0 0 NORMAL 1
923 1015 56 549 0 0 NORMAL 1
1004 1106 54 480 0 0 NORMAL 1
911 1050 47 608 0 0 Normal 1
1019 1085 46 566 0 0 Normal 1
940 968 49 0 0 Normal 1
851 992 47 594 0 0 Normal 1
982 1109 52 621 0 0 Normal 1
949 1028 51 508 0 0 Normal 1
897 1030 54 0 0 Normal 1
1036 1068 51 568 0 0 Normal 1
912 1104 51 635 0 0 Normal 1
1050 491 0 0 Normal 1
941 1038 50 539 0 0 Normal 1
951 1007 45 567 0 0 Normal 1
871 916 51 0 0 normal 1
919 1003 44 0 0 NORMAL 1
953 1032 48 702 0 0 normal 1
922 1027 745 0 0 normal 1
911 1005 48 554 0 0 NORMAL 1
965 1048 51 645 0 0 normal 1
946 936 57 0 0 normal 1
899 982 53 455 0 0 normal 1
1047 1200 58 474 0 0 normal 1
890 935 47 454 0 0 normal 1
889 1040 49 574 0 0 NORMAL 1
914 977 50 572 0 0 normal 1
879 986 41 0 0 normal 1
971 1171 51 529 0 0 normal 1
899 1080 54 528 0 0 normal 1
918 1006 49 568 0 0 normal 1
937 1005 50 497 0 0 NORMAL 1
942 997 49 545 0 0 NORMAL 1
1061 1056 54 481 0 0 NORMAL 1
947 1005 45 547 0 0 Normal 1
926 1029 47 583 0 0 Normal 1
942 954 46 0 0 Normal 1
856 972 46 579 0 0 Normal 1
998 1077 51 678 0 0 Normal 1
1053 1051 52 516 0 0 Normal 1
918 1037 48 0 0 Normal 1
974 1037 56 556 0 0 Normal 1
983 1103 57 536 0 0 Normal 1
902 991 61 0 0 Normal 1
1024 1095 51 541 0 0 Normal 1
979 1027 46 576 0 0 Normal 1
937 967 52 0 0 normal 1
1083 1156 51 0 0 NORMAL 1
1032 1055 49 715 0 0 normal 1
937 1037 718 0 0 normal 1
990 1072 47 544 0 0 NORMAL 1
1029 1057 55 659 0 0 normal 1
924 1046 57 0 0 normal 1
925 1028 57 455 0 0 normal 1
1127 1271 61 472 0 0 normal 1
911 1026 45 431 0 0 normal 1
956 1087 52 586 0 0 NORMAL 1
1035 1033 53 559 0 0 normal 1
900 985 41 0 0 normal 1
1013 1108 57 511 0 0 normal 1
977 1108 55 507 0 0 normal 1
972 1011 50 562 0 0 normal 1
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939 1038 48 511 0 0 NORMAL 1
967 1027 50 590 0 0 NORMAL 1
973 1091 49 491 0 0 NORMAL 1
924 994 49 551 0 0 Normal 1
951 1081 47 592 0 0 Normal 1
980 1076 43 0 0 Normal 1
865 1031 44 582 0 0 Normal 1
1009 1108 54 654 0 0 Normal 1
1063 1047 52 499 0 0 Normal 1
948 1074 50 0 0 Normal 1
990 1081 52 554 0 0 Normal 1
952 1065 52 569 0 0 Normal 1
887 990 57 555 0 0 Normal 1
969 1022 51 541 0 0 Normal 1
961 1018 47 580 0 0 Normal 1
915 967 47 0 0 normal 1
1081 1086 49 0 0 NORMAL 1
1013 1038 46 707 0 0 normal 1
967 1039 747 0 0 normal 1
920 1018 46 563 0 0 NORMAL 1
988 1061 50 663 0 0 normal 1
959 1043 54 0 0 normal 1
942 1025 53 467 0 0 normal 1
1074 1199 54 484 0 0 normal 1
876 1015 45 438 0 0 normal 1
1005 1087 47 593 0 0 NORMAL 1
925 1014 50 586 0 0 normal 1
932 1025 42 0 0 normal 1
1024 1062 57 509 0 0 normal 1
939 1072 54 511 0 0 normal 1
968 1004 53 561 0 0 normal 1
877 1001 49 514 0 0 NORMAL 1
913 996 47 574 0 0 NORMAL 1
961 1110 49 482 0 0 NORMAL 1
887 983 43 605 0 0 Normal 1
937 1058 45 594 0 0 Normal 1
936 1036 47 0 0 Normal 1
883 1014 48 600 0 0 Normal 1
983 1113 53 669 0 0 Normal 1
975 1071 50 515 0 0 Normal 1
931 1029 50 0 0 Normal 1
939 1092 47 580 0 0 Normal 1
935 1032 58 567 0 0 Normal 1
893 952 60 564 0 0 Normal 1
1038 1046 48 548 0 0 Normal 1
942 1035 43 562 0 0 Normal 1
918 941 51 0 0 normal 1
951 1139 55 0 0 NORMAL 1
1117 1051 46 711 0 0 normal 1
975 1053 698 0 0 normal 1
910 1010 48 567 0 0 NORMAL 1
937 1048 53 653 0 0 normal 1
955 1183 51 0 0 normal 1
965 1026 53 459 0 0 normal 1
994 1149 53 497 0 0 normal 1
759 1039 44 461 0 0 normal 1
894 1039 49 590 0 0 NORMAL 1
1001 1067 46 589 0 0 normal 1
805 942 40 0 0 normal 1
939 1081 43 554 0 0 normal 1
907 1094 53 530 0 0 normal 1
986 987 53 559 0 0 normal 1
869 965 48 469 0 0 NORMAL 1
889 1020 46 609 0 0 NORMAL 1
897 957 48 490 0 0 NORMAL 1
916 987 45 534 0 0 Normal 1
925 1006 44 589 0 0 Normal 1
912 1060 47 0 0 Normal 1
792 949 43 582 0 0 Normal 1
970 1065 53 666 0 0 Normal 1
1031 1173 44 521 0 0 Normal 1
940 1041 47 0 0 Normal 1
995 1012 54 572 0 0 Normal 1
956 1019 53 556 0 0 Normal 1
906 996 58 492 0 0 Normal 1
1029 1101 47 544 0 0 Normal 1
951 1004 45 555 0 0 Normal
878 862 51 0 0 normal 1
1122 1058 56 0 0 NORMAL 1
1045 1003 42 700 0 0 normal 1
917 1036 675 0 0 normal 1
931 1007 47 557 0 0 NORMAL 1
956 1039 50 619 0 0 normal 1
957 1066 51 0 0 normal 1
898 1011 53 468 0 0 normal 1
1053 1154 54 488 0 0 normal 1
915 1029 46 461 0 0 normal 1
948 1083 53 585 0 0 NORMAL 1
949 1053 45 568 0 0 normal 1
818 941 44 0 0 normal 1
942 1106 55 543 0 0 normal 1
948 1075 47 531 0 0 normal 1
955 994 54 562 0 0 normal 1
948 1001 50 475 0 0 NORMAL 1
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961 1036 47 564 0 0 NORMAL 1
897 957 48 490 0 0 NORMAL 1
875 1044 44 563 0 0 Normal 1
960 1027 44 592 0 0 Normal 1
924 1034 44 0 0 Normal 1
870 977 42 616 0 0 Normal 1
981 1097 53 0 0 Normal 1
1041 1137 46 513 0 0 Normal 1
942 1041 51 0 0 Normal 1
983 1021 51 554 0 0 Normal 1
1046 55 566 0 0 Normal 1
879 1016 51 498 0 0 Normal 1
978 1007 53 522 0 0 Normal 1
979 995 45 561 0 0 Normal 1
878 908 53 0 0 normal 1
1342 1183 62 0 0 NORMAL 1
1011 1027 46 672 0 0 normal 1
881 1003 718 0 0 normal 1
904 962 49 558 0 0 NORMAL 1
1012 1100 49 617 0 0 normal 1
928 914 58 0 0 normal 1
922 984 48 474 0 0 normal 1
982 1139 61 496 0 0 normal 1
952 998 47 447 0 0 normal 1
982 1078 50 568 0 0 NORMAL 1
925 1023 51 582 0 0 normal 1
881 1031 41 0 0 normal 1
992 1082 50 531 0 0 normal 1
1032 1080 50 505 0 0 normal 1
955 1068 54 556 0 0 normal 1
872 980 44 505 0 0 NORMAL 1
993 996 48 561 0 0 NORMAL 1
845 1018 46 489 0 0 NORMAL 1
897 962 45 606 0 0 Normal 1
942 1066 46 568 0 0 Normal 1
959 1022 47 0 0 Normal 1
871 967 44 598 0 0 Normal 1
1003 1124 54 0 0 Normal 1
985 1059 50 522 0 0 Normal 1
896 1021 48 0 0 Normal 1
931 1094 51 570 0 0 Normal 1
1036 55 568 0 0 Normal 1
960 1011 56 523 0 0 Normal 1
988 1050 54 549 0 0 Normal 1
925 1022 47 561 0 0 Normal 1
958 920 52 0 0 normal 1
1123 1158 54 0 0 NORMAL 1
966 994 51 669 0 0 normal 1
1031 1034 684 0 0 normal 1
931 989 50 526 0 0 NORMAL 1
1118 1048 64 564 0 0 normal 1
828 1034 57 0 0 normal 1
903 970 51 434 0 0 normal 1
987 61 496 0 0 normal 1
986 428 0 0 normal 1
964 1080 49 560 0 0 NORMAL 1
1000 46 602 0 0 normal 1
842 935 40 0 0 normal 1
1031 1001 55 536 0 0 normal 1
996 953 55 518 0 0 normal 1
985 1025 52 550 0 0 normal 1
1086 52 495 0 0 NORMAL 1
884 950 48 535 0 0 NORMAL 1
941 1090 50 477 0 0 NORMAL 1
949 996 52 495 0 0 Normal 1
929 1073 48 595 0 0 Normal 1
930 960 50 0 0 Normal 1
969 45 597 0 0 Normal 1
1003 1083 52 630 0 0 Normal 1
983 1029 49 507 0 0 Normal 1
984 955 46 0 0 Normal 1
1028 1096 57 546 0 0 Normal 1
969 1114 61 573 0 0 Normal 1
909 522 0 0 Normal 1
1036 57 541 0 0 Normal 1
942 1041 48 559 0 0 Normal 1
972 965 51 0 0 normal 1
1063 1298 55 0 0 NORMAL 1
1012 1003 48 693 0 0 normal 1
985 1105 777 0 0 normal 1
998 1118 58 543 0 0 NORMAL 1
1049 1049 53 598 0 0 normal 1
859 1010 57 0 0 normal 1
961 1044 55 444 0 0 normal 1
1078 1217 60 482 0 0 normal 1
898 941 446 0 0 normal 1
940 1012 50 575 0 0 NORMAL 1
904 51 573 0 0 normal 1
837 916 42 0 0 normal 1
1091 1086 61 540 0 0 normal 1
1097 1064 58 526 0 0 normal 1
962 1074 58 552 0 0 normal 1
1051 51 486 0 0 normal 1
949 1016 53 549 0 0 NORMAL 1
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952 57 483 0 0 NORMAL 1
936 992 54 496 0 0 Normal 1
950 1070 52 604 0 0 Normal 1
959 1060 48 0 0 Normal 1
1020 47 586 0 0 Normal 1
960 1083 56 638 0 0 Normal 1
988 1167 59 491 0 0 Normal 1
932 998 45 0 0 Normal 1
965 1096 54 547 0 0 Normal 1
1042 1075 57 578 0 0 Normal 1
881 537 0 0 Normal 1
1056 56 548 0 0 Normal 1
933 1020 46 575 0 0 Normal 1
896 948 50 0 0 normal 1
1160 1434 50 0 0 NORMAL 1
1043 1044 48 654 0 0 normal 1
965 1058 723 0 0 normal 1
927 1014 51 531 0 0 NORMAL 1
982 1048 57 583 0 0 normal 1
888 1046 54 0 0 normal 1
951 1032 50 445 0 0 normal 1
1085 1186 54 499 0 0 normal 1
829 965 450 0 0 normal 1
939 1097 49 586 0 0 NORMAL 1
950 43 604 0 0 normal 1
827 939 43 0 0 normal 1
1086 1181 57 541 0 0 normal 1
987 1064 51 481 0 0 normal 1
948 1061 51 573 0 0 normal 1
1075 50 445 0 0 NORMAL 1
891 1024 48 572 0 0 NORMAL 1
1096 55 488 0 0 NORMAL 1
911 1028 54 544 0 0 Normal 1
945 1039 49 604 0 0 Normal 1
908 1062 47 0 0 Normal 1
957 45 567 0 0 Normal 1
989 1077 56 635 0 0 Normal 1
918 1155 54 484 0 0 Normal 1
907 976 46 0 0 Normal 1
960 1073 59 544 0 0 Normal 1
1053 1064 58 597 0 0 Normal 1
894 531 0 0 Normal 1
1088 57 545 0 0 Normal 1
908 1014 48 570 0 0 Normal 1
854 958 52 0 0 normal 1
1037 1264 55 0 0 NORMAL 1
1052 1045 44 691 0 0 normal 1
956 1033 667 0 0 normal 1
933 1063 49 543 0 0 NORMAL 1
926 1039 62 598 0 0 normal 1
842 1077 60 0 0 normal 1
941 1032 48 434 0 0 normal 1
1042 1173 58 460 0 0 normal 1
852 1059 439 0 0 normal 1
949 1077 55 561 0 0 NORMAL 1
978 52 568 0 0 normal 1
831 986 42 0 0 normal 1
1045 1109 55 493 0 0 normal 1
1083 1110 48 489 0 0 normal 1
1008 1013 49 545 0 0 normal 1
1031 42 471 0 0 NORMAL 1
937 1025 48 442 0 0 NORMAL 1
1077 60 487 0 0 NORMAL 1
938 987 521 0 0 Normal 1
954 1080 47 596 0 0 Normal 1
919 1054 49 0 0 Normal 1
998 45 605 0 0 Normal 1
972 1105 54 645 0 0 Normal 1
522 0 0 Normal 1
937 1001 47 0 0 Normal 1
952 1085 58 548 0 0 Normal 1
961 1080 54 552 0 0 Normal 1
909 529 0 0 Normal 1
1044 59 552 0 0 Normal 1
0 0 Normal 1
1030 990 58 0 0 normal 1
0 0 NORMAL 1
970 1129 60 700 0 0 normal 1
1071 1104 692 0 0 normal 1
1072 67 512 0 0 NORMAL 1
1104 1094 0 0 normal 1
978 1436 58 467 0 0 normal 1
0 0 normal 1
0 0 normal 1
0 0 NORMAL 1
0 0 NORMAL 1
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0 0 Normal 1
1118 0 0 Normal 1
0 0 Normal 1
0 0 Normal 1
0 0 Normal 1
0 0 Normal 1
0 0 Normal 1
0 0 Normal 1
913 1019 54 573 0 0 Normal 1
848 916 48 0 0 normal 1
1023 1055 56 0 0 NORMAL 1
1005 976 53 736 0 0 normal 1
990 1026 755 0 0 normal 1
954 1028 49 564 0 0 NORMAL 1
1023 53 680 0 0 normal 1
946 1015 54 0 0 normal 1
939 1008 49 614 0 0 normal 1
937 1056 46 0 0 normal 1
1095 52 560 0 0 normal 1
1029 1198 49 535 0 0 normal 1
932 963 50 578 0 0 normal 1
922 983 48 503 0 0 NORMAL 1
853 1010 48 568 0 0 NORMAL 1
1004 1039 56 498 0 0 NORMAL 1
911 54 560 0 0 Normal 1
890 1041 43 0 0 Normal 1
939 48 0 0 Normal 1
868 993 45 564 0 0 Normal 1
952 1101 49 655 0 0 Normal 1
1017 1006 44 454 0 0 Normal 1
938 1032 47 0 0 Normal 1
1028 1106 54 545 0 0 Normal 1
1025 1133 63 590 0 0 Normal 1
999 930 57 522 0 0 Normal 1
996 1103 60 544 0 0 Normal 1
917 1097 47 581 0 0 Normal 1
833 858 49 0 0 normal 1
1175 1170 64 0 0 NORMAL 1
1007 1129 50 750 0 0 normal 1
964 1035 783 0 0 normal 1
917 1001 52 533 0 0 NORMAL 1
1102 52 666 0 0 normal 1
894 958 58 0 0 normal 1
908 945 55 584 0 0 normal 1
919 935 56 0 0 normal 1
812 1092 58 503 0 0 normal 1
1011 1031 58 500 0 0 normal 1
950 1019 54 556 0 0 normal 1
965 967 51 516 0 0 NORMAL 1
901 961 50 556 0 0 NORMAL 1
1061 1086 59 484 0 0 NORMAL 1
963 960 48 521 0 0 Normal 1
934 1035 42 0 0 Normal 1
903 52 0 0 Normal 1
854 947 47 549 0 0 Normal 1
920 1094 55 643 0 0 Normal 1
954 1093 47 455 0 0 Normal 1
945 1029 0 0 Normal 1
958 1049 60 546 0 0 Normal 1
1051 1064 53 567 0 0 Normal 1
919 949 58 533 0 0 Normal 1
1009 1013 58 562 0 0 Normal 1
939 52 572 0 0 Normal 1
888 941 48 0 0 normal 1
1178 1143 60 0 0 NORMAL 1
929 977 52 722 0 0 normal 1
971 1061 693 0 0 normal 1
921 1027 50 512 0 0 NORMAL 1
1087 48 655 0 0 normal 1
1009 1061 50 0 0 normal 1
934 984 53 582 0 0 normal 1
924 966 48 0 0 normal 1
995 1073 57 557 0 0 normal 1
985 1291 49 501 0 0 normal 1
1027 1080 52 558 0 0 normal 1
962 993 52 503 0 0 NORMAL 1
991 1036 49 566 0 0 NORMAL 1
969 1126 52 499 0 0 NORMAL 1
973 1072 50 547 0 0 Normal 1
952 1088 48 0 0 Normal 1
867 48 0 0 Normal 1
926 1035 45 615 0 0 Normal 1
1040 1024 52 0 0 Normal 1
999 1085 48 487 0 0 Normal 1
902 982 52 0 0 Normal 1
1012 1131 55 566 0 0 Normal 1
1113 55 575 0 0 Normal 1
945 930 61 547 0 0 Normal 1
1016 1089 54 563 0 0 Normal 1
940 47 578 0 0 Normal 1
899 966 49 0 0 normal 1
1031 1129 52 0 0 NORMAL 1
970 1041 52 725 0 0 normal 1
1055 1075 699 0 0 normal 1
910 1072 52 545 0 0 NORMAL 1
1071 52 666 0 0 normal 1
957 1051 53 0 0 normal 1
903 1031 46 586 0 0 normal 1
906 915 50 0 0 normal 1
558 1050 52 981 0 0 normal 1
1005 1225 48 522 0 0 normal 1
969 1052 55 567 0 0 normal 1
910 993 47 489 0 0 NORMAL 1
992 1018 48 564 0 0 NORMAL 1
1071 1186 48 497 0 0 NORMAL 1
952 1042 54 537 0 0 Normal 1
976 1054 45 0 0 Normal 1
842 51 0 0 Normal 1
907 1019 47 609 0 0 Normal 1
1011 1137 55 0 0 Normal 1
1026 988 45 418 0 0 Normal 1
985 1040 0 0 Normal 1
964 1055 59 534 0 0 Normal 1
1098 55 580 0 0 Normal 1
896 982 55 522 0 0 Normal 1
1006 1113 51 545 0 0 Normal 1
967 997 47 575 0 0 Normal 1
943 957 52 0 0 normal 1
1035 65 0 0 NORMAL 1
891 46 629 0 0 normal 1
1026 1042 755 0 0 normal 1
967 1020 52 554 0 0 NORMAL 1
1115 49 628 0 0 normal 1
957 1016 52 0 0 normal 1
915 1019 589 0 0 normal 1
961 43 0 0 normal 1
961 1103 54 551 0 0 normal 1
987 1153 51 462 0 0 normal 1
988 1055 49 597 0 0 normal 1
959 1007 46 522 0 0 NORMAL 1
893 1008 41 561 0 0 NORMAL 1
979 1086 55 495 0 0 NORMAL 1
988 1035 48 528 0 0 Normal 1
934 1084 50 614 0 0 Normal 1
952 52 0 0 Normal 1
884 1042 49 607 0 0 Normal 1
995 1098 53 657 0 0 Normal 1
977 1003 53 514 0 0 Normal 1
965 1032 45 0 0 Normal 1
1008 1060 52 563 0 0 Normal 1
985 1106 63 585 0 0 Normal 1
890 1102 51 544 0 0 Normal 1
989 1006 54 533 0 0 Normal 1
920 1019 48 574 0 0 Normal 1
1013 965 54 0 0 normal 1
1049 61 0 0 NORMAL 1
987 49 764 0 0 normal 1
992 1089 783 0 0 normal 1
913 1013 53 540 0 0 NORMAL 1
1246 52 624 0 0 normal 1
942 966 59 0 0 normal 1
908 994 595 0 0 normal 1
906 42 0 0 normal 1
1020 1091 54 529 0 0 normal 1
1040 1126 51 526 0 0 normal 1
973 1028 54 566 0 0 normal 1
933 1002 51 520 0 0 NORMAL 1
980 1016 53 535 0 0 NORMAL 1
993 1096 57 482 0 0 NORMAL 1
971 1040 50 527 0 0 Nrmal 1
990 1066 50 575 0 0 Normal 1
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918 46 0 0 Normal 1
910 1011 49 596 0 0 Normal 1
1020 1127 55 658 0 0 Normal 1
1035 1011 54 503 0 0 Normal 1
995 985 47 0 0 Normal 1
1088 1122 58 547 0 0 Normal 1
1053 1133 64 606 0 0 Normal 1
919 998 56 523 0 0 Normal 1
1049 1000 59 545 0 0 Normal 1
926 1032 48 557 0 0 Normal 1
867 901 50 0 0 normal 1
1203 54 0 0 NORMAL 1
953 49 722 0 0 normal 1
993 984 693 0 0 normal 1
931 976 46 568 0 0 NORMAL 1
1040 49 609 0 0 normal 1
947 1024 54 0 0 normal 1
918 928 586 0 0 normal 1
920 38 0 0 normal 1
967 1127 55 0 0 normal 1
965 1079 48 519 0 0 normal 1
983 987 49 569 0 0 normal 1
900 953 49 512 0 0 NORMAL 1
919 1061 45 563 0 0 NORMAL 1
1011 985 55 442 0 0 NORMAL 1
997 1007 47 521 0 0 Normal 1
968 1031 49 577 0 0 Normal 1
955 47 0 0 Normal 1
892 985 44 610 0 0 Normal 1
970 1089 54 652 0 0 Normal 1
1068 1096 52 482 0 0 Normal 1
940 974 49 0 0 Normal 1
965 1132 54 562 0 0 Normal 1
948 1133 65 596 0 0 Normal 1
893 940 51 525 0 0 Normal 1
967 1083 52 565 0 0 Normal 1
953 1024 573 0 0 Normal 1
868 941 53 0 0 normal 1
50 0 0 NORMAL 1
993 47 721 0 0 normal 1
990 827 699 0 0 normal 1
982 1026 49 553 0 0 NORMAL 1
1107 47 588 0 0 normal 1




896 960 0 0 normal 1
922 37 0 0 normal 1
978 1111 54 554 0 0 normal 1
959 1113 47 511 0 0 normal 1
979 998 48 576 0 0 normal 1
941 941 51 533 0 0 NORMAL 1
937 1055 48 578 0 0 NORMAL 1
961 1063 50 500 0 0 NORMAL 1
973 1064 46 522 0 0 Normal 1
998 1049 47 581 0 0 Normal 1
47 0 0 Normal 1
884 46 602 0 0 Normal 1
1009 1043 56 643 0 0 Normal 1
1084 1117 51 549 0 0 Normal 1
945 952 48 0 0 Normal 1
1014 1038 63 589 0 0 Normal 1
976 1035 54 621 0 0 Normal 1
897 988 52 555 0 0 Normal 1
974 1136 51 552 0 0 Normal 1
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1020 1143 49 583 0 0 normal 1
989 1039 48 0 0 normal 1
1046 57 0 0 normal 1
978 1089 48 631 0 0 normal 1
884 1003 49 484 0 0 Normal 1
1005 1324 46 486 0 0 normal 1
985 1057 54 495 0 0 normal 1
1122 1178 53 555 0 0 normal 1
1072 1147 54 439 0 0 NORMAL 1
955 975 50 444 0 0 NORMAL 1
932 997 50 570 0 0 normal 1
1037 1025 45 676 0 0 NORMAL 1
1004 1085 52 478 0 0 normal 1
1014 1041 50 579 0 0 normal 1
984 1087 54 522 0 0 NORMAL 1
982 1053 50 0 0 NORMAL 1
917 1189 51 539 0 0 NORMAL 1
999 1109 51 571 0 0 normal 1
916 979 47 448 0 0 normal 1
948 999 50 0 0 NORMAL 1
975 1035 49 482 0 0 NORMAL 1
965 1074 53 521 0 0 normal 1
982 1021 50 0 0 NORMAL 1
777 1152 59 429 0 0 NORMAL 1
971 969 59 523 0 0 normal 1
995 1052 49 431 0 0 normal 1
987 1027 64 470 0 0 normal 1
987 1147 52 615 0 0 normal 1
983 1078 50 0 0 normal 1
1082 56 0 0 normal 1
1039 1125 51 626 0 0 normal 1
1042 1165 57 433 0 0 normal 1
1045 1189 55 422 0 0 NORMAL 1
956 1040 50 458 0 0 normal 1
956 1088 47 637 0 0 NORMAL 1
1046 1117 56 456 0 0 normal 1
1311 1219 60 0 0 NORMAL 1
992 1108 59 538 0 0 NORMAL 1
984 1022 49 490 0 0 NORMAL 1
951 1007 48 0 0 NORMAL 1
1029 979 53 526 0 0 normal 1
1023 1054 52 0 0 NORMAL 1
1040 1036 56 509 0 0 normal 1
1114 1103 50 391 0 0 normal 1
980 1136 49 605 0 0 normal 1
988 1037 52 0 0 normal 1
1090 56 0 0 normal 1
940 1031 52 520 0 0 normal 1
1053 1198 61 437 0 0 NORMAL 1
942 988 50 571 0 0 normal 1
1064 1143 53 550 0 0 normal 1
1184 1168 56 0 0 NORMAL 1
1068 1118 64 0 0 NORMAL 1
961 1011 46 524 0 0 NORMAL 1
1070 1151 66 420 0 0 NORMAL 1
944 973 48 0 0 NORMAL 1
1016 1077 53 0 0 NORMAL 1
1014 978 56 526 0 0 normal 1
970 1086 52 447 0 0 normal 1
990 1140 51 835 0 0 normal 1
1104 53 0 0 normal 1
984 1027 50 530 0 0 normal 1
1099 1157 53 533 0 0 normal 1
937 1137 49 529 0 0 normal 1
1011 1088 51 448 0 0 NORMAL 1
965 1029 49 578 0 0 normal 1
979 1387 56 376 0 0 NORMAL 1
1076 1058 58 0 0 NORMAL 1
1046 1093 56 0 0 NORMAL 1
934 1189 51 505 0 0 NORMAL 1
975 1078 50 459 0 0 NORMAL 1
1044 1167 60 418 0 0 NORMAL 1
1012 1124 57 527 0 0 NORMAL 1
1035 1022 57 526 0 0 normal 1
1066 1183 53 1159 0 0 normal 1
1019 1089 54 473 0 0 normal 1
971 1059 54 463 0 0 normal 1
946 1041 50 514 0 0 normal 1
993 1066 49 413 0 0 normal 1
1040 1105 56 527 0 0 normal 1
1054 1133 49 562 0 0 normal 1
1007 1139 51 462 0 0 NORMAL 1
1014 918 48 398 0 0 NORMAL 1
997 1110 57 426 0 0 NORMAL 1
1074 1052 64 0 0 NORMAL 1
929 1098 54 556 0 0 NORMAL 1
993 1092 52 0 0 NORMAL 1
926 1061 52 549 0 0 NORMAL 1
1021 1069 50 580 0 0 NORMAL 1
950 1013 49 461 0 0 NORMAL 1
1045 1270 51 431 0 0 NORMAL 1
1001 1104 49 519 0 0 NORMAL 1
1035 1255 53 463 0 0 normal 1
1005 1002 55 520 0 0 normal 1
972 1070 49 486 0 0 normal 1
975 1059 52 785 0 0 normal 1
953 1029 50 0 0 normal 1
1021 1119 53 499 0 0 normal 1
905 1012 46 514 0 0 normal 1
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934 1315 48 446 0 0 normal 1
987 1050 53 511 0 0 normal 1
1044 1191 50 560 0 0 normal 1
994 1107 53 454 0 0 NORMAL 1
997 1046 54 435 0 0 NORMAL 1
956 1057 45 647 0 0 normal 1
1022 1031 51 478 0 0 NORMAL 1
1051 1005 58 0 0 NORMAL 1
948 991 56 539 0 0 NORMAL 1
983 1064 55 0 0 NORMAL 1
946 1020 47 558 0 0 NORMAL 1
992 1069 50 572 0 0 NORMAL 1
910 969 51 487 0 0 NORMAL 1
1012 1094 51 439 0 0 NORMAL 1
951 1087 57 510 0 0 NORMAL 1
875 1251 52 502 0 0 NORMAL 1
963 1020 50 529 0 0 normal 1
1003 1084 51 0 0 NORMAL 1
844 986 54 443 0 0 normal 1
928 1042 50 424 0 0 NORMAL 1
983 972 57 518 0 0 normal 1
1003 1035 51 480 0 0 normal 1
1045 48 0 0 normal 1
947 1221 46 633 0 0 normal 1
1022 1060 47 444 0 0 normal 1
988 1025 55 497 0 0 normal 1
901 972 50 584 0 0 normal 1
914 1038 49 636 0 0 NORMAL 1
978 1110 57 465 0 0 normal1 1
1028 1045 60 511 0 0 NORMAL 1
978 974 48 0 0 NORMAL 1
978 980 54 562 0 0 normal 1
1005 1057 51 0 0 NORMAL 1
1045 46 0 0 normal 1
997 1042 50 637 0 0 normal 1
1011 1109 50 435 0 0 normal 1
921 997 50 581 0 0 normal 1
952 1028 42 638 0 0 NORMAL 1
1051 1191 62 437 0 0 normal 1
1055 1134 62 519 0 0 NORMAL 1
951 1035 51 0 0 NORMAL 1
1004 1040 54 565 0 0 normal 1
963 1029 50 0 0 NORMAL 1
1071 44 0 0 normal 1
989 1043 50 620 0 0 normal 1
999 1048 47 476 0 0 normal 1
1075 1189 59 449 0 0 NORMAL 1
955 1015 48 587 0 0 normal 1
1039 1125 58 399 0 0 normal 1
923 975 48 0 0 NORMAL 1
1012 1052 52 0 0 NORMAL 1
1041 991 53 535 0 0 normal 1
929 1044 45 487 0 0 normal 1
1061 1188 55 483 0 0 normal 1
1014 1160 51 546 0 0 NORMAL 1
962 1012 50 583 0 0 normal 1
997 1073 62 0 0 NORMAL 1
972 1062 52 0 0 NORMAL 1
960 1037 47 587 0 0 normal 1
913 1086 44 478 0 0 NORMAL 1
1007 1121 59 428 0 0 NORMAL 1
940 1007 48 0 0 NORMAL 1
1012 1058 47 495 0 0 NORMAL 1
1081 991 52 545 0 0 normal 1
936 989 39 457 0 0 normal 1
980 998 48 434 0 0 normal 1
1040 1133 55 535 0 0 normal 1
1028 1125 48 578 0 0 normal 1
1032 1115 49 453 0 0 NORMAL 1
905 984 51 480 0 0 NORMAL 1
1226 1001 55 497 0 0 NORMAL 1
936 1054 56 0 0 NORMAL 1
1048 1140 57 579 0 0 NORMAL 1
938 967 48 0 0 NORMAL 1
941 1047 50 581 0 0 normal 1
979 1056 50 581 0 0 NORMAL 1
919 1039 53 491 0 0 NORMAL 1
946 1069 53 442 0 0 NORMAL 1
933 989 53 0 0 NORMAL 1
1006 1063 43 534 0 0 NORMAL 1
995 1182 51 441 0 0 normal 1
965 970 52 568 0 0 normal 1
973 1192 51 588 0 0 normal 1
952 1145 46 458 0 0 normal 1
1003 1034 57 488 0 0 normal 1
1204 1043 49 459 0 0 NORMAL 1
916 1007 48 609 0 0 NORMAL 1
980 1063 56 470 0 0 normal 1
977 1055 75 0 0 NORMAL 1
972 1026 55 535 0 0 NORMAL 1
948 1034 52 0 0 NORMAL 1
958 915 51 558 0 0 normal 1
958 1052 54 578 0 0 NORMAL 1
925 1082 55 495 0 0 NORMAL 1
952 1030 54 436 0 0 NORMAL 1
989 1058 56 526 0 0 NORMAL 1
946 943 47 0 0 NORMAL 1
969 1001 51 563 0 0 normal 1
939 1004 49 0 0 NORMAL 1
988 1156 54 455 0 0 normal 1
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984 1062 45 440 0 0 NORMAL 1
1028 0 0 normal 1
986 1149 51 614 0 0 normal 1
953 1057 48 450 0 0 normal 1
887 917 53 575 0 0 normal 1
938 987 49 610 0 0 NORMAL 1
1126 1166 70 491 0 0 NORMAL 1
978 1070 51 0 0 NORMAL 1
926 1055 51 582 0 0 normal 1
923 1069 53 0 0 NORMAL 1
1101 0 0 normal 1
1029 1169 49 629 0 0 normal 1
1084 1176 56 415 0 0 normal 1
922 956 53 569 0 0 normal 1
1159 1166 72 516 0 0 NORMAL 1
936 1004 48 0 0 NORMAL 1
1075 1110 53 558 0 0 normal 1
906 52 1074 0 0 NORMAL 1
903 1009 522 0 0 normal 1
983 1113 47 465 0 0 normal 1
1032 1123 52 488 0 0 normal 1
1002 1159 52 570 0 0 normal 1
961 974 52 567 0 0 normal 1
1054 1118 0 0 NORMAL 1
918 1051 499 0 0 NORMAL 1
994 1113 49 426 0 0 NORMAL 1
929 1085 47 0 0 normal 1
825 1057 47 490 0 0 NORMAL 1
965 1037 48 536 0 0 normal 1
876 1097 56 443 0 0 normal 1
1021 1087 52 498 0 0 normal 1
1013 1080 57 432 0 0 NORMAL 1
948 966 54 568 0 0 normal 1
1041 1020 43 289 0 0 NORMAL 1
1035 1034 0 0 NORMAL 1
1179 1229 75 498 0 0 NORMAL 1
1118 1005 68 0 0 NORMAL 1
921 1008 477 0 0 NORMAL 1
983 1119 51 412 0 0 NORMAL 1
929 1058 0 0 NORMAL 1
1073 1171 60 440 0 0 normal 1
986 1034 48 455 0 0 NORMAL 1
1288 0 0 normal 1
1122 61 600 0 0 normal 1
1064 1277 48 390 0 0 normal 1
1009 1093 52 588 0 0 NORMAL 1
1197 1179 478 0 0 NORMAL 1
0 0 NORMAL 1
1089 59 0 0 normal 1
1096 1042 70 0 0 NORMAL 1
1086 53 0 0 normal 1
1080 0 0 normal 1
1210 55 632 0 0 normal 1
1011 1119 53 446 0 0 normal 1
1154 60 503 0 0 normal 1
924 996 50 590 0 0 normal 1
939 996 45 667 0 0 NORMAL 1
1038 1141 53 479 0 0 NORMAL 1
1055 1030 51 645 0 0 normal 1
1040 1100 58 0 0 NORMAL 1
969 1018 53 547 0 0 NORMAL 1
954 1047 52 455 0 0 normal 1
914 972 46 0 0 NORMAL 1
1014 1112 50 538 0 0 normal 1
968 983 56 0 0 NORMAL 1
948 1023 80 427 0 0 NORMAL 1
1081 0 0 normal 1
1140 49 645 0 0 normal 1
973 1050 61 401 0 0 normal 1
1123 59 540 0 0 normal 1
898 952 52 593 0 0 normal 1
876 1001 46 639 0 0 NORMAL 1
961 1119 52 463 0 0 NORMAL 1
1022 1105 59 517 0 0 NORMAL 1
906 964 53 0 0 NORMAL 1
1017 1085 51 540 0 0 normal 1
1007 1027 55 0 0 NORMAL 1
1071 0 0 normal 1
983 1337 49 0 0 normal 1
1155 56 507 0 0 normal 1
1170 48 562 0 0 normal 1
1000 1149 58 440 0 0 NORMAL 1
964 1031 55 571 0 0 normal 1
1059 1086 62 0 0 NORMAL 1
1088 1068 62 0 0 NORMAL 1
985 1090 52 824 0 0 NORMAL 1
955 1085 51 468 0 0 NORMAL 1
1000 1096 56 441 0 0 NORMAL 1
1035 1076 54 500 0 0 NORMAL 1
1101 1263 61 431 0 0 normal 1
1018 1019 51 518 0 0 normal 1
950 1348 48 0 0 normal 1
1024 1132 70 516 0 0 normal 1
1213 58 583 0 0 normal 1
1166 52 593 0 0 normal 1
960 1034 46 0 0 NORMAL 1
951 991 56 587 0 0 normal 1
1088 1141 59 0 0 NORMAL 1
1031 1129 52 0 0 NORMAL 1
953 1094 56 502 0 0 NORMAL 1
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984 1118 52 461 0 0 NORMAL 1
972 1042 47 0 0 NORMAL 1
1009 1100 52 490 0 0 NORMAL 1
1039 1183 61 448 0 0 normal 1
1022 1008 54 561 0 0 normal 1
1130 0 0 normal 1
1161 1280 66 369 0 0 normal 1
1107 1235 63 447 0 0 NORMAL 1
943 1009 52 592 0 0 normal 1
1006 1111 60 571 0 0 NORMAL 1
1111 1144 57 384 0 0 NORMAL 1
1099 1079 55 548 0 0 normal 1
1185 63 0 0 NORMAL 1
1044 1092 62 506 0 0 NORMAL 1
1068 1135 60 0 0 NORMAL 1
935 980 52 0 0 NORMAL 1
1002 1066 60 556 0 0 NORMAL 1
999 1117 51 456 0 0 normal 1
56 558 0 0 normal 1
954 1016 53 583 0 0 normal 1
1047 1029 69 528 0 0 NORMAL 1
1048 1108 70 490 0 0 NORMAL 1
969 971 49 0 0 NORMAL 1
985 1063 61 0 0 NORMAL 1
1067 0 0 normal 1
1129 1079 59 462 0 0 normal 1
1105 54 499 0 0 normal 1
920 991 52 470 0 0 NORMAL 1
962 59 489 0 0 NORMAL 1
1008 1087 52 491 0 0 NORMAL 1
1074 52 0 0 NORMAL 1
1055 1078 65 508 0 0 NORMAL 1
1051 1108 53 0 0 NORMAL 1
954 1071 55 570 0 0 NORMAL 1
979 1055 47 577 0 0 normal 1
932 1067 49 489 0 0 NORMAL 1
1003 1070 54 432 0 0 NORMAL 1
983 1108 53 520 0 0 NORMAL 1
1012 1034 48 521 0 0 NORMAL 1
996 1067 54 583 0 0 normal 1
962 1034 51 0 0 NORMAL 1
1077 1035 57 477 0 0 normal 1
963 1089 47 454 0 0 NORMAL 1
49 619 0 0 normal 1
1039 1119 55 468 0 0 normal 1
1099 56 500 0 0 normal 1
962 995 56 575 0 0 normal 1
1091 58 0 0 NORMAL 1
970 1072 59 502 0 0 NORMAL 1
972 1132 73 466 0 0 NORMAL 1
1016 1077 54 419 0 0 NORMAL 1
993 1117 51 544 0 0 NORMAL 1
883 919 55 0 0 NORMAL 1
1069 1180 52 554 0 0 normal 1
965 1058 52 0 0 NORMAL 1
1074 1082 64 503 0 0 normal 1
994 1103 52 468 0 0 NORMAL 1
967 1018 46 381 0 0 NORMAL 1
1043 1058 52 402 0 0 NORMAL 1
948 1050 51 424 0 0 NORMAL 1
949 952 48 437 0 0 NORMAL 1
948 937 50 445 0 0 NORMAL 1
992 1048 53 439 0 0 NORMAL 1
878 912 51 444 0 0 NORMAL 1
987 1168 53 529 0 0 NORMAL 1
999 1055 55 448 0 0 NORMAL 1
989 1082 52 0 0 NORMAL 1
992 1089 46 597 0 1 hibernating myocardium 2
1029 1162 54 620 0 1 hibernating myocardium 2
972 1139 64 0 1 hibernating myocardium 2
987 1124 50 551 0 1 Hibernating myocardium 2
918 1036 58 445 0 1 hibernating myocadium 2
958 1004 56 403 0 2 Hibernating myocardum LAD & RCA territory 2
1135 1085 52 500 0 1 hibernating myocardium 2
1066 1180 50 617 0 1 hibernating myocardum 2
1161 1151 76 409 0 1 Hibernating myocardium 2
953 1088 62 455 0 1 hibernating myocadium 2
1136 1088 49 327 0 1 hibernating myocardium 2
1107 1127 53 504 0 1 hibernating myocardium 2
951 1106 52 474 0 1 Hibernating myocardium 2
959 1090 55 503 0 1 hibernating myocadium 2
1103 1129 61 586 0 1 hibernating myocardium 2
1028 1161 53 461 0 1 hibernating myocardium 2
967 1100 49 499 0 1 hibernating myocardium 2
1104 1080 54 341 0 1 hibernating myocardium 2
993 1063 47 569 0 1 Hibernating myocardium 2
1020 1059 49 493 0 1 Hibernating myocardium 2
984 1118 60 484 0 1 hibernating myocadium 2
1028 1116 49 595 0 1 hibernating myocardium 2
1153 1180 63 428 0 1 hibernating myocardium 2
1004 1043 49 590 0 1 Hibernating myocardium 2
1023 1172 57 613 0 1 hibernating myocardium 2
959 917 51 487 0 1 Hibernating myocardium 2
944 1079 57 515 0 1 hibernating myocadium 2
1007 1099 52 599 0 1 hibernating myocardium 2
1106 1221 57 484 0 1 hibernating myocardium 2
1091 1126 58 555 0 1 hibernating myocardium 2
1201 1115 57 617 0 1 HIBERNATING MYOCARDIUM 2
979 1015 51 589 0 1 Hibernating myocardium 2
992 1173 58 619 0 1 hibernating myocardium 2
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964 1110 49 517 0 1 Hibernating myocardium 2
928 1051 55 445 0 1 hibernating myocadium 2
992 1048 52 609 0 1 hibernating myocardium 2
1035 1040 61 361 0 0 normal 2
1054 1216 54 638 0 1 HIBERNATING MYOCARDIUM 2
976 1056 48 524 0 1 Hibernating myocardium 2
945 1009 48 618 0 1 hibernating myocardium 2
1063 1101 58 490 0 1 hibernating myocardium 2
1004 1121 53 497 0 2 hibernating myocardium 2
1106 1183 56 640 0 1 HIBERNATING MYOCARDIUM 2
1071 1163 53 485 0 2 hibernating myocardium 2
983 1082 50 318 0 1 hibernating myocardium 2
1029 1166 50 457 0 1 hibernating myocardium 2
978 1048 51 556 0 1 Hibernating myocardium 2
939 1023 49 496 0 1 Hibernating myocardium 2
1040 49 468 0 1 hibernating myocadium 2
958 1091 49 644 0 1 hibernating myocardium 2
1169 1082 51 405 0 1 hibernating myocardium 2
1071 1159 50 403 0 1 hibernating myocardium 2
987 1063 52 582 0 1 Hibernating myocardium 2
1121 619 0 1 hibernating myocardium 2
935 932 50 518 0 1 Hibernating myocardium 2
926 1069 45 507 0 1 hibernating myocadium 2
994 1056 44 650 0 1 hibernating myocardium 2
1018 1152 55 523 0 1 hibernating myocardium 2
1069 1115 65 359 0 1 hibernating myocardium 2
972 1074 58 439 0 1 hibernating myocardium 2
1123 1228 51 645 0 1 HIBERNATING MYOCARDIUM 2
967 1032 52 588 0 1 Hibernating myocardium 2
1117 608 0 1 hibernating myocardium 2
931 1040 47 534 0 1 Hibernating myocardium 2
946 1019 53 565 0 1 hibernating myocadium 2
955 1061 45 627 0 1 hibernating myocardium 2
997 1056 51 424 0 1 hibernating myocardium 2
967 1053 58 481 0 2 hibernating myocardium 2
861 1096 54 661 0 1 HIBERNATING MYOCARDIUM 2
982 1054 51 587 0 1 hibernating myocardium 2
992 1082 54 511 0 1 hibernating myocardium 2
1053 1145 55 479 0 1 hibernating myocardium 2
1074 1153 55 518 0 2 hibernating myocardium 2
1042 1158 59 654 0 1 HIBERNATING MYOCARDIUM 2
1159 620 0 1 hibernating myocardium 2
1012 1109 54 532 0 1 hibernating myocardium 2
1007 1127 53 455 0 1 hibernating myocardium 2
1003 1179 618 0 1 hibernating myocardium 2
8148 1113 58 539 0 1 hibernating myocadium 2
987 960 47 647 0 1 hibernating myocadium 2
1014 1118 49 518 0 1 hibernating myocardium 2
1011 1068 43 478 0 1 hibernating myocardium 2
1057 1079 50 401 0 1 hibernating myocardium 2
881 1159 50 678 0 1 HIBERNATING MYOCARDIUM 2
936 1006 54 546 0 1 hibernating myocardium 2
1011 1064 53 625 0 1 hibernating myocardium 2
1040 1107 53 548 0 1 hibernating myocardium 2
1044 996 62 402 0 1 hibernating myocardium 2
1239 63 583 0 4 hibernating myocardium 2
1047 1156 65 528 0 1 hibernating myocardium 2
1494 409 0 1 hibernating myocardium 2
1024 1060 52 653 0 1 HIBERNATING MYOCARDIUM 2
1086 1119 53 578 0 1 hibernating myocardium 2
933 1066 53 540 0 1 Hibernating myocardium 2
1086 1179 53 454 0 1 hibernating myocardium 2
980 1032 51 584 0 1 hibernating myocardium 2
1087 1136 52 554 0 1 hibernating mycardium 2
1147 1146 52 676 0 1 HIBERNATING MYOCARDIUM 2
888 1050 56 533 0 1 hibernating myocardium 2
1165 1202 60 497 0 1 hibernating myocardium 2
979 945 49 478 0 1 hibernating myocardium 2
1026 1103 51 607 0 1 hibernating myocardium 2
950 1044 51 517 0 1 hibernating myocardium 2
1025 1423 48 506 0 1 hibernating myocadium 2
999 1099 57 610 0 1 hibernating myocardium 2
1030 1076 49 422 0 1 hibernating myocardium 2
1049 1112 50 543 0 1 hibernating myocardium 2
959 1374 49 516 0 1 hibernating myocadium 2
1007 1063 52 590 0 1 hibernating myocardium 2
1163 1145 51 520 0 1 hibernating myocardium 2
1081 1153 51 434 0 1 hibernating myocardium 2
1043 1139 46 363 0 1 hibernating myocardium 2
1159 57 489 0 2 hibernating myocardium 2
1188 1128 63 0 1 HIBERNATING MYOCARDIUM 2
921 1121 48 491 0 1 hibernating myocardium 2
1095 1081 48 533 0 1 hibernating myocadium 2
943 1100 55 484 0 1 hibernating myocardium 2
1161 55 508 0 2 hiberrnating myocardium 2
1040 1110 54 515 0 1 hibernating myocardium 2
54 605 0 2 Hibernating myocardium 2
1050 1124 54 437 0 1 hibernating myocardium 2
1008 1039 63 644 0 1 HIBERNATING MYOCARDIUM 2
999 1123 55 539 0 1 hibernating myocardium 2
1021 1106 56 633 0 1 hibernating myocardium 2
972 1066 45 546 0 1 hibernating myocardium 2
973 1043 54 504 0 1 hibernating myocadium 2
962 1059 52 622 0 1 hibernating myocardium 2
1022 1096 54 422 0 2 hibernating myocardium 2
1082 1059 67 424 0 1 hibernating myocardium 2
1029 1121 64 645 0 1 hibernating myocardium 2
976 1063 51 620 0 1 hibernating myocardium 2
1024 1078 52 450 0 2 hibernating myocardium 2
1148 1151 64 411 0 1 hibernating myocardium 2
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1050 1102 50 391 0 2 Hibernating myocardum LAD & RCA territory 2
1003 1087 50 402 0 2 Hibernating myocardum LAD & RCA territory 2
1001 1101 49 427 0 2 Hibernating myocardum LAD & RCA territory 2
924 935 51 416 0 2 Hibernating myocardum LAD & RCA territory 2
917 1022 51 401 0 2 hibernating myocardium 2
945 1068 52 410 0 2 hibernating myocardium 2
1011 1109 50 396 0 2 hibernating myocardium 2
1016 1102 48 391 0 2 hibernating myocardium 2
1055 1106 51 438 0 2 hibernating myocardium 2
1019 1076 53 436 0 2 hibernating myocardium 2
951 1037 52 402 0 2 hibernating myocardium 2
1004 1031 52 422 0 2 hibernating myocardium 2
987 1042 50 420 0 2 hibernating myocardium 2
1009 1104 50 423 0 2 hibernating myocardium 2
956 1127 54 424 0 2 hibernating myocardium 2
1017 1073 48 417 0 2 hibernating myocardium 2
1030 1120 49 432 0 2 hibernating myocardium 2
1124 1193 60 468 1 1 <25% subendocardial infarct (FOCAL AREA) 3
1031 1299 60 606 1 1 < 25% subendocardial infarct 3
1067 1162 53 533 1 3 <25% sub endocardial viable infarct LAD TERRITORY3
1000 1143 51 635 1 1 <25% sub endocardial infarct (partly extending) 3
1082 1196 51 614 1 1 < 25% viable infarct LAD TERRITORY 3
1030 1403 69 591 1 1 < 25% subendocardial infarct 3
1009 1131 59 634 1 1 < 25% subendocardial infarct (patchy) 3
1064 1239 55 459 1 0 <25% sub endocardial infarct 3
1003 1039 51 1 1 < 25 % sub endocardial infarct 3
1136 608 1 1 <25% subendocardial infarct 3
1086 1224 54 635 1 1 < 25% VIABLE LAD INFARCT 3
1169 592 1 1 <25% subendocardial infarct 3
1023 1217 53 437 1 0 <25% subendocardial infarct 3
960 1054 51 652 1 1 < 25% sub endo cardial infarct 3
986 999 54 472 1 1 < 25% sub endocardial enhancement 3
943 964 49 491 1 1 < 25% sub endocardial enhancement 3
976 1089 51 1 1 < 25 % subendocardial infarct 3
1089 52 1 1 <25% sub endocardial infarct 3
53 619 1 1 <25 % sub endocardial infarct 3
1069 1163 66 606 1 1 < 25% sub endocardial infarct 3
1091 54 1 1 <25% subendocardial infarct 3
1218 1156 59 1 1 <25% VIABLE INFARCT LAD TERRITORY 3
1102 1124 72 623 1 1 < 25% sub endocardial infarct 3
942 1033 56 468 2 2 < 50%  VIABLE INFARCT LAD TERRITORY 4
943 1076 56 354 2 1 < 50% sub endocardial infarct 4
1057 1109 51 461 2 1 <50% infarct (partly extending) 4
984 1078 53 485 2 1 < 50 % infarct 4
1003 1091 52 347 2 1 < 50% sub endocardial infarct 4
1036 1125 47 488 2 1 <50% INFARCT 4
963 1066 48 483 2 3 <50% Viable LAD TERRITORY INFARCT 4
1005 1071 49 550 2 1 <50% VIABLE RCA INFARCT 4
1048 1061 56 2 1 <50% VIABLE CX/ RCA INFARCT 4
951 1043 48 572 2 1 < 50%  infarct 4
985 1088 61 2 1 <50% VIABLE CX/ RCA INFARCT 4
945 996 48 584 2 2 < 50%  infarct 4
980 1079 63 2 1 <50% VIABLE CX/ RCA INFARCT (partly extending)4
892 976 52 432 2 2 <50% subendocardial infarct 4
917 1022 52 400 2 2 < 50 % infarct 4
1039 1099 60 461 2 2 <50% Viable LAD territory infarct 4
969 1104 53 453 2 2 < 50%  INFARCT IN LAD TERRITORY 4
1006 1068 54 499 2 2 <50% viable  LAD infarct 4
940 1072 51 422 2 2 < 50 % infarct 4
1147 1210 64 443 2 2 < 50% Viable LAD territory infarct 4
1035 1160 54 457 2 1 <50% VIABLE INFARCT LAD TERRITORY MID CAVITY4
988 1118 51 466 2 2 <50%  INFARCT IN LAD TERRITORY 4
1067 1137 55 430 3 1 <50% infarct 4
49 1079 47 2 1 <50 %  infarct 4
996 1035 50 406 3 1 < 50 % infarct 4
1081 1173 60 436 2 2 <50% Viable LAD territory infarct 4
992 1076 49 467 2 1 <50% VIABLE INFARCT LAD TERRITORY MID CAVITY4
986 1117 48 487 2 2 <50% INFARCT IN LAD TERRITORY 4
1065 1127 51 489 2 1 <50% infarct LAD 4
1110 1116 50 478 3 1 <50% infarct 4
1110 557 2 1 <50% infarct (patchy) 4
988 1111 47 538 2 1 <50% Viable infarct RCA TERRITORY 4
1061 1176 53 469 2 1 <50% VIABLE RCA INFARCT 4
1002 1037 53 442 2 1 <50%  infarct 4
977 1050 51 593 2 1 < 50%  infarct 4
915 973 43 400 2 2 < 50 % infarct 4
885 972 51 571 2 1 <50% infarct 4
1193 961 55 533 2 1 < 50% infarct (partly extending) 4
933 1056 53 506 2 2 <50% infarct 4
1045 1230 60 407 3 1 <50% infarct(partly extending) 4
916 1114 56 548 2 1 26 to 50 % infarct 4
1226 1304 52 515 2 1 < 50% infarction (partly extending) 4
1073 958 48 466 2 1 < 50% infarct 4
948 1230 584 2 1 <50% infarct 4
899 1143 48 2 2 < 50 % infarct 4
820 998 53 490 3 2 < 50% VIABLE INFARCT LAD TERRITORY 4
1024 1024 50 502 2 2 <50% LAD infarct 4
985 1175 63 624 2 1 <50% infarct 4
987 1077 48 558 2 3 <50% viable RCA INFARCT 4
1074 1161 54 454 2 1 < 50% VIABLE RCA INFARCT 4
1010 1085 45 2 1 <50% VIABLE CX/ RCA INFARCT 4
993 1190 59 636 2 1 <50% infarct 4
1058 1068 60 2 2 < 50 % infarct 4
974 1030 47 421 3 1 < 50 % infarct 4
1003 1129 49 559 2 3 <50% viable LAD INFARCT 4
1026 1119 54 396 3 2 < 50 % infarct 4
1078 1038 54 550 2 1 <50% LAD INFARCT 4
977 1153 69 424 2 1 <50% infarct 4
967 1001 47 2 2 <50% infarct 4
993 995 52 574 2 1 < 50%  infarct 4
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1034 963 48 2 1 <50% VIABLE CX/ RCA INFARCT 4
965 992 52 522 2 1 <50% infarct 4
917 1038 51 475 2 2 <50% sub endocardial  infarct 4
938 964 54 535 3 1 <50% infarct 4
957 1103 51 502 3 2 <50% transmural infarct 4
1009 1055 67 340 3 1 <75% infarct 5
1001 1012 47 231 3 1 <75% Ischemic cardiomyopathy with non viable infarction LAD & RCA5
1148 1225 61 395 3 1 <75% Ischemic cardiomyopathy with non viable infarction LAD & RCA5
957 1078 46 3 2 < 75 % infarct 5
977 1091 50 526 3 2 <75% transmural infarct 5
1045 1105 54 3 2 <75% infarct 5
951 49 3 2 < 75 %  infarct 5
999 1122 56 586 3 2 <75% transmural infarct 5
1049 1100 53 3 2 <75% infarct 5
1044 1121 48 391 3 2 <75% transmural infarct 5
952 1052 51 3 2 <  75 % infarct 5
1291 1133 60 483 3 2 <75% transmural infarction 5
1126 1188 57 474 3 2 <75% transmural infarction 5
1103 1236 64 403 3 1 <75%  non viable infarction LAD & RCA 5
910 1055 49 3 2 < 75 % transmural infarct 5
1074 46 3 1 <75% infarct 5
1049 1095 50 504 3 2 <75% transmural infarct 5
849 1022 55 3 2 <75 % transmural infarct 5
1101 1115 47 432 3 2 <75% transmural infarct 5
1075 1175 58 422 3 2 < 75% transmural infarct 5
932 1047 48 618 3 1 50 to 75 % infarct (partly extending ) 5
871 894 57 3 2 < 75%  infarct 5
966 950 90 541 3 3 < 75 %  transmural infarct 5
946 1069 57 3 2 < 75 % infarct 5
1143 1228 61 427 3 3 <75% transmural infarct -non viable infarct LAD territory5
671 1108 62 245 3 3 <75% infarct 5
1127 1181 55 412 3 2 <75% transmural infarction 5
931 1103 57 276 3 2 <75%  infarct 5
1059 1147 54 484 3 2 <75% transmural infarction 5
1001 1226 47 3 2 < 75 % infarct 5
967 1221 56 601 3 2 <75% tramural infarct 5
970 1074 52 335 3 2 <75%  infarct 5
919 1059 59 3 2 < 75% infarct 5
938 1205 46 613 3 2 <75% transmural infarct 5
849 1064 55 297 3 2 <75% infarct 5
1059 1136 74 555 3 4 <75 % trans mural infarct 5
1089 1239 58 3 4 < 75 % infarct (partly extending) 5
1095 1593 53 3 3 < 75 % infract 5
1236 1134 55 329 3 2 <75% infarct 5
1102 1124 55 492 3 2 <75% transmural infarction 5
916 910 50 364 4 2 < 75 %  transmural infarct 5
983 1026 61 267 3 2 <75%  infarct 5
1111 1176 57 334 3 2 <75% transmural infarction 5
1092 55 3 2 <75% infarct 5
771 816 68 296 4 2 < 75 %  transmural infarct 5
1092 1173 61 497 3 3 <75% transmural infarct -non viable infarct LAD territory5
1022 1030 51 238 3 2 <75% infarct 5
1160 1106 60 339 3 2 <75% transmural infarction 5
1086 59 3 2 <75% trans mural  infarct 5
1159 45 621 3 2 <75% transmural infarct 5
1086 1165 59 268 3 3 <75% infarct 5
1147 58 3 2 < 75% transmural infarct 5
1158 53 592 3 2 < 75% trans mural infarct 5
1015 1220 60 474 3 3 <75% transmural infarct -non viable infarct LAD territory5
1089 1104 55 289 3 3 <75% infarct 5
966 1024 49 565 3 2 <75% transmural infarct 5
1038 1132 50 483 3 2 <75% NON VIABLE INFARCT LAD TERRITORY 5
965 1137 52 411 3 1 <75% non viable infarction LAD & RCA 5
1098 1229 58 536 3 1 <75% transmural infarction 5
1080 1043 52 3 2 < 75 % trans muralinfarct 5
1071 1229 52 402 3 2 <75% transmural infarction 5
1089 53 3 2 <75% transmural infarct 5
979 1025 56 427 3 2 <75% infarct 5
1195 52 3 2 <75% transmural infarct 5
1095 1083 56 428 3 2 <75% infarct 5
1020 1085 49 444 4 2 > 75% transmural infarct 6
1057 1056 57 4 2 >75% transmural infarct 6
1009 1078 59 390 4 2 >75% non viable transmural infact LAD territory 6
1149 1278 64 380 4 3 >75% Ischemic cardiomyopathy with non viable infarction LAD & RCA6
1084 1151 53 503 4 3 > 75% trans mural infarct 6
970 1163 56 404 4 2 > 75% transmural infarct 6
981 1111 59 4 3 >75% TRANSMURAL INFARCT 6
950 1096 58 303 4 3 > 75% non viable LAD INFARCT 6
1021 1171 70 452 4 4 > 75% NON VIABLE INFARCT LAD 6
1060 1154 56 350 4 2 >75% non viable transmural infact LAD territory 6
1049 1152 53 401 4 3 >75% NON VIABLE INFARCT LAD TERRITORY 6
1032 1131 47 385 4 2 >75% NON VIABLE INFARCT LAD TERRITORY 6
905 1041 66 349 4 2 >75% Trans mural LAD non viable infarct 6
1174 1363 76 323 4 4 >75% transmural infarct with aneursym 6
1043 1126 53 495 4 2 > 75 % trans mural infarct (partly extending) 6
1121 1139 60 400 4 2 > 75% transmural infarct 6
1026 1004 47 462 4 2 > 75% transmural infarct (partly extending) 6
1012 1072 54 427 4 3 > 75% transmural infarct 6
1022 1110 55 484 4 2 >75% transmural infarct 6
976 1094 48 383 4 2 > 75% NON VIABLE LAD infarct (partly extending)6
1016 1149 50 473 4 2 >75% NON VIABLE INFARCT LAD TERRITORY 6
1104 1131 68 391 4 3 >75% non viable infarct RCA territory (partly extending)6
1114 1242 70 271 4 3 >75% transmural infarct 6
1031 1155 64 329 4 2 >75% Trans mural LAD non viable infarct 6
1475 1269 59 323 4 4 > 75% trans mural infarct with aneurysm 6
1066 1364 71 449 4 2 > 75% transmural infarct 6
917 1144 59 361 4 3 > 75% transmural infarct 6
1069 1175 46 620 4 3 > 75% NON VIABLE RCA INFARCT (PARTLY EXTENDING)6
961 1130 60 530 4 2 >75% transmural infarct 6
1110 1261 53 427 4 2 > 75% nonviable RCA infarct 6
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1186 1144 72 450 4 3 >75% non viable infarct RCA trritory 6
1082 1198 61 246 4 3 >75% transmural infarct 6
1169 1344 78 275 4 3 >75% 6
1181 73 4 3 >75% transmural infarct 6
1001 1074 47 668 4 2 > 75% transmural infarct (partly extending) 6
1202 1187 58 615 4 3 > 75% NON VIABLE RCA INFARCT 6
1044 1064 54 428 4 3 >75% non viable infarct RCA territory(partly extending)6
1080 1132 56 230 4 3 >75% transmural infarct 6
1106 1284 60 393 4 3 >75% transmural infarct 6
968 1096 66 422 4 3 >75%  non viable infarction LAD & RCA (partly extending)6
1092 48 4 3 >75% transmural infarct (partly extending) 6
984 951 49 532 4 3 > 75 % trans mural infarct 6
1123 1239 61 416 4 3 > 75% transmural infarct 6
1068 1129 57 395 4 3 > 75 % transmural infarct 6
840 931 55 450 4 2 > 75 %  transmural infarct 6
1019 1019 51 462 4 2 > 75% transmural infarct 6
1007 1005 61 4 2 >75% transmural infarct 6
1108 512 4 2 >75% transmural infarct 6
921 898 75 4 3 >75% TRANSMURAL INFARCT 6
839 915 60 454 4 2 >75% transmural infarct 6
958 1112 56 534 4 3 >75% transmural LAD Infarct 6
918 1064 51 326 4 3 > 75% non viable LAD INFARCT (partly extending)6
1029 1071 63 272 4 2 >75% non viable transmural infact LAD territory 6
915 1105 50 397 4 2 >75% NON VIABLE INFARCT LAD TERRITORY 6
989 1069 64 241 3 2 <75%  infarct 6
664 1071 73 306 4 2 >75% Trans mural LAD non viable infarct(partly extending)6
1267 1258 67 277 4 3 >75% non viable infarction LAD & RCA 6
1234 1267 57 260 4 3 >75%  transmural infarct LAD territory 6
1182 1063 72 404 4 3 >75% transmural LAD territory infarct 6
1005 1151 53 519 4 2 > 75% trans mural infarct 6
1138 1284 63 410 4 3 > 75% transmural infarct 6
1063 1186 56 403 4 3 > 75 % transmural infarct(partly extending) 6
1023 1137 55 435 4 2 > 75% transmural infarct 6
1126 1219 56 4 2 >75% transmural infarct 6
1138 1213 82 4 1 >75% TRANSMURAL INFARCT 6
966 1010 56 366 4 2 >75% transmural infarct 6
1023 1112 50 526 4 3 >75% transmural LAD Infarct 6
980 1168 59 285 4 3 > 75% non viable LAD INFARCT 6
929 1017 54 396 4 4 > 75% NON VIABLE INFARCT LAD 6
1060 1137 60 365 4 2 >75% non viable transmural infact LAD territory 6
1032 1120 55 514 4 2 >75% non viable infrct LAD 6
1031 1060 53 359 4 2 >75% NON VIABLE INFARCT LAD TERRITORY 6
962 1099 60 235 4 3 >75% transmural infarct 6
824 1083 65 313 4 2 >75% Trans mural LAD non viable infarct 6
864 952 52 252 4 1 Ischemic cardiomyopathy with non viable infarction LAD & RCA6
1027 1084 61 261 4 3 >75% transmural infarct LAD territory 6
1244 1433 84 328 4 3 >75% transmural LAD territory infarct 6
1049 1184 51 540 4 2 > 75 % transmural infarct 6
1089 1248 55 366 4 4 > 75% trans mural infarct with aneurysm 6
1022 1185 51 452 4 3 > 75% transmural infarct 6
1037 996 53 387 4 2 > 75% transmural infarct 6
949 1044 49 636 4 2 > 75% transmural infarct (partly extending) 6
1068 1193 61 411 4 2 > 75% transmural infarct 6
1027 1130 57 4 2 >75% transmural infarct 6
1110 1101 54 507 4 2 >75% transmural infarct 6
1031 1081 51 4 1 >75% TRANSMURAL INFARCT (partly extending) 6
994 1058 52 512 4 2 >75% transmural infarct 6
1038 1145 54 522 4 3 >75% transmural LAD Infarct 6
958 1056 49 384 4 3 > 75% non viable LAD INFARCT (partly extending)6
1058 1082 46 408 4 4 >75% NON VIABLE INFARCT LAD (partly extending)6
1034 1031 55 444 4 2 >75% NON VIABLE INFARCT LAD TERRITORY (partly extending)6
1096 1156 58 358 4 3 >75% non viable infarct RCA territory(partly extending)6
1144 1216 86 274 4 3 >75% transmural infarct 6
944 1109 48 350 4 2 >75% Trans mural LAD non viable infarct 6
1103 1067 60 424 4 3 >75% transmural LAD territory infarct 6
988 1057 49 488 4 2 >75 % trans mural infarct 6
1219 1305 49 323 4 4 >75% trans mural infarct with aneurysm 6
1081 1104 58 487 4 2 > 75% transmural infarct 6
1084 1074 92 451 4 2 > 75% transmural infarct 6
1059 1166 59 339 4 2 > 75% transmural infarct 6
1099 1192 64 638 4 3 > 75% NON VIABLE RCA INFARCT (PARTLY EXTENDING)6
1116 1171 57 539 4 2 >75% transmural infarct 6
1125 1108 73 335 4 3 >75% non viable infarct RCA territory 6
1120 1150 59 280 4 3 >75% transmural infarct 6
1058 1047 47 4 2 >75% TRANSMURAL INFARCT 6
1128 1250 61 277 4 3 >75% non viable infarction LAD & RCA 6
1204 46 4 3 >75% transmural infarct 6
942 1037 47 625 4 2 > 75% transmural infarct (partly extending) 6
1132 1344 58 641 4 3 > 75% NON VIABLE RCA INFARCT 6
1157 1159 60 342 4 3 > 75% non viable infarct RCA territory(partly extending)6
994 1133 55 237 4 3 >75% transmural infarct 6
1018 1068 54 4 2 >75% TRANSMURAL INFARCT 6
1108 1021 53 338 4 3 >75% transmural infarct 6
1022 1111 51 460 4 3 >75% non viable infarction LAD & RCA (partly extending)6
1081 44 4 3 > 75% transmural infarct (partly extending) 6
992 1195 51 561 4 3 > 75% transmural infarct 6
871 1070 54 602 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCX(partly extending)6
984 1041 59 384 3 2 <75%  infarct 6
1069 1057 49 397 4 3 >75% transmural infarct 6
948 866 347 4 3 > 75 % transmuralinfarct 6
1110 1127 71 398 4 3 > 75% transmural infarct 6
1056 1069 59 326 4 3 > 75 % transmural infarct 6
824 928 62 266 4 3 > 75 %  transmural infarct 6
930 1017 54 319 4 2 > 75% transmural infarct 6
982 1074 55 442 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
961 947 4 2 >75% transmural infarct 6
1010 1116 505 4 2 >75% transmural infarct 6
1011 1050 68 4 3 >75% TRANSMURAL INFARCT 6
1066 1143 48 455 4 3 > 75% NON VIABLE INFARCT LAD TERRITORY 6
995 1063 52 445 4 2 >75% trans mural infarct 6
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678 910 53 358 4 3 >75% transmural infarct 6
990 1146 61 456 4 3 >75% non viable LAD infarct 6
917 1046 293 4 3 > 75% non viable LAD INFARCT 6
1038 1062 62 245 4 2 >75% non viable transmural infact LAD territory 6
1056 1053 49 332 4 2 >75%  NON VIABLE INFARCT LAD TERRITORY PART OF LCX6
780 1044 79 349 4 3 >75% Trans mural LAD non viable infarct 6
1264 841 62 278 4 3 >75%  non viable infarction LAD & RCA 6
847 1154 73 255 4 3 >75% transmural infarct LAD territory 6
1403 960 52 330 4 3 >75% transmural LAD territory infarct 6
1052 1262 79 528 4 3 > 75 % transmural infarct 6
838 899 370 4 2 > 75 % trans mural infarct 6
1091 1320 60 481 4 3 > 75% transmural infarct 6
1125 1283 61 396 4 3 > 75 % transmural infarct 6
999 1047 53 276 4 3 > 75 %  transmural infarct 6
1047 1042 62 370 4 2 > 75% transmural infarct 6
1022 1041 49 650 4 2 > 75% transmural infarct (partly extendly) 6
1006 1090 54 440 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1151 1265 64 409 4 3 >75% transmural infarct -non viable infarct LAD territory6
1140 1231 4 2 >75% transmural infarct 6
1011 1192 81 4 3 >75% TRANSMURAL INFARCT 6
1018 1110 52 475 4 3 > 75% NON VIABLE INFARCT LAD TERRITORY 6
1026 1112 58 422 4 3 >75% transmural infarct 6
1026 1142 54 464 4 3 >75% non viable LAD infarct 6
952 1016 299 4 3 > 75% non viable LAD INFARCT 6
984 1111 73 408 4 4 >75% NON VIABLE INFARCT LAD 6
1023 1132 55 257 4 2 >75% non viable transmural infact LAD territory 6
1023 1057 55 410 4 2 >75% NON VIABLE INFARCT LAD TERRITORY 6
1098 1126 67 318 4 3 >75% Trans mural LAD non viable infarct 6
957 1116 52 352 4 3 >75% non viable infarction LAD & RCA 6
1050 982 72 293 4 2 >75% transmural infarct LAD territory 6
1151 1217 67 282 4 3 >75% transmural LAD territory infarct 6
930 1129 54 525 4 2 > 75 % transmural infarct 6
1214 4 3 > 75% transmural infarct 6
1031 1061 49 253 4 3 > 75 %  transmural infarct 6
1035 1166 58 443 4 2 > 75% transmural infarct 6
972 999 39 447 4 2 > 75% transmural infarct 6
982 1066 48 352 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1062 1282 56 594 4 3 >75% NON VIABLE RCA INFARCT 6
1000 1095 65 538 4 3 >75% transmural infarct -non viable infarct LAD territory6
1132 1212 70 526 4 2 >75% transmural infarct 6
1214 1118 53 4 3 >75% TRANSMURAL INFARCT 6
942 1061 47 529 4 3 > 75%  NON VIABLE INFARCT LAD TERRITORY 6
988 1218 52 604 4 3 >75% transmural infarct 6
955 1066 49 555 4 3 >75% non viable LAD infarct 6
1204 1263 62 320 4 3 >75% non viable RCA territory infarct 6
980 53 1174 4 2 >75% TRANSMURAL INFARCT 6
1022 1133 56 404 4 3 >75% Trans mural LAD non viable infarct 6
1061 1201 55 268 4 3 >75% non viable infarction LAD & RCA 6
1117 1006 53 401 4 3 >75% transmural LAD territory infarct 6
1129 4 3 >75% transmural infarct 6
926 871 398 4 2 > 75 % trans mural infarct 6
1007 1248 56 462 4 3 > 75% transmural infarct 6
796 1012 54 335 4 3 > 75 %  transmural infarct 6
972 974 49 473 4 2 > 75% transmural infarct 6
1033 1161 55 407 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1030 1155 601 4 1 > 75% transmural infarct (extending partly) 6
981 1094 50 512 4 3 > 75% NON VIABLE INFARCT LAD TERRITORY 6
823 1070 53 506 4 2 > 75% transmural infarct 6
937 1006 59 519 4 3 >75% transmural infarct (partly extending) 6
925 1044 57 590 4 3 >75% non viable LAD infarct 6
765 1160 42 483 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCX(partly extending)6
1140 974 56 557 4 3 > non viable infarct RCA territory (partly extending)6
985 1119 55 4 2 >75% TRANSMURAL INFARCT(partly extending) 6
1017 1086 51 377 4 3 >75% transmural infarct 6
1213 1186 88 4 4 > 75 % transmural infarct 6
1120 1105 77 332 4 4 > 75 % transmural infarct 6
1111 345 4 4 > 75 %  transmural infarct 6
1013 1115 4 3 > 75% transmural infarct 6
1125 1509 73 479 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1283 1434 52 641 4 3 > 75% NON VIABLE RCA INFARCT 6
1091 1259 65 452 4 3 > 75% transmural infarct -non viable infarct LAD territory6
1170 4 2 >75% transmural infarct 6
4 3 >75% TRANSMURAL INFARCT 6
1163 1327 90 397 4 3 > 75% NON VIABLE INFARCT LAD TERRITORY 6
980 1392 62 471 4 2 >75% Transmural infarct 6
1067 1057 53 445 4 3 >>75% transmural infarct (calcified thrombus with anersym of apex)6
1033 1131 59 402 4 3 >75% non viable LAD infarct 6
1067 1157 48 395 4 4 > 75% non viable LAD INFARCT (BALOONING AT APEX)6
1477 1414 70 391 4 4 >75% NON VIABLE INFARCT LAD 6
1161 1214 71 294 4 4 >75% non viable transmural infact LAD territory APICAL ANEURYSM6
1257 1087 62 367 4 3 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCXSS6
1071 1150 73 390 4 3 >75% Trans mural LAD non viable infarct 6
1048 1159 49 325 4 3 >75% infarct LAD & RCA 6
1324 1358 72 247 4 4 >75% transmural infarct LAD territory 6
1490 1377 66 422 4 3 >75% transmural LAD territory infarct 6
1047 1149 58 561 4 3 > 75 % transmral infarct 6
1178 50 408 4 3 > 75 % transmural infarct 6
1105 1231 60 393 4 3 > 75 % transmural infarct 6
948 1081 49 439 4 2 > 75% transmural infarct 6
1060 1103 54 4 2 >75% transmural infarct 6
1027 1147 59 500 4 3 >75% non viable infarct LAD territory 6
1009 1077 55 300 4 2 >75% non viable transmural infact LAD territory 6
979 1149 61 440 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCXSS6
855 774 56 407 4 2 >75% Trans mural LAD non viable infarct 6
1273 1219 49 237 4 3 >75%  non viable infarction LAD & RCA 6
1165 1129 64 285 4 2 >75% transmural infarct LAD territory 6
1018 1103 52 569 4 3 > 75 % transmural infarct 6
808 1266 58 4 3 > 75 % trans mural infarct 6
1064 67 418 4 3 > 75 % transmural infarct 6
1100 1213 62 345 4 3 > 75 % transmural infarct 6
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938 1058 54 363 4 2 > 75% transmural infarct 6
1096 1140 62 4 2 >75% transmural infarct 6
994 1091 55 569 4 2 >75% transmural infarct 6
982 1014 75 4 3 >75% TRANSMURAL INFARCT 6
993 1120 53 484 4 3 >75% NON VIABLE INFARCT LAD TERRITORY 6
955 1120 61 695 4 2 >75% transmural infarct 6
950 1119 66 381 4 3 >75% non viable infarct LAD territory 6
942 1076 45 336 4 3 > 75% non viable LAD INFARCT 6
956 990 55 411 4 4 > 75%  non viable infarct LAD 6
1101 1229 67 313 4 2 >75% non viable transmural infact LAD territory 6
958 1081 68 335 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCXSS6
806 757 82 387 4 2 >75% Trans mural LAD non viable infarct 6
1144 1302 73 246 4 3 >75% non viable infarction LAD & RCA 6
1178 1146 64 276 4 2 >75% transmural infarct LAD territory 6
574 646 70 260 4 3 >75% transmural infarct 6
1075 1111 65 555 4 2 > 75 % transmural infarct 6
1253 1371 50 329 4 4 > 75% trans mural infarct with aneurysm 6
998 1138 83 453 4 2 >75% transmural infarct 6
1026 1192 54 274 4 3 > 75% transmural infarct 6
1059 1109 52 632 4 3 > 75% NON VIABLE RCA INFARCT 6
1084 1154 62 488 4 2 >75% transmural infarct 6
1109 1189 66 364 4 3 >75% non viable RCA infarct 6
1010 1063 50 4 2 >75% TRANSMURAL INFARCT 6
1195 1306 66 292 4 3 >75% non viable infarction LAD & RCA 6
949 1031 53 478 4 3 >75% transmural infarct 6
981 1056 52 562 4 2 > 75 % transmural infarct 6
1078 4 3 >75% transmural infarct 6
1056 1199 57 441 4 3 > 75 % transmural infarct 6
991 1110 52 424 4 2 > 75% transmural infarct 6
1100 1214 67 464 4 2 > 75% transmural infarct 6
998 1045 55 419 4 3 > 75% transmural infarct 6
1106 1193 52 579 4 3 > 75% NON VIABLE RCA INFARCT 6
1132 1168 70 518 4 2 >75% transmural infarct 6
1089 1157 79 4 3 >75% TRANSMURAL INFARCT 6
893 1062 51 552 4 3 >75% NON VIABLE INFARCT LAD TERRITORY 6
999 1052 53 740 4 3 >75% transmural infarct 6
1017 1128 46 491 4 3 >75% NON VIABLE LAD infarct 6
1089 1160 60 352 4 3 >75% non viable RCA INFARCT 6
971 1006 52 4 2 >75% TRANSMURAL INNFARCT (partly extending)6
1132 1274 55 271 4 3 >75% non viable infarction LAD & RCA 6
1018 1011 56 458 4 3 >75% transmural  infarct 6
1079 54 601 4 2 > 75 % transmural infarct 6
1040 1223 52 477 4 3 > 75 % transmural infarct 6
1075 49 417 4 2 > 75% transmural infarct 6
913 1029 49 286 4 3 > 75% non viable LAD INFARCT 6
1008 1098 50 416 4 4 > 75% NON VIABLE INFARCT LAD 6
1009 1116 48 411 4 2 >75% non viable transmural infact LAD territory 6
1026 1055 57 482 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCX6
1138 1149 72 287 4 3 >75% transmural infarct 6
1054 1135 70 347 4 2 >75% Trans mural LAD non viable infarct 6
1061 1041 55 296 4 2 >75% transmural infarct LAD territory 6
1150 52 619 4 2 > 75 % trans mural infarct 6
1164 4 3 >75% transmural infarct 6
1095 1278 48 419 4 4 >75% trans mural infarct with aneurysm 6
1060 1188 42 459 4 3 > 75 % transmural infarct 6
1119 1247 66 419 4 3 > 75 % transmural infarct 6
967 53 319 4 2 > 75% transmural infarct 6
995 1090 56 375 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1219 1106 56 467 4 3 >75% transmural infarct -non viable infarct LAD territory6
1164 57 4 2 >75% transmural infarct 6
1095 1144 60 4 3 >75% TRANSMURAL INFARCT 6
1000 1132 60 488 4 3 >75% NON VIABLE INFARCT LAD TERRITORY 6
995 1076 54 463 4 3 >75% transmural infarct 6
1113 1138 51 480 4 3 >75% Non viable LAD infarct 6
867 955 50 280 4 3 > 75% non viable LAD INFARCT 6
983 1095 61 404 4 4 >75% NON VIABLE INFARCT LAD 6
1028 1133 55 372 4 2 >75% non viable transmural infact LAD territory 6
1046 1070 59 491 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCX6
1045 1118 64 537 4 3 >75% NON VIABLE RCA INFARCT 6
977 1019 60 260 4 3 >75% transmural infarct 6
1025 1099 68 337 4 3 >75% Trans mural LAD non viable infarct 6
902 1099 43 269 4 3 >75% non viable infarction LAD & RCA 6
1144 1114 66 308 4 2 >75% transmural infarct LAD territory 6
966 961 60 266 4 3 >75% transmural  infarct 6
1327 62 596 4 2 > 75 % transmural infarct (partly extending) 6
986 1208 52 562 4 3 > 75 % transmural infarct (partly extending) 6
970 1500 46 591 4 2 > 75% transmural infarct ( partly extending) 6
848 1101 51 369 4 2 >75% transmural infarct 6
1190 46 605 0 0 > 75 % transmural infarct 6
1354 4 3 >75% transmural infarct 6
928 1028 53 4 2 > 75 % transmural infarct 6
1093 1541 54 423 4 3 > 75 % transmural infarct 6
1089 1150 59 421 4 3 >75% transmural infarct 6
935 991 52 361 3 2 > 75% transmural infarct 6
1013 47 473 4 2 > 75% transmural infarct 6
912 1237 46 498 4 2 > 75% transmural infarct (partly extending) 6
1094 1128 52 499 4 3 > 75% transmural infarct & THROMBUS IN DISTAL LAD TERRITORY6
1127 1199 64 666 4 3 > 75% NON VIABLE RCA INFARCT 6
1103 1267 66 560 4 3 >75% transmural infarct -non viable infarct LAD territory6
1003 1069 54 4 3 >75% TRANSMURAL INFARCT 6
1057 1066 54 543 4 3 >75% NON VIABLE INFARCT LAD TERRITORY 6
1036 1068 57 531 4 2 >75% TRANSMURAL INFARCT 6
887 1065 56 536 4 3 >75% transmural infarct (calcified thrombus with anersym of apex)6
973 1034 50 445 4 3 >75% non viable LAD infarct 6
1093 1099 56 526 4 2 >75% NON VIABLE INFARCT LAD TERRITORY PART OF LCX6
848 1020 56 389 4 2 >75% transmural infarct 6
1005 1072 52 401 4 3 >75% Non viable LAD INFARCT 6
1068 1131 52 430 4 3 >75% Non viable LAD INFARCT 6
1056 1102 53 405 4 3 >75% Non viable LAD INFARCT 6
1161 1306 67 282 4 3 > 75% Non viable LAD INFARCT 6
1039 1111 53 426 4 3 >75% non viable LAD infarct 6
